dacarbazine has been researched along with Hodgkin Disease in 1120 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 138 (12.32) | 18.7374 |
| 1990's | 191 (17.05) | 18.2507 |
| 2000's | 257 (22.95) | 29.6817 |
| 2010's | 384 (34.29) | 24.3611 |
| 2020's | 150 (13.39) | 2.80 |
| Authors | Studies |
|---|---|
| Arcuti, E; Cicinelli, E; Gaudio, F; Laddaga, FE; Masciandaro, P; Masciopinto, P; Musto, P; Nardelli, C; Specchia, G; Vacca, MP | 1 |
| Kusumoto, S | 2 |
| Alba, E; Casanova, M; Chícharo, JR; Díaz, C; Espeso, M; Galvez-Carvajal, L; Medina, Á; Quero, C; Ramos, I; Rueda, A | 1 |
| Izaguirre-Riesgo, A; Menéndez-González, L; Montero-Rodríguez, Á; Orts-Cortés, MI; Tranche-Iparraguirre, S | 1 |
| Abruzzese, E; Botto, B; Buglione, M; Ciccone, G; Evangelista, A; Filippi, AR; Franzone, P; Freilone, R; Frezza, GP; Gioia, DM; Gotti, M; Grapulin, L; Levis, M; Nardella, A; Nassi, L; Pavone, V; Pulsoni, A; Re, A; Ricardi, U; Rigacci, L; Rota-Scalabrini, D; Sacchetti, GM; Santoro, A; Simontacchi, G; Tani, M; Zaja, F; Zanni, M; Zilioli, VR; Zinzani, PL | 1 |
| Borsi, E; Ionita, I; Pescaru, M; Potre, C; Potre, O; Samfireag, M; Sima, A; Tudor, R | 1 |
| Burrows, SR; Doolan, DL; Meehan, MT; Miles, JJ; Wong, Y | 1 |
| Hatanaka, N; Karasuno, T; Kusakabe, S; Sata, H; Yasumi, M | 1 |
| Albano, D; Albano, S; Chianca, V; Costa, A; Cuocolo, R; Faraone, R; Ficola, U; Galia, M; Lagalla, R; Micci, G; Midiri, M; Paratore, R; Patti, C; Tarantino, V; Ugga, L | 1 |
| Arora, R; Bakhshi, S; Biswas, A; Chandra, J; Dinand, V; Jain, S; Kalra, M; Mahajan, A; Mandal, P; Radhakrishnan, V; Seth, R; Sharma, A; Singh, M; Taluja, A; Thulkar, S; Verma, N | 1 |
| Atienza-Cuevas, L; Bernal-Florindo, I; Fernandez-Valle, MDC; Garcia-Rojo, M; Moran-Sanchez, J; Perez-Requena, J; Romero-Garcia, R; Santisteban-Espejo, A | 1 |
| Åkesson, L; Enblad, G; Fohlin, H; Glimelius, B; Glimelius, I; Goldkuhl, C; Lagerlöf, I; Molin, D; Palma, M | 1 |
| Advani, RH; Ahmed, S; Allen, P; Bailey, NA; Bartlett, NL; Bond, DA; Cheson, BD; Evens, AM; Feldman, TA; Hamid, MS; Jang, H; Karmali, R; Kim, S; Maddocks, KJ; Magarelli, G; Malecek, MK; Pagel, JM; Patel, K; Ramchandren, R; Rutherford, SC; Shah, M; Spinner, MA; Stephens, DM; Strouse, C; Tees, MT; Watkins, MP; Yazdy, MS | 1 |
| Hamayel, HF; Odeh, R | 1 |
| Arikoglu, T; Balci, Y; Citak, EC; Gundogan, BD; Taskinlar, S | 1 |
| Balode, G; Balodis, A; Hasnere, S; Nikulshin, S; Pimenova, A | 1 |
| Chen, H; Gui, L; He, X; Liu, P; Qin, Y; Shi, Y; Tao, Y; Yang, J; Yang, S; Zhang, C; Zhou, L; Zhou, S; Zhou, Y | 1 |
| Giulino-Roth, L; Rodriguez-Hernandez, A | 1 |
| Evens, AM; Przespolewski, E; Torka, P | 1 |
| Bahadoram, M; Bahadoram, S; Hassanzadeh, S; Keikha, A; Keikhaei, B; Mahmoudian-Sani, MR | 1 |
| Berlin, K; Gordon, LI; Soriano, N | 1 |
| Connors, JM; Freeman, CL; Gerrie, AS; Huang, S; Jamroz, A; Savage, KJ; Scott, DW; Sehn, LH; Slack, G; Toze, CL; Villa, D; Zhu, K | 1 |
| Buvat, I; Ciarrocchi, A; Ciavarella, S; Cottereau, AS; Donati, B; Durmo, R; Luminari, S; Meignan, M; Merli, F; Nioche, C; Nizzoli, ME; Rebaud, L; Ruffini, A; Vegliante, MC; Versari, A | 1 |
| André, M; Casasnova, RO; Cottereau, AS; Deau, B; Dupuis, J; Federico, M; Feugier, P; Fornecker, LM; Fortpied, C; Gac, AC; Ghesquières, H; Joly, B; Joubert, C; Kanoun, S; Lazarovici, J; Meignan, M; Moatti, H; Morschhauser, F; Nicolas-Virelizier, E; Raemaekers, J; Rossi, C; Stamatoullas, A; Traverse-Glehen, A | 1 |
| Alarion, N; Burlet, B; Casasnovas, O; Durand, A; Le Dû, K; Martin, L; Rabi, H; Ramla, S; Robert, P; Rossi, C; Tabouret-Viaud, C | 1 |
| Abramson, JS; Advani, R; Ansell, SM; Bartlett, NL; Campana, F; Connors, JM; Dong, C; Długosz-Danecka, M; Eom, HS; Evens, AM; Fenton, K; Friedberg, JW; Gallamini, A; Hutchings, M; Kim, WS; Puhlmann, M; Radford, J; Ramchandren, R; Savage, KJ; Smolewski, P; Straus, DJ | 1 |
| André, M; Aurer, I; Bonnet, C; Borel, C; Bouabdallah, K; Casasnovas, RO; Dartigues, P; Di Renzo, N; Federico, M; Feugier, P; Fornecker, LM; Gac, AC; Hutchings, M; Lazarovici, J; Lugtenburg, P; Meignan, M; Molina, L; Nicolas-Virelizier, E; Pascal, L; Specht, L; Stamatoullas, A; Touati, M; Traverse-Glehen, A; Vander Borght, T; Versari, A | 1 |
| Ando, J; Ando, M; Komatsu, N; Yasuda, H | 1 |
| Adefres, B; Chang, EM; Huang, TQ; Parikh, N; Raldow, A; Smith, CP | 1 |
| Chen, Q; Ding, M; Dong, M; Ge, J; Hou, H; Kong, X; Lei, Y; Qian, S; Wang, W; Wang, Z; Wen, Q; Zhang, M; Zhang, X; Zhang, Y; Zhu, L | 1 |
| Abramson, JS; Armand, P; Barnes, JA; Bello, CM; Bengston, E; Jacobsen, E; LaCasce, AS; Lansigan, F; Martignetti, R; Metzler, S; Patterson, V; Redd, R; Shah, B; Sokol, L; Takvorian, T; Turba, E | 1 |
| Bouyer, S; Debiais, C; Delwail, V; Gardembas, M; Gastinne, T; Gruchet, C; Guidez, S; Leleu, X; Levy, A; Machet, A; Moya, N; Noel, S; Poudou, C; Sabirou, F; Systchenko, T; Tomowiak, C | 1 |
| Abramson, J; Bartlett, NL; Blum, K; Bogart, J; Cheson, B; Dockter, T; Hsi, E; Kostakoglu, L; LaCasce, AS; Leonard, JP; Ruppert, AS; Schöder, H; Wagner-Johnston, N | 1 |
| Al-Ibraheem, A; Almasri, N; Anwer, F; Halahleh, K; Jaradat, I; Juweid, ME; Khalaf, AN; Ma'koseh, M; Mansour, A; Obeidat, S; Shagera, QA | 1 |
| Barrington, SF; Dunn, JT; Duran, A; Ilyas, H; Mikhaeel, NG; Mir, N; Subesinghe, M | 1 |
| Arora, RS; Bakhshi, S; Chandra, J; Dinand, V; Jain, S; Kalra, M; Kapoor, G; Kumar, R; Mahajan, A; Mallick, S; Mandal, P; Radhakrishnan, V; Sajid, M; Seth, R; Singh, M; Taluja, A; Verma, N | 1 |
| Baues, C; Borchmann, P; Bormann, M; Bröckelmann, PJ; Bühnen, I; Dickhut, A; Engert, A; Fuchs, M; Halbsguth, TV; Herhaus, P; Kaul, H; Kerkhoff, A; Kobe, C; Mathas, S; Meissner, J; Schaub, V; Trautmann-Grill, K; von Tresckow, B | 1 |
| Bergesio, F; Bianchi, A; Biggi, A; Chauvie, S; Chiaravalloti, A; Fallanca, F; Gallamini, A; Gregianin, M; Guerra, L; La Nasa, G; Menga, M; Patti, C; Pavoni, C; Picardi, M; Rambaldi, A; Romano, A; Schiavotto, C; Schillaci, O; Sorasio, R; Trentin, L; Viviani, S | 1 |
| Barraclough, A; Berkahn, L; Cheah, CY; Chung, E; Cochrane, T; Dickinson, M; Doo, NW; Forsyth, C; Giri, P; Hamad, N; Hawkes, EA; Johnston, AM; Keane, C; McQuilten, ZK; Morgan, S; Mutsando, H; Nguyen, J; Opat, S; Ratnasingam, S; Talaulikar, D; Wellard, C; Wood, EM | 1 |
| Andre, M; Aurer, I; Barrington, SF; Clifton-Hadley, L; Counsell, N; Federico, M; Fiaccadori, V; Fortpied, C; Illidge, T; Neven, A; Phillips, EH; Radford, J; Raemaekers, JMM | 1 |
| Andera, LF; Antel, K; Brown, K; Dawood, T; Du Toit, C; Louw, VJ; Mohamed, Z; Oosthuizen, J; Opie, JJ; Simba, K; Van der Vyfer, L; Verburgh, E | 1 |
| Hachiya, K; Imai, H; Miyazaki, K; Miyoshi, H; Nishimura, K; Ohshima, K; Okugawa, Y; Suzuki, K; Tamaru, S; Tawara, I; Tono, Y; Yamaguchi, M | 1 |
| Cutter, DJ; Daly, P; Duane, FK; Gillham, C; Houlihan, OA; McArdle, O; Ntentas, G | 1 |
| Ali, N; El Nabarawy, NM; Hussein, H; Salah, Z; Selim, M; Sidhom, I | 1 |
| Borchmann, P; Bröckelmann, PJ; Bühnen, I; Engert, A; Garcia Marquez, MA; Grund, J; Iben, K; Kellermeier, F; Klapper, W; Müller-Meinhard, B; Plütschow, A; Reinke, S; Schlößer, HA; von Tresckow, B | 1 |
| Garai, I; Illés, Á; Miltényi, Z | 1 |
| Chen, BE; Djurfeldt, M; Hay, AE; Meyer, R; Mian, H; Pater, J; Prica, A; Ringash, J; Shepherd, L; Sussman, J; Winter, JN | 1 |
| Bloudek, B; Burke, JM; Fanale, M; Liu, N; Migliaccio-Walle, K; Phillips, T; Yu, KS | 1 |
| El-Galaly, TC; Eloranta, S; Entrop, JP; Fosså, A; Glimelius, I; Holte, H; Jakobsen, LH; Marklund, A; Molin, D; Smedby, KE; Smeland, KB; Weibull, CE; Øvlisen, AK | 1 |
| Fanale, M; Liu, N; Narkhede, M; Surinach, A; Winter, A; Yu, KS | 1 |
| Akrawikrai, T; Bunworasate, U; Chamnanchanunt, S; Iam-Arunthai, K; Nakhahes, C; Suwanban, T; Thungthong, P | 1 |
| Baues, C; Borchmann, P; Bühnen, I; Dietlein, M; Eich, HT; Eichenauer, DA; Engert, A; Fuchs, M; Greil, R; Hartmann, S; Hertenstein, B; Just, M; Kaul, H; Kobe, C; Moccia, A; Topp, MS; von Tresckow, B; Zijlstra, JM | 1 |
| Peccatori, FA; Pirosa, MC | 1 |
| Casasnovas, O; Rossi, C | 1 |
| Baiocchi, O; Biasoli, I; Bonamin Sola, C; Boquimpani, C; Buccheri, V; Carvalho Palma, L; Castro, N; Chiattone, CS; Colaço Villarim, C; de Oliveira Marques, M; de Oliveira Paula E Silva, R; de Souza, C; Gaiolla, R; Goveia, L; Pagnano, K; Perobelli, L; Praxedes, M; Ribas, AC; Silveira, T; Soares, A; Solza, C; Souza Medina, S; Spector, N; Steffenello, G; Traina, F; Zattar Cecyn, K | 1 |
| Costa, RS; Henriques, R; Patrício, A | 1 |
| Attri, LK; Chandrappa, Y; Kulkarni, P; Mahadevappa, M; Pura Krishnamurthy, K | 1 |
| Abdalla, A; Ali, N; Elnashar, A; Khorshed, E; Moussa, E; Zaghloul, MS | 1 |
| Beeks, A; Fanale, M; He, D; Liu, N; Robert, N; Yasenchak, C; Yu, KS | 1 |
| Alipour, V; Arabloo, J; Azari, S; Ehsanzadeh, SJ; Gorji, HA; Rezapour, A | 1 |
| Angelopoulou, MK; Gallamini, A; Liaskas, A; Panayiotidis, P; Pereyra, P; Vassilakopoulos, TP | 1 |
| Izumiyama, K; Kobayashi, M; Kondo, T; Mori, A; Morioka, M; Saito, M; Yokoyama, E | 1 |
| Gallamini, A; Gastaud, L; Kurlapski, M; Sudria, A | 1 |
| Ballot, DE; Carr, A; du Plessis, L; Geel, J; Goga, Y; Hendricks, M; Hramyka, A; Kelsey, T; Louw, L; Madzhia, E; Mathew, R; Metzger, ML; Naidoo, T; Neethling, B; Netshituni, V; Ngcana, T; Omar, F; Plessis, JD; Schickerling, T; van Zyl, A | 1 |
| Bloudek, B; Burke, JM; Liu, N; Migliaccio-Walle, K; Phillips, T; Reynolds, J | 1 |
| Choi, Y; Diefenbach, CS | 1 |
| Beyhan Sagmen, S; Comert, S; Doğan, C; Fidan, A; Kıral, N; Küçüköz Uzun, A; Torun Parmaksız, E; Turan Erkek, E; Yılmaz Haksal, Ç; Yılmaz, G | 1 |
| Bocchia, M; Cencini, E; Fabbri, A; Santoni, A; Sicuranza, A | 1 |
| Baues, C; Borchmann, P; Diehl, V; Dietlein, M; Dührsen, U; Eich, H; Engert, A; Fuchs, M; Goergen, H; Greil, R; Hertenstein, B; Keller, UB; Kobe, C; Krause, SW; Kuhnert, G; Lohri, A; Maschmeyer, G; Meissner, J; Rosenwald, A; Sasse, S; Schäfer, E; Soekler, M; Thiemer, J; Topp, MS; Viardot, A; Vogelhuber, M; von Tresckow, B; Wilhelm, M; Zijlstra, JM | 1 |
| Asad, M; Mehreen, A; Ria, S; Sindhu, II; Wali, RM | 1 |
| Ansell, SM; Habermann, TM; Liu, H; Polley, MY; Ristow, K; Taparra, K | 1 |
| Ansell, SM; Botto, B; Habermann, TM; Inwards, DJ; Johnston, PB; Micallef, IN; Novo, M; Nowakowski, GS; Ristow, KM; Vitolo, U; Witzig, TE; Young, JR | 1 |
| Alfano, R; Argenziano, G; Conforti, C; Corneli, P; Piccolo, V; Russo, T; Zalaudek, I | 1 |
| Baues, C; Borchmann, P; Dietlein, M; Engert, A; Fuchs, M; Goergen, H; Kobe, C; Müller, H; von Tresckow, B | 1 |
| Åkesson, L; Björkholm, M; Enblad, G; Erlanson, M; Fluge, Ø; Fohlin, H; Fosså, A; Glimelius, B; Glimelius, I; Goldkuhl, C; Gustavsson, A; Holte, H; Johansson, AS; Lagerlöf, I; Linderoth, J; Molin, D; Nome, O; Palma, M; Raud, C; Østenstad, B | 1 |
| Anderson, NR; Collins, J; O'Bryen, J | 1 |
| Knox, B; Mai, H; Mirza, K; Singh, D | 1 |
| Connors, JM; Gerrie, AS; Hayden, AR; Lee, DG; Savage, KJ; Scott, DW; Sehn, LH; Slack, GW; Villa, D | 1 |
| Altuntaş, F; Bakırtaş, M; Başçı, S; Batgi, H; Çakar, MK; Dal, MS; Darçın, T; İskender, D; Merdin, A; Mert, D; Şahin, D; Tetik, A; Ulu, BU; Yiğenoğlu, TN; Yıldız, J | 1 |
| Bu, B; Liu, W; Mei, D; Ping, L; Qiu, J; Song, Y; Wang, H; Wang, X; Wu, M; Xie, Y; Yang, M; Yi, K; Zhao, L; Zhu, J | 1 |
| Anoop, P; Anumula, SK; Danthala, M; Golamari, KR; Gunari, P; Janarthinakani, M; Karpurmath, SV; Malipatil, B; Nandennavar, M; Niraimathi, K; Patil, C; Prasad, K; Raman, SG; Rangarajan, B; Rathnam, K; Reddy, N; Roopa, SP; Seshachalam, A; Shewade, HD; Udupa, KS | 1 |
| Farrugia, MK; Vargo, JA | 1 |
| Bonfichi, M; Botto, B; Broccoli, A; Dona, M; Evangelista, A; Gioia, D; Gotti, M; Kovalchuk, S; Mannelli, L; Nassi, L; Pagani, C; Puccini, B; Pulsoni, A; Re, A; Rigacci, L; Salvi, F; Santoro, A; Spina, M; Stelitano, C; Zinzani, PL | 1 |
| Bari, A; Bonfichi, M; Botto, B; Evangelista, A; Gioia, D; Levis, A; Marcheselli, R; Meli, E; Molinari, AL; Nassi, L; Pagani, C; Pavone, V; Puccini, B; Pulsoni, A; Re, A; Sacchi, S; Santoro, A; Tani, M; Tucci, A; Vitolo, U; Zinzani, P | 1 |
| Huang, X; Lu, J; Qiu, L; Wang, Q; Yang, S | 1 |
| Advani, R; Alekseev, S; Ansell, SM; Bartlett, NL; Connors, JM; Długosz-Danecka, M; Feldman, T; Fenton, K; Forero-Torres, A; Gallamini, A; Hutchings, M; Illés, Á; Kim, WS; Lech-Maranda, E; Liu, R; Miao, H; Munoz, J; Picardi, M; Radford, J; Ramchandren, R; Savage, KJ; Smolewski, P; Straus, DJ; Walewski, J; Younes, A; Zinzani, PL | 1 |
| Chan, K; Cheung, MC; Prica, A; Vijenthira, A | 1 |
| Bellesi, S; Colloca, G; Cuccaro, A; D'Alò, F; De Stefano, V; Fusco, D; Galli, E; Hohaus, S; Maiolo, E | 1 |
| Kara, B; Kart, KK; Koksal, Y | 1 |
| Nieder, C | 1 |
| Becker, S; Bessi, L; Bohers, E; Burel, L; Camus, V; Contentin, N; Cornic, M; Decazes, P; Dubois, S; Etancelin, P; Jardin, F; Lanic, H; Lemasle, E; Lenain, P; Lepretre, S; Lequesne, J; Loret, J; Marcq, B; Ménard, AL; Picquenot, JM; Stamatoullas, A; Tilly, H; Veresezan, EL; Viailly, PJ; Viennot, M | 1 |
| Ghorab, Z; Micieli, A; Micieli, JA | 1 |
| Brown, AM; Devata, S; Marini, BL; Nachar, VR; Perissinotti, AJ; Reid, JH | 1 |
| Frerker, B; Hildebrandt, G | 1 |
| Adouni, O; Bertucci, F; Birnbaum, D; Finetti, P; Gamoudi, A; Manai, M; Mezlini, A; Zawati, I | 1 |
| Cisternino, S; Cotteret, C; Driessen, M; Marcais, A; Pham, YV; Schlatter, J | 1 |
| Cappuccio, I; Del Vecchio, S; Della Pepa, R; Fonti, R; Giordano, C; Mainolfi, C; Mascolo, M; Nicolai, E; Pane, F; Picardi, M; Pugliese, N; Rascato, MG; Salvatore, M; Troncone, G; Venetucci, P; Vigliar, E | 1 |
| Baues, C; Borchmann, P; Bormann, M; Bröckelmann, PJ; Engert, A; Fuchs, M; Goergen, H; Halbsguth, TV; Hüttmann, A; Keller, U; Kerkhoff, A; Klapper, W; Kobe, C; Mathas, S; Meissner, J; Mettler, J; Ordemann, R; Rosenwald, A; Sasse, S; Sökler, M; von Tresckow, B; Zimmermann, A | 1 |
| Angelov, D; Cotter, AG; Fay, M; Lambert, JS; McGettrick, P; McGinty, T; O'Kelly, B; Sheehan, G | 1 |
| Bohn, JP; Botto, B; Cavallo, F; Cerchione, C; Cuzzocrea, S; De Lorenzo, S; Dogliotti, I; Ferrero, S; Loseto, G; Martinelli, G; Mian, M; Mondello, P; Musolino, C; Nappi, D; Schmitt, C; Straus, DJ; Willenbacher, W; Wolf, D | 1 |
| Boilève, A; Cassou-Mounat, T; Jehanno, N; Kirova, Y; Kuhnowski, F | 1 |
| Bartlett, NL; Constine, LS; Evens, AM; Friedberg, JW; Ha, CS; Hsi, ED; Kahl, BS; Knopp, MV; LeBlanc, M; Leonard, JP; Li, H; Pinnix, CC; Rimsza, L; Schöder, H; Smith, S; Zhang, J | 1 |
| Fukuda, Y; Hamano, Y; Iizuka, H; Inano, T; Izumi, H; Nakamura, N; Noguchi, M; Okubo, M; Sakajiri, S; Sawada, T; Sekiguchi, N; Sekiguchi, Y; Shirane, S; Sugimoto, K; Takizawa, H; Tomita, S | 1 |
| Advani, RH; Corbelli, KS; Daadi, SE; Hoppe, RT; Qian, Y; Rosenberg, SA; Von Eyben, R; Weil, CR | 1 |
| Aguilar, A; Iniesta, I; Monzó, S; Policiano, C; Rubio Rubio, JM; Subirá, J | 1 |
| Jin, Z; Wang, Y; Wang, Z; Wei, N | 1 |
| Ansell, SM; Budde, LE; Deal, AM; Ghosh, N; Noe, JF; Olajide, O; Park, SI; Reddy, NM; Shea, TC | 1 |
| Arratibel, N; Baile, M; Blázquez, A; Caballero, MD; Diaz, LG; García-Sanz, R; Moran, JC; Sobejano, E; Veiga, Á | 1 |
| Alexander, E; Attygalle, A; Chau, I; Cunningham, D; El-Sharkawi, D; Hujairi, N; Iyengar, S; Kumar, R; Mohammed, K; Sharma, B | 1 |
| Bigirimana, JB; Butera, Y; DeBoer, RJ; Driscoll, CD; Fadelu, TA; Lehmann, L; Mpunga, T; Muhayimana, C; Nguyen, C; Paciorek, A; Park, PH; Ruhangaza, D; Shulman, LN; Shyirambere, C; Umwizerwa, A | 1 |
| Guo, B; Li, Q; Liang, X; Nan, Y; Shi, Y; Xiang, Y; Xiao, C; Yang, T; Zhang, W | 1 |
| Das, H; Kilaru, S; Kolluri, S; Mohapatra, D; Mohapatra, SSG; Panda, SS; Sahoo, N | 1 |
| André, MPE; Bellei, M; Brice, P; Brière, J; Carde, P; Casasnovas, O; Clément-Filliatre, L; Depaus, J; Douxfils, J; Dupuis, J; Federico, M; Fortpied, C; Gianni, AM; Gobbi, PG; Heczko, M; Hutchings, M; Iannitto, E; Mounier, N; Rambaldi, A; Valagussa, P; Viviani, S; Zinzani, PL | 1 |
| Celli, L; Celli, M; Corsi, A; D'Avanzo, M; Giona, F; Lapietra, G; Moleti, ML; Testi, AM; Turchetti, A; Zambrano, A | 1 |
| Bouabdallah, K; Debus, L; Dilhuydy, MS; Dimicoli, S; Favre, S; Galtier, J; Gros, FX; Lascaux, A; Meynard, L; Milpied, N; Sauvezie, M | 1 |
| Demir, I; Gunes, AK; Pehlivan, M | 1 |
| Dehou, MF; Forsyth, R; Leus, HJ; Molina, TJ; Robin, V | 1 |
| Dörr, W; Eggers, C; Geinitz, H; Kopatz, V; Lassmann, H | 1 |
| Huang, JT; Lu, SY; Sun, FF; Sun, XF; Wang, J; Wu, B; Zhen, ZZ; Zhu, J | 1 |
| Ahmed, K; Amin, MSA; Brunckhorst, O; Gleeson, M; Kazmi, M; Scott, C; Wrench, D | 1 |
| Battistini, R; Bolis, S; Cantonetti, M; Chauvie, S; Cimminiello, M; Fallanca, F; Ficola, U; Gallamini, A; Gini, G; Guerra, L; Mulé, A; Oppi, S; Patti, C; Pavoni, C; Picardi, M; Rambaldi, A; Romano, A; Rossi, A; Schiavotto, C; Sorasio, R; Tarella, C; Trentin, L; Viero, P; Viviani, S; Zanotti, R | 1 |
| Bello, C; Chavez, J; Grajales-Cruz, A; Isenalumhe, L; Lim, A; Pinilla-Ibartz, J; Rose, A; Saeed, H; Sandoval-Sus, J; Shah, B; Sokol, L; Todd, A | 1 |
| Ahmed, S; Bankston, ME; Boyce, D; Dabaja, BS; Fang, P; Flowers, C; Gunther, JR; Iyer, SP; Lee, HJ; Milgrom, SA; Nair, R; Nastoupil, L; Neelapu, S; Parmar, S; Pinnix, CC; Rodriguez, MA; Steiner, R; Strati, P; Westin, J | 1 |
| Advani, RH; Allen, PB; Bayer, RA; Bearden, J; Chmiel, JS; Dillehay, G; Eisner, RM; Evens, AM; Gordon, LI; Karmali, R; Mou, E; O'Shea, K; Palmer, B; Pro, B; Savas, H; Winter, JN | 1 |
| Boucher, K; Brander, DM; Byrd, JC; Cooperrider, J; Danilov, A; Davids, M; Gaballa, S; Glenn, MJ; Hill, B; Kander, E; Mato, A; Pagel, JM; Parikh, SA; Parry, EM; Phillips, T; Rhodes, J; Rogers, K; Shadman, M; Smith, SM; Stephens, DM; Winter, A | 1 |
| Baues, C; Behringer, K; Borchmann, P; Bröckelmann, PJ; Engert, A; Fuchs, M; Guhl, T; Moccia, AA; Müller, H; Pabst, T; Rank, A; Soekler, M; Vieler, T; von Tresckow, B | 1 |
| Chiwata, M; Fujioka, M; Imaizumi, Y; Kitanosono, H; Makiyama, J; Miyazaki, Y; Nakashima, J; Watanabe, H; Yoshida, S | 1 |
| Baues, C; Borchmann, P; Bröckelmann, PJ; Dietlein, M; Engert, A; Fuchs, M; Goergen, H; Keller, U; Kerkhoff, A; Kobe, C; Meissner, J; Mettler, J; Müller, H; Sasse, S; Trautmann-Grill, K; van Heek, L; Voltin, CA; von Tresckow, B | 1 |
| Wei, Y; Yuan, Z; Zhang, J; Zhong, W | 1 |
| Liu, Y; Qu, W; Sun, LY; Wang, L; Wei, L; Yuan, LL; Zeng, ZG; Zhu, ZJ | 1 |
| Ayadi, M; Bahri, O; Berjeb, KK; Braham, M; Chakroun, N; Chtourou, S; Debbabi, L; Fadhlaoui, A; Hamdoun, M; Hannachi, H; Kacem, K; Zemni, Z; Zhioua, F | 1 |
| Abramson, JS; Ansell, SM; Chua, NS; Connors, JM; Engley, G; Fenton, K; Friedberg, JW; Gallamini, A; Gautam, A; Hutchings, M; Illés, Á; Jolin, H; Kořen, J; LaCasce, AS; Liu, R; Molina, L; Radford, J; Shibayama, H; Sureda, A; Sýkorová, A | 1 |
| Dann, EJ; Lopez-Alonso, R; Mashiach, T; Qi, S; Weiler-Sagie, M; Yahalom, J | 1 |
| Angelopoulou, MK; Drakos, E; Giakoumis, X; Herold, N; Medeiros, LJ; Pangalis, GA; Panitsas, F; Rassidakis, GZ; Vassilakopoulos, TP; Xagoraris, I | 1 |
| Barista, I; Civriz, S; Doğan, M; Ercolak, V; Gurkan, E; Kaplan, MA; Karadurmus, N; Laçin, S; Paydas, S; Seydaoglu, G; Yagci, M; Yildiz, B | 1 |
| LeBlanc, TW; Tarnasky, AM; Troy, JD | 1 |
| Collins, A; Cooke, L; Docherty, S; Follows, GA; Fowler, A; Grigoropoulos, N; Hodson, A; Johnson, P; Karanth, M; Kirkwood, AA; Lentell, I; Maw, K; Padayatty, J; Qian, W; Russell, J; Sadullah, S; Saha, C; Shah, N; Uttenthal, BJ | 1 |
| Ashykhmin, A; Gorbach, O; Kadnikova, T; Karnabeda, O; Karpova, O; Kmetyuk, I; Kosinova, V; Kostiukova, N; Kozlov, V; Kriachok, I; Lukjanec, O; Mykhalska, L; Novikov, M; Novosad, O; Oliinichenko, O; Pastushenko, I; Skrypets, T; Stratienko, V | 1 |
| Doo, NW; Trotman, J | 1 |
| Fujii, H; Goda, S; Hiraoka, N; Matsumoto, Y; Matsuyama, A; Omura, A; Ono, S; Shiotsu, S; Suga, Y; Sugitani, M; Takumi, C; Tanaka, S; Tsuji, T; Yuba, T | 1 |
| Advani, RH; Barr, PM; Batlevi, CL; Budde, E; Caron, P; Casulo, C; Constine, LS; Dandapani, SV; Drill, E; Drullinsky, P; Friedberg, JW; Grieve, C; Hamilton, A; Hamlin, PA; Hoppe, RT; Horwitz, SM; Joseph, A; Khan, N; Kumar, A; Laraque, L; Matasar, MJ; Moskowitz, AJ; Moskowitz, CH; Noy, A; Palomba, ML; Schöder, H; Straus, DJ; Vemuri, S; Yahalom, J; Yang, J; Younes, A; Zelenetz, AD | 1 |
| Boldizsár, S; Rottek, J; Schneider, T; Szaleczky, E; Varga, F | 1 |
| Ansell, SM; Connors, JM; Dlugosz-Danecka, M; Evens, AM; Feldman, T; Fenton, K; Forero-Torres, A; Gallamini, A; Gautam, A; Grigg, A; Jolin, H; Kim, WS; Liu, R; Oki, Y; Pocock, C; Radford, J; Savage, KJ; Tuscano, J; Younes, A | 1 |
| Cui, F; Yan, J; Zhao, S | 1 |
| Eichenauer, DA; Engert, A | 2 |
| Arora, A; Arora, RS; Bakhshi, S; Chandra, J; Dinand, V; Jain, S; Kalra, M; Kapoor, G; Mahajan, A; Mandal, P; Radhakrishnan, V; Sajid, M; Seth, R; Singh, M; Taluja, A; Thulkar, S; Verma, N | 1 |
| Balzarotti, M; Bonfichi, M; Califano, C; Carella, M; Carlo-Stella, C; Chauvie, S; Chimienti, E; Ciammella, P; Consoli, U; Fabbri, A; Gallamini, A; Ghiggi, C; Giordano, L; Kovalchuk, S; Liberati, AM; Mazza, R; Merli, F; Musso, M; Palombi, F; Pulsoni, A; Ricardi, U; Ricci, F; Rodari, M; Santoro, A; Sorasio, R; Specchia, G; Spina, M | 1 |
| Collins, GP; Cwynarski, K; Phillips, EH | 1 |
| Buckle, A; Clifton-Hadley, L; Cutter, DJ; Darby, SC; Diez, P; Hoskin, PJ; Illidge, T; Ntentas, G; Popova, B; Radford, J; Ramroth, J | 1 |
| Baues, C; Borchmann, P; Celik, E; Eich, H; Engert, A; Fuchs, M; Goergen, H; Kobe, C; Marnitz, S; Rosenbrock, J; Voltin, CA | 1 |
| Alabbas, F; Aljabry, MS; Alkhayat, N; Alshahrani, M; Alsharif, O; Alshieban, S; Alsuhaibani, O; Alzouman, M; Asiri, S; Binhassan, A; Elborai, Y; Elyamany, G; Hamzi, H; Ibrahim, W; Othman, M; Sedick, Q | 1 |
| Barbatti, M; Behal, H; Bruno, B; Decanter, C; Delepine, J; Labreuche, J; Manier, S; Morschhauser, F; Pigny, P; Robin, C | 1 |
| Bakhshi, S; Bhethanabhotla, S; Biswas, A; Ganguly, S; Khadgawat, R; Mittal, A; Mohan, A; Patel, C; Vishnubhatla, S | 1 |
| Bénard, F; Cheng, PTM; Connors, JM; Craig, JW; Farinha, P; Freeman, CL; Gascoyne, RD; Gerrie, AS; Lo, AC; Pickles, T; Savage, KJ; Scott, DW; Sehn, LH; Skinnider, B; Slack, GW; Tonseth, RP; Villa, D; Wilson, D | 1 |
| Advani, RH; Ballard, HJ; Bartlett, NL; Bennani, NN; Carter, J; Churnetski, MC; Cohen, JB; David, KA; Evens, AM; Feldman, TA; Grover, NS; Hill, BT; Hu, R; Hwang, SR; Isaac, K; Magarelli, G; Malecek, MK; Mou, E; Orellana-Noia, VM; Portell, CA; Svoboda, J; Voorhees, TJ | 1 |
| Connors, JM; Deyell, RJ; Goddard, KJ; Marr, KC; Savage, KJ | 1 |
| Filippi, AR; Hoppe, B; Levis, M; Parikh, R | 1 |
| Aamir, MN; Ahmad, M; Malik, MZ; Muahammad, S | 1 |
| Chirwa, TC; Eyal, KC; Geel, JA; Goga, Y; Hendricks, MG; Omar, F; Rowe, B; Stefan, DC; Stones, DK; Vaithilingum, M; Van Emmenes, B; van Zyl, A; Wedi, O | 1 |
| Arcondo, F; Cordova, E; Morganti, L; Odzak, A; Rodriguez, C; Silva, M; Zylberman, M | 1 |
| Borchmann, P; Borchmann, S; Bröckelmann, PJ; Buerkle, C; Diehl, V; Engert, A; Fuchs, M; Goergen, H; Kreissl, S; Müller, H; Plütschow, A; Sasse, S | 1 |
| Atenafu, EG; Crump, M; Kukreti, V; Kuruvilla, J; Marras, TK; Sun, HL; Tsang, R | 1 |
| Brillant, C; Engert, A; Monsef, I; Skoetz, N; von Tresckow, B; Will, A | 1 |
| Abadi, U; Abdah-Bortnyak, R; Akria, L; Bairey, O; Bar-Shalom, R; Barzilai, E; Ben-Yehuda, D; Dann, EJ; Epelbaum, R; Filanovsky, K; Goldschmidt, N; Horowitz, NA; Kagna, O; Kornberg, A; Lavie, D; Mashiach, T; Paltiel, O; Ruchlemer, R; Shpilberg, O; Tadmor, T | 1 |
| Anglaret, B; Audhuy, B; Bologna, S; Bouabdallah, R; Brice, P; Brière, J; Carde, P; Casasnovas, O; de Jong, D; de Weerdt, O; Delarue, R; Eghbali, H; Fermé, C; Henry-Amar, M; Janvier, M; Lugtenburg, PJ; Lybeert, MLM; Marjanovic, Z; Noordijk, EM; Raemaekers, JMM; Reman, O; Salles, G; Sebban, C; Spina, M; Tersteeg, RJHA; Thomas, J; Thyss, A; van Imhoff, GW; Vranovsky, A | 1 |
| Catania, S; Cefalo, G; Gandola, L; Massimino, M; Materazzo, C; Meazza, C; Moschetti, I; Podda, M; Schiavello, E; Terenziani, M | 1 |
| Ansell, SM; Connors, JM; Fanale, M; Park, SI; Younes, A | 1 |
| Abou Yehia, Z; Akhtari, M; Chuang, H; Dabaja, BS; Dong, W; Fanale, M; Fayad, LE; Garg, N; Gunther, JR; Hagemeister, FB; Lee, HJ; Mawlawi, O; Milgrom, SA; Oki, Y; Osborne, EM; Pinnix, CC; Reddy, JP; Rohren, E; Smith, GL | 1 |
| Díaz, J; Ernst, D; Soto, K | 1 |
| Becker, I; Eichenauer, DA; Engert, A; Franklin, J; Monsef, I | 1 |
| Alfaro, E; Felice, MS; Fiandrino, F; Galluzzo, ML; Guitter, M; Millán, N; Sanchez La Rosa, C; Zubizarreta, PA | 1 |
| Advani, RH; Bartlett, NL; Chen, L; Connors, JM; Constine, LS; Evens, AM; Friedberg, JW; Friedman, DL; Gascoyne, RD; Gordon, LI; Henderson, TO; Hong, F; Horning, S; Kahl, BS; Kelly, KM; Leonard, JI; Li, H; McNeer, JL; Parsons, SK; Schwartz, CL; Shah, B; Smith, SM; Wroblewski, KE | 1 |
| Stephens, DM | 1 |
| Chen, YH; Jacene, HA; Kamran, SC; Mauch, PM; Ng, AK | 1 |
| Bergesio, F; Biggi, A; Chamier-Cieminska, A; Chauvie, S; Dziuk, M; Fallanca, F; Fijolek-Warszewska, A; Gallamini, A; Giza, A; Knopinska-Posluszny, W; Kobylecka, M; Kroll-Balcerzak, R; Kulikowski, W; Kurczab, P; Lesniewski-Kmak, K; Malkowski, B; Romanowicz, A; Rybka, J; Subocz, E; Swietlik, D; Tajer, J; Walewski, J; Woszczyk, D; Wróbel, T; Zaucha, JM; Zaucha, R | 1 |
| Min, L; Tang, B; Tang, F; Tu, C; Ye, Y; Zhang, W; Zhou, Y | 1 |
| Corradini, P; Crippa, F; Farina, L; Gianni, AM; Guidetti, A; Mazzocchi, A; Miceli, R; Paterno', E; Spina, F; Taverna, F; Viviani, S | 1 |
| Adams, HJA; Kwee, TC | 3 |
| Amro, L; Batahar, SA; Jridi, S; Sajiai, H; Serhane, H | 1 |
| Bartlett, NL | 3 |
| Alekseev, S; Ansell, SM; Bartlett, NL; Chen, R; Connors, JM; Cunningham, D; Feldman, T; Gallamini, A; Huebner, D; Illés, Á; Jolin, HA; Josephson, NC; Jurczak, W; Kim, WS; Lech-Maranda, E; Liu, R; Oki, Y; Picardi, M; Radford, J; Ramchandren, R; Rosta, A; Sachs, J; Savage, KJ; Smolewski, P; Song, E; Straus, DJ; Walewski, J; Younes, A; Zinzani, PL | 1 |
| Avena, P; Cotzia, P; Domingo-Vidal, M; Dulau-Florea, A; Gong, J; Leiby, B; Lin, Z; Lisanti, MP; Martinez-Outschoorn, U; Mikkilineni, L; Pro, B; Sotgia, F; Sprandio, J; Uppal, G; Whitaker-Menezes, D; Zhan, T | 1 |
| Dabaja, BS; Fanale, M; Gunther, JR; Milgrom, SA; Pinnix, CC | 1 |
| Auvinen, P; Bur, H; Haapasaari, KM; Karihtala, P; Kuittinen, O; Marin, K; Soini, Y; Turpeenniemi-Hujanen, T | 2 |
| Akhtar, S; Aleem, A; Alsaleh, K | 1 |
| Billett, AL; LaCasce, AS; Marcus, KJ; Ozuah, NW | 1 |
| Ames, MM; Easterling, TR; Hays, K; Hebert, MF; Kantrowitz-Gordon, I; Kaplan, HG; Kayode, O; Kumar, AR; Reid, JM; Safgren, SL | 1 |
| Avigdor, A; Battistini, R; Bergesio, F; Biggi, A; Billio, A; Bolis, S; Cantonetti, M; Chauvie, S; Chiaravalloti, A; Cimminiello, M; Corradini, P; Fallanca, F; Ferreri, AJM; Ficola, U; Gallamini, A; Gavarotti, P; Gianni, AM; Gini, G; Gottardi, D; Gregianin, M; La Nasa, G; Miglino, M; Mulé, A; Parvis, G; Patti, C; Pavoni, C; Picardi, M; Prosperini, G; Rambaldi, A; Rapezzi, D; Romano, A; Rossi, A; Schiavotto, C; Tarella, C; Trentin, L; Viero, P; Viviani, S; Zanotti, R | 1 |
| Dinh, T; Olshen, AB; Pampaloni, MH; Phelps, AS; Robbins, E; Stieglitz, E | 1 |
| Andre, M; Bardet, S; Bellei, M; Brice, P; Casasnovas, O; Castagnoli, A; Chartier, L; Cottereau, AS; Deau, B; Federico, M; Fortpied, C; Hutchings, M; Loft, A; Meignan, M; Raemaekers, J; Raveloarivahy, T; Ricardi, U; Ricci, R; Van Zele, E; Vander Borght, T; Versari, A | 1 |
| Annunziata, S; Arribas, A; Bertoni, F; Boldorini, R; Bruscaggin, A; Carlo-Stella, C; Cavalli, F; Ceriani, L; Cocomazzi, A; Condoluci, A; Cuccaro, A; Cupelli, E; Deambrogi, C; Di Trani, M; Diop, F; Forestieri, G; Gaidano, G; Gerber, B; Ghielmini, M; Giordano, A; Guidetti, F; Hohaus, S; Larocca, LM; Locatelli, SL; Manzoni, M; Martini, M; Moccia, AA; Nassi, L; Neri, A; Rossi, D; Rufini, V; Santoro, A; Spina, V; Stathis, A; Stüssi, G; Terzi-Di-Bergamo, L; Zucca, E | 1 |
| Almeida-Aróstegui, NA; Calbacho-Robles, M; Chinea-Rodríguez, A; García-Cosío-Piqueras, M; Gorospe, L | 1 |
| Karim, F; Memon, AM | 1 |
| Akhtar, S; Elhassan, TAM; Elshenawy, MA; Maghfoor, I; Shahzad Rauf, M | 1 |
| Bröckelmann, PJ; Engert, A; Sasse, S | 1 |
| Bilmon, I; Douglas, G; Grigg, A; Minson, A | 1 |
| Andraos, TY; Aristophanous, M; Chuang, HH; Dabaja, BS; Fanale, MA; Gunther, JR; Hancock, D; Ludmir, EB; Mikhaeel, NG; Milgrom, SA; Nastoupil, L; Oki, Y; Pham, M; Pinnix, CC; Wirth, A | 1 |
| Kim, GI; Lee, SJ; Park, J; Rho, JY | 1 |
| Gallamini, A; Pavoni, C; Rambaldi, A; Viviani, S | 1 |
| Bouabdallah, K; Hindié, E; Mesguich, C; Milpied, N | 1 |
| Carella, AM; Corradini, P; Mussetti, A; Ricardi, U; Vitolo, U; Viviani, S | 1 |
| Ito, M; Ito, R; Kageyama, Y; Katayama, N; Kawakami, K; Masuya, M; Nagaharu, K; Yamaguchi, T | 1 |
| Benna, NE; Bennani, N; Fares, S; Hadri, H; Karkouri, M; Lembarki, G; Moussali, N; Moutiqui, T; Naoumi, S; Quessar, A; Regragui, M | 1 |
| Baues, C; Behringer, K; Böll, B; Borchmann, P; Eichenauer, DA; Engert, A; Fuchs, M; Goergen, H; Greil, R; Markova, J; Meissner, J; Neubauer, A; Plütschow, A; Sasse, S; Topp, MS; von Tresckow, B; Zijlstra, JM | 1 |
| González, JT; Peña, C; Villegas, P; Voisin, J | 1 |
| Aquino-Parsons, C; Bénard, F; Connors, JM; Farinha, P; Gascoyne, RD; Gerrie, AS; Morris, J; Pickles, T; Savage, KJ; Scott, DW; Sehn, LH; Slack, GW; Tonseth, P; Villa, D; Wilson, D | 1 |
| Bartlett, NL; Chang, JE; Cheson, BD; Friedberg, JW; Grecula, JC; Hsi, ED; Jung, SH; Kahl, BS; Kostakoglu, L; Leonard, JP; Moskowitz, CH; Pitcher, B; Popplewell, LL; Schöder, H; Straus, DJ; Wagner-Johnston, N | 1 |
| Eslami, A; Jha, KK; Mathur, AD; Wang, H | 1 |
| Cheson, B; Narkhede, M; Sarraf Yazdy, M | 1 |
| Advani, RH; Bociek, GR; Evens, AM; Fanale, M; Gordon, LI; Hamlin, PA; Helenowski, IB; Jovanovic, BD; Klein, AK; Smith, SM; Winter, JN | 1 |
| Bartlett, NL; Fanale, MA; Fayad, LE; Gladstone, DE; Goy, A; Kasamon, YL; Lee, HJ; Oki, Y; Portlock, CS; Strati, P; Turturro, F; Wilson, WH; Younes, A | 1 |
| Cervantes-Barragán, DE; Frias, S; Gallardo, E; Lozano, V; Marchetti, F; Molina, B; Navarrete-Meneses, P; Ramos, S | 1 |
| Aster, JC; Isabelle, I; Manirakiza, A; Morgan, EA; Mugabe, MC; Omondi, J; Ruhangaza, D; Wong, WJ | 1 |
| Delea, TE; Eichten, C; Fenton, K; Grossman, A; Josephson, N; Moskowitz, AJ; Richhariya, A; Sharma, A | 1 |
| Arcamone, M; Bruzzese, D; Capobianco, G; Corazzelli, G; De Filippi, R; Galati, D; Morelli, E; Pinto, A; Zanotta, S | 1 |
| André, M; Delcourt, A; Depaus, J | 1 |
| Advani, RH; Spinner, MA | 1 |
| Ayesh Haj Yousef, MH; Eyadeh, A; Jibreel, MJ; Khasawneh, R; Rawashdeh, RA; Saleh, JA | 1 |
| Atta, J; Böll, B; Borchmann, P; Bürkle, C; Eichenauer, DA; Engert, A; Feuring-Buske, M; Fuchs, M; Pfreundschuh, M; Plütschow, A; Sökler, M; Thielen, I; Vogelhuber, M; von Tresckow, B | 1 |
| Awan, FT; Baiocchi, RA; Blum, KA; Bond, DA; Dotson, E; Maddocks, K | 1 |
| Advani, RH; Ansell, SM; Bartlett, NL; Chen, R; Connors, JM; Engley, G; Feldman, T; Fenton, K; Forero-Torres, A; Friedberg, JW; Gopal, AK; Gordon, LI; Kuruvilla, J; Manley, TJ; Ramchandren, R; Savage, KJ; Straus, DJ; Younes, A | 1 |
| Jackson, C; Lamar, Z; Strowd, L | 1 |
| Bakhshi, S; Bhethanabhotla, S; Sharma, MC; Tiwari, A; Vishnubhatla, S | 1 |
| Basquiera, AL; Cabane, V; Cabrejo, M; Casale, MF; Castano, V; Cerutti, I; Fernandez, I; Grecco, HF; Kurgansky, N; Mariano, R; Milone, G; Negri, P; Pavlovsky, A; Pavlovsky, S; Prates, V; Remaggi, G; Riddick, M; Roveri, E; Rudoy, S; Saba, S; Sackmann, F; Sakamoto, F; Taus, R; Varela, AI; Venturini, C; Zabaljauregui, S; Zoppegno, L | 1 |
| Cicinelli, E; Curci, P; Depalo, R; Gaudio, F; Laddaga, FE; Masciandaro, P; Nardelli, C; Perrone, T; Specchia, G | 1 |
| Hasséus, B; Johansson, JE; Jonasson, P; Skallsjö, K | 1 |
| Barrington, SF; Clifton-Hadley, L; Counsell, N; Culligan, D; Hancock, B; Hoskin, P; Illidge, T; Johnson, P; McMillan, A; O'Doherty, MJ; Pettengell, R; Phillips, EH; Popova, B; Radford, J; Townsend, W | 1 |
| Kamei, S; Minami, H; Mitsuke, K; Morita, A; Takahashi, H; Yokota, Y | 1 |
| Abramson, JS; Arnason, JE; Avigan, D; Barnes, JA; Bello, CM; Hochberg, EP; Joyce, R; LaCasce, AS; Neuberg, D; Redd, R; Sokol, L; Takvorian, RW | 1 |
| Ashizawa, M; Fujiwara, SI; Hatano, K; Ikeda, T; Ito, S; Kanda, Y; Kawaguchi, SI; Kawasaki, Y; Mashima, K; Minakata, D; Morita, K; Muroi, K; Nagayama, T; Nakano, H; Ochi, SI; Oh, I; Ohmine, K; Sato, K; Toda, Y; Umino, K; Yamamoto, C; Yamasaki, R | 1 |
| Deyell, RJ; Eftekhari, A; Ingley, KM; Nadel, HR; Potts, JE; Wilson, DC | 1 |
| Barr, PM; Bartlett, NL; Evens, AM; Friedberg, JW; Hsi, ED; Kahl, BS; Knopp, MV; LaCasce, AS; LeBlanc, M; Leonard, JP; Li, H; Moskowitz, CH; Rimsza, LM; Schöder, H; Smith, SM; Stephens, DM; Straus, DJ | 1 |
| Cabrera C, ME; Puga L, B; Salinas, M; Torres, V | 1 |
| Bargetzi, MJ; Böll, B; Borchmann, P; Diehl, V; Eich, HT; Eichenauer, DA; Engert, A; Fuchs, M; Görgen, H; Greil, R; Junghanß, C; Pluetschow, A; Rothe, A; Scherpe, A; Schmalz, O; von Tresckow, B; Weidmann, E | 1 |
| Evens, AM; Hong, F | 1 |
| Barrington, SF; Biggi, A; Chauvie, S; Gallamini, A; Gregianin, M; Hofman, MS; Hutchings, M; Kostakoglu, L; Malkowski, B; Meignan, M | 1 |
| Aslan, D; Cetin, M; Eroglu, C; Eser, B; Kaynar, L; Keklik, M; Kurnaz, F; Mentes, S; Orhan, O; Sahin, C; Sivgin, S; Soyuer, S; Unal, A; Yildiz, OG | 1 |
| Buckstein, R; Chan, K; Cheung, MC; Graczyk, J | 1 |
| Meyer, RM | 2 |
| Datsenko, PV; Evstikheev, ÉV; Golub, SV; Gombolevskiĭ, VA; Ivashin, AV; Pan'shin, GA; Sotnikov, VM | 3 |
| Miralles, P; Morgades, M; Ribera, JM; Rubio, R; Valencia, ME; Xicoy, B | 1 |
| Borchmann, P; Kreissl, S | 1 |
| Bachanova, V; Connors, JM | 1 |
| Kenzaka, T; Morita, Y; Ohno, N; Yoshimoto, H | 1 |
| Aulitzky, W; Borchmann, P; Diehl, V; Dührsen, U; Engert, A; Fuchs, M; Hertenstein, B; Klimm, B; Lindemann, W; Maschmeyer, G; Plütschow, A; Sasse, S; Vieler, T; Wongso, D | 1 |
| Filatova, LV; Gershanovich, ML; Plotnikova, AA; Semiglazova, TIu | 1 |
| Borchmann, P; Diehl, V; Engert, A; Haverkamp, H; Rancea, M; Skoetz, N; Trelle, S | 1 |
| Askaa, J; Baggerly, KA; Coombes, KR; Knudsen, S; Mazin, W; Wang, W | 1 |
| Cao, H; Weber, R; Yamamoto, K; Yang, LX | 1 |
| Argnani, L; Broccoli, A; Celli, M; Derenzini, E; Pellegrini, C; Zinzani, PL | 1 |
| Chong, A; Chung, JS; Hong, JS; Jeong, SY; Kim, JH; Kim, SJ; Lee, JJ; Lee, SM; Moon, JH; Shin, HJ; Song, MK | 1 |
| Amorós, F; Enríquez, R; Heredia, L; Millán, I; Sánchez, M; Sirvent, AE | 1 |
| Abbasi, NZ; Ali, F; Jalal-ud-Din, M; Khan, AA; Memon, KH; Sheikh, AS; Zahur, Z | 1 |
| Borchmann, P; Chen, BE; Connors, JM; Crump, M; Diehl, V; Dörken, B; Eich, HT; Engert, A; Fuchs, M; Goergen, H; Gospodarowicz, MK; Hay, AE; Horning, SJ; Klimm, B; Lohri, A; Markova, J; Meyer, RM; Pearcey, RG; Shepherd, LE; Winter, JN | 1 |
| Dive, C; Gibb, A; Greystoke, A; Hampson, G; Illidge, T; Johnson, P; Linton, K; Lister, A; Neeson, S; Pettitt, A; Radford, J; Ranson, M; Smith, E | 1 |
| Fukayama, M; Honda, A; Ichikawa, M; Kurokawa, M; Nakamura, F; Nannya, Y; Shintani, Y | 1 |
| Cella, L; Conson, M; D'Avino, V; Di Biase, A; Liuzzi, R; Pacelli, R; Picardi, M; Pugliese, N; Salvatore, M; Solla, R | 1 |
| Collins, GP; Eyre, TA; King, AJ | 1 |
| Ansell, SM; Connors, JM; Fanale, M; Huebner, D; Hunder, NN; O'Meara, MM; Park, SI; Younes, A | 1 |
| Kewitz, S; Kramm, CM; Staege, MS; Stiefel, M | 1 |
| Borchmann, P | 1 |
| Hay, AE; Meyer, RM | 1 |
| Ansell, SM | 2 |
| Quillen, K; Raman, V; Sloan, JM | 1 |
| Castillo, JJ; Gavini, A; Reagan, JL; Winer, ES | 1 |
| Canellos, GP; Devita, VT; Friedberg, JW; Lister, TA; Rosenberg, SA | 1 |
| Barbaud, A; Bursztejn, AC; Cribier, B; Cuny, JF; Levy, E; Schmutz, JL; Schoeffler, A; Weinborn, M | 1 |
| Carbonell, F; del Puig Cozar, M; Martínez-Sanjuan, V; Pellicer, B; Sanchez, M; Villegas, C | 1 |
| Perez, CA; Van Driessche, F | 1 |
| Chen, YH; Marcus, KJ; Michaelson, EM; Ng, AK; Silver, B; Stevenson, MA; Tishler, RB | 1 |
| Abbatiello, P; Cantonetti, M; Chiaravalloti, A; Danieli, R; Di Pietro, B; Guazzaroni, M; Orlacchio, A; Schillaci, O; Simonetti, G; Travascio, L | 1 |
| Botto, B; Ciammella, P; Filippi, AR; Gavarotti, P; Iotti, C; Merli, F; Piva, C; Ragona, R; Ricardi, U; Vitolo, U | 1 |
| Abruzzese, E; André, MP; Bardet, S; Bellei, M; Bouabdallah, R; Brice, P; Brusamolino, E; Casasnovas, RO; Federico, M; Fermé, C; Fortpied, C; Girinsky, T; Gotti, M; Hutchings, M; Lievens, Y; Lugtenburg, PJ; Meignan, M; Morschhauser, F; Olivier, P; Oumedaly, R; Raemaekers, JM; Raveloarivahy, T; Re, A; Sebban, CJ; Stamatoullas, A; van der Borght, T; van der Maazen, R; van Imhoff, G; Versari, A | 1 |
| Aloj, L; Becchimanzi, C; Bonelli, A; Capobianco, G; Corazzelli, G; De Chiara, A; De Filippi, R; de Lutio, E; Donnarumma, D; Frigeri, F; Gatani, T; Ionna, F; Lastoria, S; Marcacci, G; Pinto, A; Russo, F; Volzone, F | 1 |
| Kang, SY; Li, YX; Shi, YK; Sun, SY; Sun, Y; Tao, YX; Zhou, LQ | 1 |
| Armitage, JO; Bartlett, NL; Bast, MA; Eastwood, DC; Fenske, TS; Havlat, L; Jewell, SW; Pingali, SR; Thompson, JR; Vose, JM; Wagner-Johnston, ND | 1 |
| Daw, S; Hayward, J; Hewitt, M; Kirkwood, A; McCarthy, K; Morland, B; Shankar, A | 1 |
| Andjelic, B; Antic, D; Bila, J; Bogdanovic, A; Djurasinovic, V; Jakovic, L; Mihaljevic, B; Todorovic, M | 1 |
| Hochhaus, A; Kunert, C; Schnetzke, U; Scholl, S; Schrenk, K; Spies-Weisshart, B | 1 |
| Andre, M; Aoudjhane, A; Bachy, E; Bologna, S; Brice, P; Briere, J; Carde, P; Casasnovas, O; Colin, P; Delmer, A; Devidas, A; Gabarre, J; Gaillard, I; Heczko, M; Humbrecht, C; Jaubert, J; Mounier, N; Nicolas-Virelizier, E | 1 |
| Connors, JM | 5 |
| Cheson, BD | 2 |
| Fukushima, T; Hyakuna, N; Masuzaki, H; Morichika, K; Nakachi, S; Nishi, Y; Shimabukuro, N; Tamaki, K; Tedokon, I; Tomoyose, T | 1 |
| Huang, WW; Tharp, MD | 1 |
| Yahalom, J | 1 |
| Curi Tuma, M; Salazar Gangas, C; Sandoval Osses, M | 1 |
| Alberini, JL; Aupérin, A; Bonniaud, G; Celebic, A; Edeline, V; Elleuch, M; Fermé, C; Girinsky, T; Ribrag, V; Ruelle, C | 1 |
| Auger, J; Berthaut, I; Brugnon, F; Bujan, L; Daudin, M; Hennebicq, S; Moinard, N; Rives, N; Saias, J; Szerman, E; Walschaerts, M | 1 |
| Biggi, A; Coleman, M; Czuczman, MS; Danielewicz, I; Diehl, L; Hutchings, M; Kostakoglu, L; Lamonica, D; Loft, A; Malkowski, B; Nanni, C; Specht, L; Stern, R; Zaucha, JM; Zinzani, PL | 1 |
| Bates, A; Cooke, R; Cunningham, D; Falk, SJ; Gilson, D; Hancock, BW; Harris, SJ; Horwich, A; Hoskin, PJ; Linch, DC; Lister, A; Lucraft, HH; Radford, J; Stevens, AM; Swerdlow, AJ; Syndikus, I; Williams, MV | 1 |
| Fujimaki, K; Hashimoto, C; Ishibashi, D; Ishigatsubo, Y; Ishiyama, Y; Itabashi, M; Kawasaki, R; Koyama, S; Kuwabara, H; Motomura, S; Nakajima, Y; Numata, A; Sakai, R; Takahashi, H; Takasaki, H; Tanaka, M; Tomita, N; Watanabe, R; Yamamoto, E | 1 |
| Enblad, G; Englund, A; Gustafsson, G; Hopstadius, C; Ljungman, G | 1 |
| Abramson, JS; Beltran, BE; Besson, C; Bibas, M; Bower, M; Brühlmann, J; Castillo, JJ; Collins, JA; Connors, JM; Cooley, TP; Cwynarski, K; Dalia, S; Furman, M; Furrer, H; Montoto, S; Nguyen, ML; Novak, U; Ribera, JM; Tanaka, PY; Vose, JM; Xicoy, B | 1 |
| Li, SJ; Vercauteren, SM | 1 |
| Nagai, H | 2 |
| Fujiwara, S; Muroi, K; Nagai, T; Oh, I; Ozawa, K; Sato, M; Tatara, R | 1 |
| Abali, H; Akinci, MB; Aksoy, S; Dogan, M; Ozdemir, N; Sendur, MA; Yazici, O; Yazilitas, D; Zengin, N | 1 |
| Dieckmann, K; Kluge, R; Körholz, D; Mauz-Körholz, C; Vordermark, D | 1 |
| Bento, L; Besalduch, J; Casasus, M; Daumal, J; Garcia, JF; Gutiérrez, A; Herraez, I; Lopez-Perezagua, P; Martinez-Serra, J; Mestre, F; Nicolau, C; Ramos, R; Rodriguez, J | 1 |
| Longo, DL; Sznol, M | 1 |
| Little, RF; Uldrick, TS | 1 |
| Hughes, CL; Kovitz, C; Oki, Y; Yorio, JT | 1 |
| Behringer, K; Bentz, M; Böll, B; Borchmann, P; Diehl, V; Eich, H; Engert, A; Fuchs, M; Goergen, H; Greil, R; Hahn, D; Hallek, M; Hassler, A; Hitz, F; Koch, P; Krause, SW; Kriz, J; Lange, E; Lindemann, HW; Mahlberg, R; Markova, J; Mathas, S; Meissner, J; Mezger, J; Sasse, S; Schalk, E; Semrau, R; Skoetz, N; Soekler, M; Stein, H; Topp, MS; Vieler, T; Vogelhuber, M; von Tresckow, B; Wilhelm, M; Zijlstra, JM | 1 |
| Casasnovas, O; Coiffier, B | 2 |
| Ganesan, P; Ganesan, TS; Kannan, K; Krishnakumar, R; Lakshmipathy, KM; Mahajan, V; Radhakrishnan, V; Rajaraman, S; Rajendranath, R; Sagar, TG; Sundersingh, S; Udupa, K | 1 |
| Amadon, JP; Hathaway, AR; Keith, BA | 1 |
| Gandikota, N; Hartridge-Lambert, S; Migliacci, JC; Portlock, CS; Schöder, H; Yahalom, J | 1 |
| Akhtar, S; Alhuraiji, A | 1 |
| Alonso, JM; Alonso-Nogues, E; Dominguez-Iglesias, F; Fernandez-Alvarez, C; Fernandez-Alvarez, R; Gonzalez, ME; Gonzalez-Rodriguez, AP; Medina, J; Payer, AR; Rubio-Castro, A; Sancho, JM; Solano, J; Vicente, JM; Zanabili, Y | 1 |
| Beaven, AW; Diehl, LF; Kelsey, CR; Kim, GJ; Prosnitz, LR; Torok, JA; Wu, Y | 1 |
| Ahmed, S; Akhtari, M; Allen, PK; Arzu, I; Dabaja, B; Fanale, MA; Fayad, L; Fowler, N; Hagemeister, FB; Milgrom, S; Nastoupil, L; Nieto, Y; Oki, Y; Osborne, EM; Pinnix, CC; Reddy, JP; Reed, V; Rodriguez, MA; Romaguera, J; Smith, GL; Turturro, F; Westin, J; Wogan, CF | 1 |
| Barone, L; Belsito Petrizzi, V; Califano, C; D'Arco, AM; De Lorenzo, S; Iovino, V; Langella, M; Maglione, V; Rivellini, F | 1 |
| Abdelkhalek, ER; Beshir, MR; Elbehedy, R; Elsafy, UR; Hassan, TH; Kamal, NM; Saleh, SH; Sherbiny, HS; Sherief, LM | 1 |
| Bouabdallah, R; Brice, P; Camus, V; Franchi, P; Lanic, H; Mareschal, S; Rahal, I; Stamatoullas, A; Tilly, H | 1 |
| Corazzelli, G; Pinto, A | 1 |
| Alarcón, C; Alonso, JM; Chamorro, C; deAndrés-Galiana, EJ; Del Coz, JJ; Fernández, R; Fernández-Martínez, JL; Gonzalez, S; González-Ordóñez, A; González-Rodríguez, AP; Luaces, O; Medina, J; Morán, M; Nogués, EA; Ortiz, S; Palicio, MA; Payer, AR; Solano, J; Taboada, F; Vargas, M; Vicente, JM; Zanabilli, Y | 1 |
| Advani, RH; Bartlett, NL; Blum, KA; Cheson, BD; Fisher, RI; Friedberg, JW; Gascoyne, RD; Gordon, LI; Habermann, TM; Hong, F; Hoppe, RT; Horning, SJ; Kahl, BS; Robinson, KS; Stewart, DA; Stiff, PJ; Tuscano, JM; Wagner, H | 1 |
| Barrington, S; Brownell, A; Counsell, N; Culligan, D; Hancock, B; Hoskin, P; Illidge, T; Johnson, P; Kruger, A; Lister, A; McMillan, A; O'Doherty, M; Pettengell, R; Popova, B; Radford, J; Smith, P; Wimperis, J | 1 |
| Armitage, JO; Longo, DL | 1 |
| Cavalli, F; Ceriani, L; Griguolo, G; Mazzucchelli, L; Stathis, A; Zucca, E | 1 |
| Gallamini, A; Kostakoglu, L | 1 |
| Datsenko, PV; Panshin, GA | 1 |
| Ando, K; Kawai, H; Kojima, M; Miyamoto, M; Nakamura, N; Ogawa, Y; Ogiya, D; Ohmachi, K | 1 |
| Botto, B; Buglione, M; Ciammella, P; Filippi, AR; Iotti, C; Livi, L; Magrini, SM; Merli, F; Re, A; Ricardi, U; Saieva, C; Simontacchi, G; Vaggelli, L | 1 |
| Follows, GA | 1 |
| Filatova, LV | 2 |
| Illidge, T | 1 |
| Algarte-Genin, M; Besson, C; Bonnet, F; Boué, F; Brice, P; Costagliola, D; Costello, R; Gabarre, J; Goujard, C; Hendel-Chavez, H; Lambotte, O; Lancar, R; Marchand, L; Marchou, B; Meyohas, MC; Mounier, N; Partisani, M; Prevot, S; Raffi, F; Raphael, M; Taoufik, Y; Trabelsi, S | 1 |
| Abruzzese, E; Bocchia, M; Bono, R; Bosi, A; Cencini, E; Cox, MC; Di Lollo, S; Di Napoli, A; Fabbri, A; Fratoni, S; Gini, G; Goteri, G; Kovalchuk, S; Lazzi, S; Leoncini, L; Mancuso, S; Rigacci, L | 1 |
| Advani, RH; Bartlett, NL; Blum, KA; Cheson, BD; Crump, M; Diefenbach, CS; Fisher, RI; Friedberg, JW; Gascoyne, RD; Gordon, LI; Habermann, TM; Hong, F; Hoppe, RT; Horning, SJ; Kahl, BS; Li, H; Stewart, DA; Stiff, PJ; Tuscano, JM; Wagner, H | 1 |
| Burrows, SH; Mannari, D | 1 |
| Kang, S; Li, Y; Shi, Y; Sun, Y; Tao, Y; Zhou, L | 1 |
| Almagro-Casado, E; Cantos, B; Pérez-Callejo, D; Provencio, M; Salas, C; Sánchez, A | 1 |
| Apel, A; Avigdor, A; Ben-Bassat, I; Dann, EJ; Davidson, T; Kedmi, M; Levi, I; Nagler, A; Polliack, A | 1 |
| Boltežar, L; Jezeršek Novaković, B; Pintarić, K | 1 |
| Huh, J; Jeon, YK; Koh, YW; Suh, C; Yoon, DH | 1 |
| Amorim, S; Bouabdallah, R; Brice, P; Garciaz, S; Harel, S; Thieblemont, C | 1 |
| Annechini, G; Fiore, G; Gandini, L; Lenzi, A; Lombardo, F; Pallotti, F; Paoli, D; Pulsoni, A; Rizzo, F | 1 |
| Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C | 1 |
| Specht, L | 2 |
| Almquist, H; Barrington, SF; Berkahn, L; Brun, E; D'Amore, F; Federico, M; Fosså, A; Franceschetto, A; Fulham, MJ; Hjorthaug, K; Johnson, PW; Kirkwood, AA; Luminari, S; Molin, D; O'Doherty, MJ; Pike, LC; Radford, J; Roberts, TH; Sinclair, DA; Smith, P; Stevens, L; Trotman, J; Viney, ZN | 1 |
| Buckstein, R; Chan, KK; Cheung, MC; Graczyk, J; Prica, A | 1 |
| Bierman, PJ; Bociek, RG; Kallam, A | 1 |
| Angelucci, E; Bari, A; Bellei, M; Ciccone, G; Ilariucci, F; Levis, A; Liberati, AM; Mannina, D; Merli, F; Monagheddu, C; Rota Scalabrini, D; Salvi, F; Stelitano, C; Tamiazzo, S; Vallisa, D; Vitolo, U; Zallio, F | 1 |
| Fukuhara, N; Harigae, H; Ichikawa, S; Ichinohasama, R; Katsushima, H; Takahashi, T | 1 |
| Behringer, K; Böll, B; Borchmann, P; Borchmann, S; Bröckelmann, PJ; Bürkle, C; Diehl, V; Eichenauer, DA; Engert, A; Fuchs, M; Goergen, H; Greil, R; Hitz, F; Kerkhoff, A; von Tresckow, B | 1 |
| Arakelyan, S; Avagyan, A; Bardakchyan, S; Danielyan, S; Hakobyan, L; Harutyunyan, L; Iskanyan, S; Safaryan, L; Sargsyan, L; Tamamyan, G; Voskanyan, A; Zohrabyan, D | 1 |
| Bajpai, R; Jain, S; Kapoor, G | 1 |
| Chong, G; Doig, R; Grigg, A; Ha, FJ; Hamid, A; Hawkes, EA; Jalali, A; Mckendrick, J; Schwarer, AP | 1 |
| Huh, J; Kim, S; Lee, SW; Park, CS; Park, JH; Park, JS; Suh, C; Sung, H; Yoon, DH | 1 |
| Bocchia, M; Cencini, E; Fabbri, A | 1 |
| Angelopoulou, MK; Boutsikas, G; Dimopoulou, MN; Dimou, M; Flevari, P; Gainaru, G; Kanellopoulos, A; Konstantopoulos, K; Koutsi, K; Kyrtsonis, MC; Meletis, J; Moschogiannis, M; Panayiotidis, P; Pangalis, GA; Papageorgiou, L; Petevi, K; Plata, E; Sachanas, S; Siakantaris, MP; Telonis, V; Tsaftaridis, P; Tsirkinidis, P; Variami, E; Vassilakopoulos, TP; Viniou, NA; Yiakoumis, X | 1 |
| Cédrin-Durnerin, I; Grynberg, M; Sermondade, N; Seroka, A; Sifer, C; Sonigo, C | 1 |
| Caocci, G; Carcassi, C; Caria, R; Celeghini, I; Di Raimondo, F; Gallamini, A; Greco, M; La Nasa, G; Lai, S; Littera, R; Martino, M; Oppi, S; Porcella, R; Romano, A | 1 |
| Bisi, G; Botto, B; Buglione, M; Ciammella, P; Filippi, AR; Iotti, C; Mangoni, M; Marcheselli, L; Merli, F; Ricardi, U; Simontacchi, G; Versari, A | 1 |
| Barr, PM; Bartlett, NL; Cheson, BD; Cook, JR; Evens, AM; Fanale, MA; Fisher, RI; Friedberg, JW; Gascoyne, RD; Hsi, ED; Kahl, BS; Knopp, MV; LaCasce, AS; LeBlanc, M; Lechowicz, MJ; Leonard, JP; Li, H; Mittra, ES; Moskowitz, CH; Noy, A; Press, OW; Rimsza, LM; Schöder, H; Straus, DJ; Sweetenham, JW | 1 |
| Fukuhara, S; Itami, J; Kitahara, H; Kobayashi, Y; Maeshima, AM; Makita, S; Maruyama, D; Miyamoto, K; Munakata, W; Taniguchi, H; Tobinai, K | 1 |
| Aurer, I; Bologna, S; Brice, P; Caillot, D; Carde, P; Casasnovas, O; Coiffier, B; Ferme, C; Fortpied, C; Gaillard, I; Glimelius, B; Karrasch, M; Khaled, H; Lugtenburg, PJ; Meyer, R; Morschhauser, F; Mounier, N; Seftel, M; Sureda, A; Wolf, M | 1 |
| Advani, RH; Lynch, RC | 1 |
| Eich, HT; Kriz, J | 1 |
| Akhtari, M; Allen, PK; Dabaja, BS; Fanale, MA; Gunther, JR; Mawlawi, O; Milgrom, SA; Osborne, EM; Pinnix, CC; Reddy, JP; Smith, GL; Yehia, ZA | 1 |
| Bálint, BL; Illés, Á; Jóna, Á; Miltényi, Z; Póliska, S | 1 |
| Barrington, S; Berkahn, L; Carella, A; d'Amore, F; Enblad, G; Federico, M; Fosså, A; Franceschetto, A; Fulham, M; Johnson, P; Kirkwood, A; Luminari, S; O'Doherty, M; Patrick, P; Radford, J; Roberts, T; Sidra, G; Smith, P; Stevens, L; Trotman, J; Viney, Z | 1 |
| Danilov, AV; Friedberg, JW; Li, H; Noy, A; Press, OW; Reid, E; Shapira, I; Smith, SM; Swinnen, LJ | 1 |
| Borchmann, S; Engert, A; von Tresckow, B | 1 |
| Barr, PM; Caron, P; Casulo, C; Chiu, A; Constine, LS; Drullinsky, P; Friedberg, JW; Gerecitano, JF; Hamilton, A; Hamlin, PA; Horwitz, SM; Jacob, AG; Kumar, A; Matasar, MJ; McArthur, GN; McCall, SJ; Moskowitz, AJ; Moskowitz, CH; Noy, A; Palomba, ML; Portlock, CS; Schöder, H; Straus, DJ; VanderEls, N; Verwys, SL; Yahalom, J; Yang, J; Younes, A; Zelenetz, AD; Zhang, Z | 1 |
| Johnson, PWM; Vassilakopoulos, TP | 1 |
| Chen, G; Chen, Y; Huang, R; Jiang, Y | 1 |
| Bordenave, L; Bouabdallah, K; Cazeau, AL; Guyot, M; Hindié, E; Mesguich, C; Milpied, N; Soubeyran, P | 1 |
| Agati, P; Agostinelli, C; Argnani, L; Biggi, A; Borra, A; Broccoli, A; d'Amore, F; Fanti, S; Fuligni, F; Gallamini, A; Gascoyne, RD; Hamilton-Dutoit, S; Kamper, P; Kulikowski, W; Levis, A; Małkowski, B; Merli, F; Patti, C; Piccaluga, PP; Pileri, SA; Rigacci, L; Romano, A; Rybka, J; Sista, MT; Steidl, C; Stelitano, C; Stracqualursi, L; Subocz, E; Tajer, J; Trentin, L; Tripodo, C; Vitolo, U; Zaucha, JM; Zinzani, PL | 1 |
| Abou Yehia, Z; Akhtari, M; Allen, PK; Dabaja, BS; Fanale, MA; Gunther, JR; Horace, T; Jiang, W; Mawlawi, O; Mikhaeel, GN; Milgrom, SA; Oki, Y; Pinnix, CC; Reddy, J; Shank, JH; Smith, G; Suki, T; Tang, C; Turner, S | 1 |
| Bakhshi, S; Bhethanabhotla, S | 1 |
| Johnson, PW | 1 |
| Bakhshi, S; Bhethanabhotla, S; Chopra, A; Jain, S; Kapoor, G; Mahajan, A; Vishnubhatla, S | 1 |
| Brice, P; Dhedin, N; Poirot, C | 1 |
| Anderson, RA; Kelsey, TW; McLaughlin, M; Telfer, EE; Wallace, WH | 1 |
| Grynberg, M; Sermondade, N; Sonigo, C | 1 |
| Akhtari, M; Chuang, H; Dabaja, BS; Dong, W; Fanale, M; Garg, N; Gunther, JR; Khoury, JD; Mawlawi, O; Milgrom, SA; Oki, Y; Osborne, EM; Pinnix, CC; Reddy, JP; Rohren, E; Smith, GL; Suki, T; Yehia, ZA | 1 |
| Cheson, BD; Kostakoglu, L | 1 |
| Bouaouina, N; Fourati, N; Kanoun Belajouza, S; Khlif, A; Regaieg, H | 1 |
| André, MPE; Bellei, M; Bouabdallah, R; Brice, P; Casasnovas, O; Delarue, R; Edeline, V; Federico, M; Fermé, C; Fiaccadori, V; Fortpied, C; Girinsky, T; Gotti, M; Hutchings, M; Meignan, M; Merli, F; Raemaekers, J; Raveloarivahy, T; Re, A; Reman, O; Sebban, C; Specht, L; Stamatoullas, A; van der Maazen, R; van Imhoff, G; Versari, A | 1 |
| Campanelli, M; Caputo, MD; Del Poeta, G; Foà, R; Frustaci, AM; Galieni, P; Gentile, M; Gozzetti, A; Guarini, A; Innocenti, I; Laurenti, L; Mauro, FR; Morabito, F; Motta, M; Murru, R; Raponi, S; Reda, G; Tedeschi, A | 1 |
| Engert, A | 1 |
| Camci, C; Comez, G; Kalender, ME; Pehlivan, Y; Sari, I; Sevinc, A | 1 |
| Behringer, K; Diehl, V; Engert, A; Fuchs, M; Halbsguth, T; Josting, A; Nogova, L; Reineke, T; Sieniawski, M | 1 |
| Andersen, AN; Andersen, CY; Ernst, E; Loft, A; Rasmussen, PE; Rosendahl, M; Westergaard, LG | 1 |
| Diehl, V; Evens, AM; Hutchings, M | 1 |
| Nangalia, J; Smith, H; Wimperis, JZ | 1 |
| Brice, P; Casasnovas, O; Cazeneuve, C; Gabarre, J; Koscielny, S; Lenoir, G; Morschhauser, F; Ribrag, V; Salles, G; Stamatoullas, A | 1 |
| Andrieu, JM; Arakelyan, N; Berthou, C; Colonna, P; de Guibert, S; Delwail, V; Desablens, B; Jais, JP; Moles, MP; Quittet, P | 1 |
| Alves, AC; Baiocchi, OC; Oliveira, JS; Souza, EM; Zanichelli, MA | 1 |
| Csóka, M; Deák, B; Gergely, L; Illés, A; Jakab, Z; Keresztes, K; Kovács, G; Molnár, Z; Müller, J; Rosta, A; Schneider, T; Simon, Z; Várady, E | 1 |
| Eduardo, Cde P; Eduardo, Fde P; Lang-Bicudo, L; Zezell, DM | 1 |
| Alm El-Din, MA; El-Badawy, SA; Taghian, AG | 1 |
| Radford, J | 1 |
| Feng, FY; Gu, DZ; He, XH; Niu, Y; Shi, YK; Zhou, LQ | 1 |
| Angrilli, F; Baldini, L; Brugiatelli, M; Cervetti, G; Di Renzo, N; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Luminari, S; Marcheselli, L; Mazza, P; Merli, F; Montanini, A; Musto, P; Polimeno, G; Pozzi, S; Scalone, R; Stelitano, C | 1 |
| Date, RS; Mellor, S; Nair, B; Umer, MA; Ward, JB | 1 |
| Ben Salem, D; Casasnovas, O; Couaillier, JF; Krausé, D; Lambert, A; Piard, F; Régis, A | 1 |
| Arai, A; Ichinohasama, R; Miura, O; Oshikawa, G; Sasaki, K | 1 |
| Brugiatelli, M; Danova, M; Federico, M; Gentile, M; Gobbi, PG; Iannitto, E; Luminari, S; Mammi, C; Merli, F; Morabito, F; Quintana, G; Rovati, B; Stelitano, C; Valentino, F | 1 |
| Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Villani, M; Viviani, S | 1 |
| Carbone, A; Gloghini, A; Serraino, D; Spina, M | 1 |
| Angrilli, F; Baldini, L; Brugiatelli, M; Callea, V; Calvaruso, G; Federico, M; Gobbi, PG; Iannitto, E; Liardo, E; Luminari, S; Marcheselli, L; Merli, F; Minardi, V; Molica, S; Petrini, M; Polimeno, G; Quarta, G; Stelitano, C; Tripodo, C; Vallisa, D | 1 |
| Czerminski, J; LaCasce, AS; Mauch, PM; Ng, AK; Sher, DJ; Van Den Abbeele, A | 1 |
| Avigdor, A; Ben-Bassat, I; Bulvik, S; Dann, EJ; Levi, I; Nagler, A; Perez-Avraham, G; Polliack, A; Shemtov, N; Shimoni, A | 1 |
| Howson-Jan, K; Hsia, CC; Rizkalla, KS | 1 |
| Cullen, MH; Hancock, BW; Johnson, PWM; Owadally, WS; Radford, JA; Stenning, SP; Sydes, MR | 1 |
| Al-Jasir, B; Alomary, I; Alsaeed, E; Bence-Bruckler, I; Cross, P; Genest, P; Huebsch, L; Samant, R | 1 |
| Aulitzky, WE; Bentz, M; Diehl, V; Dörken, B; Engert, A; Franklin, J; Hänel, M; Hasenclever, D; Koch, P; Löffler, M; Lohri, A; Ludwig, WD; Müller-Hermelink, HK; Pfreundschuh, M; Rummel, M; Sezer, O; Trümper, L; Wilhelm, M | 1 |
| Blomannova, E; Dienstbier, Z; Fridrichova, M; Loucka, M; Skala, E | 1 |
| Cotta, CV; Drakos, E; Leventaki, V; Medeiros, LJ; Rassidakis, GZ; Vega, F | 1 |
| Cunningham, D; Hancock, BW; Horwich, A; Hoskin, PJ; Jack, A; Johnson, PW; Linch, D; Lowry, L; Mead, B; Patrick, P; Pettengell, R; Pettitt, A; Popova, B; Qian, W; Smith, P; Sweetenham, J | 1 |
| Abella, E; Berenguer, J; Esteban, H; López-Guillermo, A; Mahillo, B; Miralles, P; Morgades, M; Navarro, JT; Ribera, JM; Rubio, R; Sureda, A; Valencia, ME; Xicoy, B | 2 |
| Björkholm, M; Cherif, H; Kalin, M; Kristinsson, SY; Lebbad, M | 1 |
| Haratoh, R; Irie, R; Miyakawa, S; Tanese, K; Wakabayashi, A; Yamamoto, K | 1 |
| Mukesh, M; Murray, P; Shuttleworth, D | 1 |
| Aldinucci, D; Carbone, A; Colombatti, A; Gloghini, A; Lorenzon, D; Olivo, K; Rapana', B | 1 |
| Leong, C; Lim, ST; Loh, Y; Ngeow, J; Quek, R; Tan, HC; Tan, I; Tao, M | 1 |
| Bennett, JM; Glick, JH; Hong, F; Wiernik, PH | 1 |
| Azambuja, D; Biasoli, I; Britto, L; Lossos, IS; Morais, JC; Natkunam, Y; Pulcheri, W; Scheliga, A; Spector, N | 1 |
| García-Sanz, R; González-López, TJ; Graciani, IF; Hermida, G; San Miguel, JF; Vázquez, L | 1 |
| Bonetti, E; Dondi, A; Falorio, S; Federico, M; Gobbi, PG; Merli, F; Quarta, G; Rosti, V; Stelitano, C; Valentino, F | 1 |
| Canellos, GP; Johnson, JL; Niedzwiecki, D | 1 |
| Kuruvilla, J | 1 |
| Akazawa, T; Akechi, T; Furukawa, TA; Inagaki, A; Katsumata, R; Nakaaki, S; Okuyama, T; Sagawa, R; Shinagawa, Y | 1 |
| Song, YQ; Zhu, J | 1 |
| Abramson, JS; Canellos, GP; Fisher, DC; LaCasce, AS | 1 |
| Akioka, T; Hanafusa, T; Hiraoka, N; Hirata, Y; Iwaki, K; Kobayashi, K; Nakayama-Ichiyama, S; Oka, S; Takayama, A; Takubo, T; Tsuji, M; Yokote, T | 1 |
| Fermé, C; Mounier, N | 1 |
| George, IA; George, R; Rajan, SJ; Seshadri, P | 1 |
| Cheung, MC; Hicks, LK; Leitch, HA | 1 |
| Abe, D; Ariyoshi, N; Kitada, M; Koga, H; Nakamura, H; Nakasa, H; Nakaseko, C; Nishimura, M; Saeki, H; Suzuki, T; Takeuchi, M; Yamazaki, S | 1 |
| Oki, Y; Younes, A | 1 |
| Cullen, M; Hancock, BW; Johnson, PW; Radford, JA; Stenning, SP; Sydes, MR | 1 |
| Avila, G; Bar, D; Bezares, RF; Cerutti, I; Corrado, C; Giunta, M; Lastiri, F; Pagani, F; Palomino, E; Pavlovsky, MA; Pavlovsky, S; Prates, MV; Zoppegno, L | 1 |
| Bauer, K; Brillant, C; Engert, A; Herbst, C; Kluge, S; Monsef, I; Skoetz, N | 1 |
| Andrieu, JM; Arakelyan, N; Berthou, C; Brière, J; Colonna, P; Delwail, V; Desablens, B; Jais, JP; Moles-Moreau, MP; Sénécal, D | 1 |
| Kagaya, H; Miura, M; Nara, M; Saitoh, H; Sawada, K; Takahashi, N | 1 |
| Flampouri, S; Hoppe, BS; Li, Z; Mendenhall, NP | 1 |
| Baldini, L; F, FG; Ferrario, A; Goldaniga, M; Olivero, B; Radaelli, F; Rossi, F | 1 |
| Agaoglu, F; Basaran, G; Basaran, M | 1 |
| Akioka, T; Hanafusa, T; Hiraoka, N; Hirata, Y; Kobayashi, K; Miyoshi, T; Nakayama, S; Oka, S; Takubo, T; Tsuji, M; Yokote, T | 1 |
| Bergsträsser, E; Dieckmann, K; Dörffel, W; Fosså, A; Hasenclever, D; Hummel, M; Karlén, J; Klapper, W; Kluge, R; Körholz, D; Mann, G; Mauz-Körholz, C; Pelz, T; Ruschke, K; Stein, H; Stiefel, M; Vilser, C; Voigt, A; Vordermark, D; Winkler, M | 1 |
| Lampka, E; Sagan, D; Semczuk, A | 1 |
| Borchmann, P; Debus, J; Diehl, V; Döhner, H; Dörken, B; Eich, HT; Engert, A; Görgen, H; Greil, R; Grosu, AL; Ho, A; Karstens, JH; Markova, J; Müller, RP; Müller-Hermelink, HK; Pabst, T; Rank, A; Schmidberger, H; Wiegel, T; Willich, N | 1 |
| Buccheri, V; Cerci, JJ; Delbeke, D; Izaki, M; Linardi, CC; Meneghetti, JC; Pitella, FA; Pracchia, LF; Soares, J; Trindade, E | 1 |
| Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M | 1 |
| Culakova, E; Lyman, GH; Pettengell, R; Schwenkglenks, M; Szucs, TD | 1 |
| Albayrak, M; Coskun, U; Gursel, T; Kaya, Z; Keskin, EY; Kocak, U; Uluoglu, O | 1 |
| Berger, B; Bokemeyer, C; Borchmann, P; Debus, J; Diehl, V; Dörken, B; Eble, MJ; Eich, HT; Engert, A; Fuchs, M; Ganser, A; Greil, R; Ho, A; Kirchner, H; Král, Z; Lohri, A; Müller, RP; Müller-Hermelink, HK; Plütschow, A; Rank, A; Schubert, J; Sökler, M; Trümper, L; Wilhelm, M; Willborn, KC | 1 |
| Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Viviani, S | 1 |
| Bueso-Ramos, C; Fayad, L; Greaves, WO | 1 |
| Asaoku, H; Chou, T; Fukuda, H; Hirano, M; Hotta, T; Ikeda, S; Itoh, K; Kagami, Y; Kinoshita, T; Mikuni, C; Nakamura, S; Nasu, K; Ogura, M; Ohnishi, K; Ohno, H; Ohtsu, T; Okabe, K; Okamoto, M; Sasaki, T; Shimoyama, M; Takenaka, T; Tobinai, K | 1 |
| Chen, DB; Shen, DH; Wang, Y | 1 |
| Bozhenko, VK; Datsenko, PV; Pan'shin, GA; Podol'skiĭ, PN; Sotnikov, VM | 1 |
| Barrington, S; Biggi, A; Cantonetti, M; Chauvie, S; Di Raimondo, F; Fallanca, F; Feldman, T; Ficola, U; Fiore, F; Gallamini, A; Gavarotti, P; Gianni, AM; Leone, M; Mulè, A; Patti, C; Rambaldi, A; Rossi, A; Sorasio, R; Stelitano, C; Viviani, S | 1 |
| da Costa, AA; de Lima, VC; Flora, AC; Soares, FA; Stroher, M | 1 |
| Fujimaki, K; Fujisawa, S; Fujita, H; Harano, H; Hashimoto, C; Hyo, R; Ishigatsubo, Y; Ito, S; Kanamori, H; Koharazawa, H; Miyazaki, T; Motomura, S; Ohshima, R; Takasaki, H; Takemura, S; Tomita, N; Yamazaki, E | 1 |
| Illés, A; Kovács, G; Molnár, Z; Müller, J; Rosta, A; Váróczy, L | 1 |
| Arizcorreta, A; Gil-Fernández, JJ; Gómez-Herruz, P; Guillen, H | 1 |
| Al Nawakil, C; Beranger, N; Brice, P; Brière, J; de Bazelaire, C; de Kerviler, E; Ertault, M; Franchi, P; Sibon, D; Thieblemont, C | 1 |
| Andresen, S; Bolwell, B; Copelan, E; Dean, R; Maragulia, JC; Moskowitz, AJ; Moskowitz, CH; Pohlman, B; Smith, SD; Sobecks, R; Sweetenham, J; Vanak, JM | 1 |
| Beaudre, A; Ferreira, I; Ghalibafian, M; Girinsky, T; Lefkopoulos, D; Lessard, NA; Messai, T; Paumier, A; Pichenot, C | 1 |
| El Shahat, AM; Elmasry, OA; Shaaban, M; Tantawy, AA; Toaima, DN | 1 |
| Abboud, M; Dabaja, B; Fisher, C; Mazloom, A; Phan, J; Reed, V; Salehpour, M; Shihadeh, F; Wogan, C; Zreik, T | 1 |
| Böll, B; Borchmann, P; Diehl, V; Halbsguth, TV | 1 |
| Dimeo, FC | 1 |
| Banzer, W; Bernhörster, M; Jäger, E; Rosenhagen, A; Thiel, C; Vogt, L | 1 |
| Avivi, I; Dann, EJ; Hardak, E; Igla, M; Rowe, JM; Shaham, B | 1 |
| Belin, L; Bollet, MA; Campana, F; Decaudin, D; Fourquet, A; Haberer, S; Kirova, YM; Le Scodan, R; Moisson, P; Pierga, JY; Reyal, F; Savignoni, A; Stevens, D | 1 |
| Hatta, Y; Hirabayashi, Y; Horikoshi, A; Iriyama, N; Kodaira, H; Takeuchi, J; Tanaka, T | 1 |
| Straus, DJ | 3 |
| Hayward, J; Hewitt, M; McCarthy, K; Morland, B; Shankar, A; Visaduraki, M | 1 |
| Bhagirath, V; Chin-Yee, BH; Chin-Yee, IH; Lazo-Langner, A; Mangel, JE; Minuk, LA; Monkman, K | 1 |
| Alterini, R; Bosi, A; Carrai, V; Caruso, JP; Landi, C; Perrone, T; Puccini, B; Rigacci, L | 1 |
| Bonadonna, G; Bonfante, V; Brusamolino, E; Gallamini, A; Gianni, AM; Gotti, M; Levis, A; Liberati, AM; Pogliani, EM; Pregno, P; Pulsoni, A; Rambaldi, A; Rossi, A; Rota Scalabrini, D; Specchia, G; Valagussa, P; Vitolo, U; Viviani, S; Zaja, F; Zinzani, PL | 1 |
| Cunningham, D; Hawkes, EA; Wotherspoon, A | 1 |
| Bauer, K; Brillant, C; Engert, A; Monsef, I; Skoetz, N | 1 |
| Andreozzi, J; Becker, M; Bernstein, SH; Constine, L; Fisher, RI; Friedberg, JW; Keller, SF; Kelly, JL; Liesveld, J; Oliva, J; Phillips, G; Rich, L; Sensenig, E | 1 |
| Al-Mansour, M; Connors, JM; Gascoyne, RD; Savage, KJ; Sehn, LH; Skinnider, B | 1 |
| Johnson, PW; Lim, SH | 1 |
| Argnani, L; Baccarani, M; Broccoli, A; Castagnoli, A; Fanti, S; Puccini, B; Rigacci, L; Stefoni, V; Vaggelli, L; Zanoni, L; Zinzani, PL | 1 |
| Federico, M; Gentile, M; Gobbi, P; Hohaus, S; Iannitto, E; La Sala, A; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Montanini, A; Morabito, F; Scalone, R; Stelitano, C; Voso, MT | 1 |
| Dib, M; Gagnadoux, F; Paris, A; Rousselet, MC; Tazi, A; Urban, T | 1 |
| Borchmann, P; Diehl, V; Engert, A | 1 |
| Baldini, L; Bellei, M; Bordonaro, R; Chisesi, T; Federico, M; Gobbi, P; Levis, A; Liberati, M; Luminari, S; Marcheselli, L; Merli, F; Montanini, A; Pavone, V; Pesce, EA; Stelitano, C; Vitolo, U | 1 |
| Chen, YH; Dosoretz, AP; Fisher, DC; Fox, AM; Freedman, AS; LaCasce, AS; Mauch, PM; Ng, AK; Silver, B | 1 |
| Batty, N; Copeland, A; Dabaja, BS; Feng, L; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Samaniego, F; Younes, A | 1 |
| Casey, DJ; Kim, AY; Olszewski, AJ | 1 |
| Hotta, T; Shimoyama, M; Tobinai, K; Tsukasaki, K | 1 |
| Chen, BE; Connors, JM; Crump, M; Dar, AR; Djurfeldt, MS; Gospodarowicz, MK; Horning, SJ; Meyer, RM; Pearcey, RG; Shepherd, LE; Shustik, C; Stewart, DA; Wells, WA; Winter, JN | 1 |
| Behringer, K; Borchmann, P; Diehl, V; Eibl, AD; Eichenauer, DA; Engert, A; Fuchs, M; Goergen, H; Halbsguth, T; Kuehr, M; Mueller, H; Reiners, KS; Renno, JH; Rosenbrock, J; Thielen, I; van der Ven, K; von Wolff, M | 1 |
| Andjelic, BM; Jakovic, LR; Mihaljevic, BS | 1 |
| Dembla, V; Elkins, SL; Files, JC; Walker, BN | 1 |
| Bassi, E; Bergonzi, M; Coriani, C; Federico, M; Gobbi, PG; Iannitto, E; Luminari, S; Merli, F; Polimeno, G | 1 |
| Borchmann, P; Diehl, V; Eich, HT; Engert, A; Fuchs, M; Greil, R; Klimm, B; Kral, Z; Lohri, A; Markova, J; Meissner, J; Mueller, RP; Plütschow, A; Soekler, M; Stein, H; Topp, MS; von Tresckow, B; Zijlstra, JM | 1 |
| Angelopoulou, MK; Bartzis, V; Bitsani, A; Boutsikas, G; Dimou, M; Efthimiou, A; Georgiou, G; Kalpadakis, C; Kanellopoulos, A; Karali, V; Korkolopoulou, P; Koutsoukos, K; Kyrtsonis, MC; Meletis, J; Moschogianni, M; Ntalageorgos, T; Panayiotidis, P; Pangalis, GA; Pappi, V; Patsouris, E; Pessach, E; Petevi, K; Rassidakis, G; Tsopra, O; Vardounioti, I; Vassilakopoulos, TP; Yiakoumis, X; Zografos, E | 1 |
| Bolacchi, F; Danieli, R; Della Gatta, F; Gaspari, E; Mancini, A; Orlacchio, A; Ragano Caracciolo, C; Schillaci, O; Simonetti, G | 1 |
| Opie, JJ; Shuttleworth, MH; Swart, L; van Schalkwyk, WA | 1 |
| Bower, M; Cwynarski, K; Fields, P; Marcus, R; McNamara, C; Montoto, S; Okosun, J; Shaw, K; Virchis, A; Warbey, V | 1 |
| Chen, DB; Shen, DH | 1 |
| Ambinder, RF; Gladstone, DE; Gocke, CD; Habermann, TM; Herman, JM; Jacene, HA; Jones, RJ; Kasamon, YL; Link, BK; Matsui, WH; Perkins, B; Popplewell, LL; Swinnen, LJ | 1 |
| Chuang, HH; Copeland, AR; Dabaja, BS; Dang, N; Fanale, MA; Fayad, LE; Feng, L; Goy, A; Hagemeister, F; Kwak, LW; Macapinlac, HA; McLaughlin, P; Neelapu, SS; Oki, Y; Pro, B; Rodriguez, MA; Romaguera, J; Samaniego, F; Younes, A; Yuan, Y | 1 |
| Arai, A; Honma, R; Igarashi, A; Imadome, K; Kurata, M; Miura, O; Omoto, E; Uchida, E | 1 |
| Alfò, M; Annechini, G; Cavalieri, E; De Sanctis, V; Enrici, RM; Filippone, FR; Minniti, G; Muni, R; Osti, MF; Pulsoni, A; Valeriani, M | 1 |
| Chen, B; Dai, JR; Fang, H; Jin, J; Li, YX; Liu, XF; Liu, YP; Lu, NN; Ren, H; Song, YW; Wang, SL; Wang, WH; Wu, RY; Yu, ZH; Zhang, XM | 1 |
| Anter, AH; Awad, IA; Hamed, RH | 1 |
| Kuruvilla, J; Uhm, J | 1 |
| Garcia, JF; Gutierrez, A; Martinez-Serra, J; Matheu, G; Mestre, F; Ramos, R; Rodriguez, J; Ros, T; Sánchez, L | 1 |
| Ballanti, S; Dammacco, F; Di Ianni, M; Falzetti, F; Iodice, G; Martelli, MF; Minelli, O; Reale, A; Ria, R; Serio, G; Vacca, A | 1 |
| Andersen, CY; Schmidt, KT | 1 |
| Eggers, SD; Habermann, TM; Klebig, RR; Neff, BA; Pittock, SJ; Shepard, NT | 1 |
| Aznar Oroval, E; García-Lozano, T; Juan Bañón, JL; Lorente Alegre, P | 1 |
| Filatova, LV; Gershanovich, ML; Semiglazova, TIu; Tarasenkova, AA | 1 |
| Dinand, V; Prakash, A; Sachdeva, A; Yadav, SP | 1 |
| Boro, J; Cheung, MC; Ezzat, HM; Harris, M; Hicks, LK; Leitch, HA; Lima, VD; Montaner, JS | 1 |
| Ahmad, M; Ashraf, SM; Gupta, A; Kumar, A; Rizvi, I; Zaidi, N; Zaman, S | 1 |
| Andrieu, JM; Arakelyan, N; Berthou, C; Brière, J; Casassus, P; Colombat, P; Colonna, P; Desablens, B; Gastinne, T; Ghandour, C; Jais, JP; Le Pourhiet-Le Mevel, A; Moles-Moreau, MP; Quittet, P; Tomowiack, C | 1 |
| Horibe, K; Inada, H; Kobayashi, R; Koga, Y; Kumagai, M; Mimaya, J; Mori, T; Nakazawa, A; Takimoto, T; Tsurusawa, M | 1 |
| Huang, JJ; Jiang, WQ; Li, ZM; Xia, Y; Zhu, YJ | 1 |
| Daya, R; Feng, Q; Zak, D | 1 |
| Cağdaş, M; Calik, AN; Satilmiş, S; Velibey, Y | 1 |
| Hirano, M; Hotta, T; Ishizawa, K; Itoh, K; Kinoshita, T; Kobayashi, Y; Morishima, Y; Nakamura, S; Ogura, M; Shibata, T; Shimoyama, M; Tobinai, K; Tsukasaki, K; Ueda, R | 1 |
| Abo-Madyan, Y; Giordano, FA; Welzel, G; Wenz, F | 1 |
| Illés, A; Jóna, A; Lieber, A; Miltényi, Z; Páyer, E; Simon, Z; Szilasi, M | 1 |
| Filatova, LV; Gershanovich, ML; Semiglazov, TIu; Tarasenkova, AA | 1 |
| Augustine, DX; Garg, A; Knechtli, C | 1 |
| Barratt, N; Gupta, RK; O'Donoghue, L; Quintyne, KI; Wallis, F | 1 |
| Casini, M; Cavattoni, IM; Cortelazzo, S; Deola, S; Farsad, M; Mian, M; Pescosta, N | 1 |
| Hwang, W; Lee, YS; Phipps, C | 1 |
| Bauer, K; Engert, A; Hübel, K; Monsef, I; Rancea, M; Skoetz, N | 1 |
| Dunleavy, K; Eberle, FC; Grant, C; Jaffe, ES; Pittaluga, S; Wilson, WH | 1 |
| Chhanabhai, M; Connors, JM; Donaldson, J; Gascoyne, RD; Hoskins, PJ; Klasa, RJ; Moccia, AA; Savage, KJ; Sehn, LH; Shenkier, TN; Skinnider, B; Slack, GW | 1 |
| Dave, KS; Greaves, W; Kunkalla, K; Liang, CS; Medeiros, LJ; Sanchez-Espiridion, B; Singh, RR; Vega, F; Xiao, L; Younes, A | 1 |
| Advani, RH; Bartlett, NL; Buckstein, R; Connors, JM; Fisher, RI; Gascoyne, RD; Gordon, LI; Hong, F; Horning, SJ; Kahl, BS; Rimsza, LM; Scott, DW; Steidl, C; Tan, KL | 1 |
| Bower, M; Chilton, D; Cwynarski, K; de Vos, J; Fields, P; Gandhi, S; Gribben, JG; Johnson, M; Marcus, R; Montoto, S; Okosun, J; Orkin, C; Shanyinde, M; Shaw, K; Tenant-Flowers, M; Wilson, A; Young, AM | 1 |
| Alt, J; Arasteh, K; Berger, M; Engert, A; Fätkenheuer, G; Hentrich, M; Hoffmann, C; Mosthaf, F; Müller, M; Nickelsen, M; Planker, M; Rieke, A; Rockstroh, JK; Schmidmaier, R; Schürmann, D; Seidel, E; Siehl, J; Wolf, T; Wyen, C | 1 |
| Cantonetti, M; Caracciolo, CR; Chiaravalloti, A; Danieli, R; Di Pietro, B; Pagani, M; Schillaci, O; Simonetti, G; Tavolozza, M; Travascio, L | 1 |
| Hagihara, M; Hua, J; Inoue, M; Iwaki, Y | 1 |
| Hartridge-Lambert, SK; Lim, RC; Maragulia, JC; Portlock, CS; Schöder, H | 1 |
| Behringer, K; Borchmann, P; Diehl, V; Eibl, AD; Engert, A; Fuchs, M; Goergen, H; Halbsguth, T; Kuehr, M; Mueller, H; Reiners, KS; Renno, JH; Rosenbrock, J; Schober, T; Stumpf, V; Thielen, I; van der Ven, K; von Wolff, M; Wessels, C; Wiehlpütz, M | 1 |
| Dong, M; He, XH; Liu, P; Shi, YK; Xing, PY; Yang, JL; Zhou, LQ | 1 |
| Advani, R; Bartlett, NL; Blum, KA; Cheson, BD; Connors, JM; Fisher, RI; Friedberg, JW; Gascoyne, RD; Gordon, LI; Gospodarowicz, M; Habermann, TM; Hong, F; Hoppe, RT; Horning, SJ; Kahl, BS; Stiff, PJ; Tuscano, JM; Wagner, H | 1 |
| Chim, CS; Choi, PT; Lee, WK | 1 |
| Dhull, AK; Kaushal, V; Soni, A | 1 |
| Cappabianca, S; Falcone, U; Guastafierro, S | 1 |
| Aznar, MC; Maraldo, MV; Petersen, PM; Specht, L; Vogelius, IR | 1 |
| Deluen, F; Ferroir, JP; Huguet, F; Marseguerra, R; Pène, F; Schlienger, M; Touboul, E | 1 |
| McGrath, SE; Walker-Bone, K; Webb, A | 1 |
| Han, F; Li, Z; Wang, P; Wang, Q; Wang, ZM; Xu, AE; Zheng, JH | 1 |
| Advani, RH; Balise, R; Greenberg, PL; Hoppe, RT; Horning, SJ; Koontz, MZ; Rosenberg, SA | 1 |
| Andreo, FC; Navarro, JT; Ribera, JM; Torrent, A | 1 |
| Bertuccio, P; Bosetti, C; Chatenoud, L; La Vecchia, C; Levi, F; Negri, E; Rodriguez, T | 1 |
| Advani, R; Bartlett, NL; Cheson, BD; Connors, JM; Evens, AM; Fisher, RI; Gascoyne, RD; Gordon, LI; Gospodarowicz, M; Hong, F; Hoppe, RT; Horning, SJ; Kahl, BS; Miller, TP; Stiff, PJ; Wagner, H | 1 |
| Advani, R; Ambinder, RF; Bartlett, NL; Cheson, BD; Fisher, RI; Gascoyne, RD; Gellert, LL; Gordon, LI; Hong, F; Horning, SJ; Hsieh, WS; Kahl, BS; Kanakry, JA; Lemas, MV; Li, H; Miller, TP; Stiff, P; Tan, KL | 1 |
| Burger, IA; Goldman, DA; Gonen, M; Hricak, H; Kumar, A; Schöder, H; Vargas, HA; Zelenetz, AD | 1 |
| Portlock, CS | 2 |
| De Propris, MS; De Vellis, A; Gastaldi, R; Gentile, G; Mandelli, F; Martino, P; Picardi, V; Pirillo, MF | 1 |
| Fenyvesi, T; Karádi, I; Rosta, A; Sármán, P; Schneider, T; Szücs, S; Zsáry, A | 1 |
| Dumoulin, FL; Fischer, HP; Platen, E; Sauerbruch, T | 1 |
| Aurer, I; Basić, N; Boban, D; Bogdanić, V; Grgić-Markulin, L; Jakić-Razumović, J; Kovacević, J; Labar, B; Mrsić, M; Nemet, D; Radman, I; Santek, F; Zupancić-Salek, S | 1 |
| Andrieu, JM; Briére, J; Cassasus, P; Colonna, P; Desablens, B; Dib, M; Djeridane, M; Escoffre-Barbe, M; Ghandour, C; Lacotte-Thierry, L; Lamy, T; Lejeune, F; Maisonneuve, H; Oudard, S; Simon, M; Traullé, C; Vigier, M | 1 |
| Nohgawa, M; Sugiyama, T; Yonetani, N | 1 |
| Angelopoulou, MK; Bonadonna, G; Bonfante, V; Cabanillas, F; Chilosi, M; Gianni, AM; Giardini, R; Herling, M; Kittas, C; McDonnell, TJ; Medeiros, LJ; Nadali, G; Pangalis, GA; Pizzolo, G; Rassidakis, GZ; Sarris, AH; Vassilakopoulos, TP; Viviani, S | 1 |
| Ambrosetti, A; Benedetti, F; Nadali, G; Pizzolo, G; Ricetti, MM; Trolese, A; Visco, C; Zanotti, R | 1 |
| Leo, F; Pastorino, U; Solli, PG; Spaggiari, L; Veronesi, G; Villa, G | 1 |
| Aleĭnikova, OV; Pochetukhin, KV; Strongin, IuS | 1 |
| Barista, I; Cabanillas, F; Chronowski, GM; Cox, JD; Ha, CS; Hagemeister, FB; Hess, MA; Sarris, AH; Tucker, SL; Wilder, RB | 1 |
| del Palacio, A; Garau, M; Molina, L; Relaño, MT | 1 |
| Diehl, V | 1 |
| Canellos, GP; Connors, JM; Duggan, DB; Fisher, RI; Glick, JH; Johnson, JL; Peterson, BA; Petroni, GR | 1 |
| Kroll, M; Lu, HH; Lynch, GR; Massarweh, S; Sears, DA; Shahab, I; Teh, BS; Udden, MM | 1 |
| Hardoff, R; Hefetz, M; Stark, P; Steinmetz, A | 1 |
| Caglevic, C; Osorio, G | 1 |
| Barth, D; Berinstein, NL; Imrie, KR; Mangel, J | 1 |
| Diehl, V; Dörken, B; Dühmke, E; Franklin, J; Hasenclever, D; Herrmann, R; Lathan, B; Loeffler, M; Müller-Hermelink, HK; Paulus, U; Pfreundschuh, M; Tesch, H | 1 |
| Bellei, M; Brice, P; Brugiatelli, M; Carella, AM; Colombat, P; Di Renzo, N; Fabbiano, F; Federico, M; Gisselbrecht, C; Goldstone, A; Luminari, S; Moretti, L; Nagler, A | 1 |
| Longo, DL | 2 |
| Andrieu, JM; Atmani, S; Bernard, M; Berthou, C; Briere, J; Casassus, P; Colonna, P; Delwail, V; Desablens, B; Dib, M; Ghandour, C; le Maignan, C; Le Mevel, A; Maisonneuve, H; Traulle, C; Vigier, M | 1 |
| Boissevain, F; De Wit, M; Diehl, V; Duhmke, E; Engert, A; Hasenclever, D; Herrmann, R; Josting, A; Koch, P; Loffler, M; Mezger, J; Muller, RP; Muller-Hermelink, HK; Pfistner, B; Renner, H; Schiller, P; Schmidt, BF; Sieber, M; Willich, N; Wolf, J | 1 |
| Avilés, A; Castañeda, C; Cleto, S; González, M; Huerta-Guzmán, J; Neri, N; Talavera, A | 1 |
| Burke, M; McCaffrey, G; Nandurkar, H; Opeskin, K | 1 |
| Ekert, H | 2 |
| Cella, G; Pancotto, P; Reimers, P; Salvano, L; Stevanato, F | 1 |
| Belhaj Ali, Z; Benna, F; Besbes, M; Bouaouina, N; Boussen, H; Gammoudi, A; Ghilen, L; Kochbati, L; Maalej, M; Rahal, K | 1 |
| Apostolidis, J; Bakiri, M; Baltadakis, J; Grigoriou, E; Harhalakis, N; Karakasis, D; Karmiris, TD; Mihalakeas, H; Mitsouli, C; Nikiforakis, E; Pagoni, M; Spanou, E; Tsantekidou, M | 1 |
| Ogawa, M | 1 |
| Buchheidt, D; Hofheinz, R; Hummel, M | 1 |
| Crump, M; Gospodarowicz, MK; Hodgson, DC; Pintilie, M; Sun, A; Tsang, RW; Wells, W | 1 |
| Gardembas-Pain, M; Mege, M; Pabot du Chatelard, P | 1 |
| Dinshaw, KA; Gupta, T; Laskar, S; Muckaden, MA; Naresh, KN; Pai, SK; Saikia, TK; Vimal, S | 1 |
| Hollander, SL | 1 |
| Piotrowski, A; Simpson, L; Taylor, S | 1 |
| Behrendt, H; Furstner, F; van den Berg, H; van den Bos, C | 1 |
| Fisher, DC; Li, S; Mauch, PM; Neuberg, D; Ng, AK; Silver, B; Stevenson, MA | 1 |
| Bischof, H; Brosteanu, O; Diehl, V; Doelken, G; Duehmke, E; Engert, A; Fischer, R; Georgii, A; Glunz, A; Greil, R; Hansmann, ML; Hasenclever, D; Hermann, R; Koch, B; Koch, P; Loeffler, M; Mueller, RP; Munker, R; Oertel, J; Paulus, U; Pfistner, B; Roller, S; Rueffer, U; Schalk, KP; Schober, T; Sieber, M; Stein, H; Tesch, H; von Kalle, K; Willich, N; Worst, P | 1 |
| Isayama, Y; Kawashima, K; Takashima, H | 1 |
| Diehl, V; Eich, HT; Engert, A; Franklin, J; Gossmann, A; Hansemann, K; Josting, A; Kocher, M; Krug, B; Müller, RP; Semrau, R; Skripnitchenko, R; Staar, S | 1 |
| Brosteanu, O; Diehl, V; Hasenclever, D; Loeffler, M | 1 |
| Bertolone, S; Koerner, P; Oliapuram Jose, B; Paris, KJ; Patel, CC; Silverman, CL; Spanos, WJ; Yashar, CM | 1 |
| Canellos, GP; Duggan, D; Johnson, J; Niedzwiecki, D | 1 |
| Buitendijk, S; Hählen, K; Hakvoort-Cammel, FG; van den Heuvel-Eibrink, M | 1 |
| Anargyrou, K; Angelopoulou, MK; Boussiotis, VA; Boutsis, DE; Dimopoulou, MN; Karkantaris, C; Kokoris, SI; Kontopidou, FN; Kyrtsonis, MC; Michalopoulos, T; Panayiotidis, P; Pangalis, GA; Papavassiliou, C; Siakantaris, MP; Tsaftaridis, P; Variamis, E; Vassilakopoulos, TP | 1 |
| Bayazit, YA; Camci, C; Erbagci, Z; Erkiliç, S; Koçer, NE | 1 |
| Bonadonna, G; Bonfante, V; Di Russo, A; Valagussa, P; Villani, F; Viviani, S | 1 |
| Goy, A; Moskowitz, C; Myers, J; Noy, A; Portlock, CS; Qin, J; Straus, DJ; Yahalom, J; Zelenetz, AD | 1 |
| Erdoğan, S; Ergin, M; Hakverdi, S; Hazar, B; Seyrek, E; Tuncer, I | 1 |
| Abrams, J; Al-Katib, A; Ibrahim, D; Karanes, C; Lai, P; Millenson, M; Pemberton, P; Smith, MR; Varterasian, M; Yeslow, G | 1 |
| Grigg, A | 1 |
| Atahan, IL; Barista, I; Caglar, M; Caner, B; Cengiz, M; Engin, H; Güllü, I; Gürkaynak, M; Ozyar, E; Tekuzman, G; Yildiz, F; Zengin, N; Zorlu, F | 1 |
| Alba, E; de Las Nieves, MA; Gumá, J; Herrero, J; Llanos, M; Márquez, A; Miramón, J; Rueda Domínguez, A | 1 |
| Arya, LS; Bakhshi, S; Dawar, R; Dinand, V; Singh, R; Thavaraj, V | 1 |
| Ballova, V; Diehl, V; Dühmke, E; Eich, HT; Engert, A; Haverkamp, H; Hentrich, M; Josting, A; Löffler, M; Müller-Hermelink, HK; Naumann, R; Pfistner, B; Rüffer, JU; Wilhelmy, M; Worst, P | 1 |
| Bernardo, MV; Fisher, DC; Mauch, PM; Ng, AK; Silver, B; Stevenson, MA; Van Den Abbeele, A | 1 |
| Boettcher, HD; Diehl, V; Eich, HT; Engert, A; Franklin, J; Glossmann, JP; Josting, A; Müller, RP; Nogová, L; Schober, T; Schulz, U; Sieber, M | 1 |
| Garipidou, V; Kaloutsi, V; Perifanis, V; Tziomalos, K; Vakalopoulou, S; Zafiriadou, E | 1 |
| Balcerska, A; Balwierz, W; Chybicka, A; Depowska, T; Drozyńska, E; Kaczmarek-Kanold, M; Klekawka, T; Kowalczyk, J; Kołakowska-Mrozowska, B; Kołtan, A; Krawczuk-Rybak, M; Krenke, K; Matysiak, M; Moryl-Bujakowska, A; Moszant, A; Odój, T; Raś, M; Sońta-Jakimczyk, D; Sopyło, B; Stanuch, H; Stolarska, M; Wachowiak, J; Wysocki, M | 2 |
| Esik, O; Illés, A; Molnár, Z | 1 |
| de Berker, D; Williamson, PJ | 1 |
| Bernard Hesseling, P; Wessels, G | 1 |
| Illés, A; Molnár, Z; Udvardy, M | 1 |
| Bezjak, A; Burns, BF; Connors, JM; Dar, AR; Ding, K; Djurfeldt, MS; Gospodarowicz, MK; Horning, SJ; Meyer, RM; Pearcey, RG; Shepherd, LE; Wells, WA; Winter, JN | 1 |
| Canellos, GP | 5 |
| Fenyvesi, T; Jánoskuti, L; Karádi, I; Keltai, K; Pásztor, E; Rosta, A; Sármán, P; Schneider, T; Szücs, S; Zsáry, A | 1 |
| Bonadonna, G; Bonfante, V; Gianni, AM; Valagussa, P; Viviani, S | 1 |
| Jost, LM; Stahel, RA | 1 |
| Brillant, C; Diehl, V; Dühmke, E; Eich, HT; Engert, A; Haverkamp, U; Kocher, M; Müller, RP; Sehlen, S; Skripnitchenko, R | 1 |
| Al-Katib, A; Jenkins, BD; Mohamed, A; Snower, D | 1 |
| Donley, K; Grgurević, I; Kujundzić, M; Martinović, M; Pavletic, S; Pejsa, V; Stancić, V | 1 |
| Avilés, A; Cleto, S; Huerta-Guzman, J; Nambo, JM; Neri, N; Talavera, A | 1 |
| Chikuie, N; Hosoi, K; Inoue, M; Ishikawa, K; Maeda, H; Min, KY; Satoh, T; Tokumine, Y; Ueda, K | 1 |
| Campbell, B; Di Iulio, J; MacManus, M; Milner, A; Ryan, G; Wirth, A | 1 |
| Bökkerink, JP; Claviez, A; Dörffel, W; Körholz, D; Lüders, H; Mann, G; Pötter, R; Riepenhausen, M; Rühl, U; Scheel-Walter, HG; Schellong, G | 1 |
| Arya, LS; Bakhshi, S; Dawar, R; Dinand, V; Rath, GK; Singh, R; Thavaraj, V; Vats, TS | 1 |
| Angelucci, E; Baldini, L; Bordonaro, R; Broglia, C; Cavanna, L; Chisesi, T; Deliliers, GL; Federico, M; Gobbi, PG; Levis, A; Liberati, M; Merli, F; Pavone, V; Santini, G; Stelitano, C; Vitolo, U | 1 |
| Ansell, SM; Colgan, JP; Habermann, TM; Martin, WG; Ristow, KM; Witzig, TE | 1 |
| Behringer, K; Breuer, K; Diehl, V; Engert, A; Klimm, B; May, M; Nogova, L; Reineke, T; Schmitz, T; Wildt, L | 1 |
| Diehl, V; Engert, A; Klimm, B | 1 |
| Abate, G; Anania, C; Comella, P; Coucourde, F; Di Finizio, G; Fiore, M; Frezza, P; Scoppa, G; Zarrilli, D | 1 |
| Clawson, S; Cullen, MH; Hancock, BW; Jack, AS; Johnson, PW; MacLennan, KA; Radford, JA; Ryder, D; Smith, P; Stenning, SP; Sydes, MR; Walewski, J | 1 |
| Cox, JD; Das, P; Ha, CS | 1 |
| Alpert, TE; Hatoum, GF; Morbidini-Gaffney, S; Sagerman, RH | 1 |
| Elbl, L; Kral, Z; Navratil, M; Smardova, L; Vasova, I; Vorlicek, J | 1 |
| Gook, D; Grigg, A; Lade, S; McKendrick, J; Mitchell, P; Seshadri, T; Seymour, JF; Spencer, A; Stern, C; Tiedemann, K | 1 |
| Ling, JY; Sun, XF; Wang, ZH; Xia, Y; Zhen, ZJ | 1 |
| Alba, E; Olmos, D; Rueda, A; Viciana, R | 1 |
| Barros, C; Howard, SC; Hsu, SC; Hudson, MM; Lins, M; Maciel, K; Metzger, ML; Pedrosa, F; Pedrosa, M; Pui, CH; Ribeiro, RC | 1 |
| Cobanoglu, U; Erduran, E; Yaris, N | 1 |
| Chand, VK; Link, BK; Ritchie, JM; Shannon, M; Wooldridge, JE | 1 |
| Chaloupka, V; Elbl, L; Jedlicka, F; Krejcí, M; Mayer, J; Navrátil, M; Tomásková, I; Vásová, I; Vorlícek, J | 1 |
| Connors, JM; Foltz, LM; Song, KW | 1 |
| Elbl, L; Jedlicka, F; Kral, Z; Smardova, L; Tomaskova, I; Vasova, I; Vorlicek, J; Wagnerova, B | 1 |
| Amiguet García, JA; Crusells Canales, MJ; Cuesta Muñoz, J; Letona Carbajo, S; Navarro Calzada, J; Sanjoaquín Conde, I | 1 |
| Arora, B; Biswas, G; Deshmukh, C; Khadwal, A; Kurkure, PA; Shetty, V | 1 |
| Baker, K; Chandra, D; Ewton, A | 1 |
| Chaloupka, V; Elbl, L; Jedlicka, F; Navrátil, M; Tomásková, I; Vásová, I; Vorlícek, J | 1 |
| Audebert, F; Hartmann, P; Kullmann, F; Schneidewind, A; Schölmerich, J | 1 |
| Cullen, MH; Hancock, BW; Johnson, PW; Radford, JA; Stenning, SP; Sydes, MR | 1 |
| Argon, D; Basa, S; Seçkinel, SA; Tecimer, T; Varol, A | 1 |
| Han, JZ; Jin, J; Li, YX; Liu, XF; Liu, YP; Song, YW; Wang, SL; Wang, WH; Yu, ZH; Zhou, LQ | 1 |
| Bonfante, V; Cabanillas, F; Federico, M; Gianni, AM; Luminari, S; Medeiros, LJ; Nadali, G; Pangalis, G; Peethambaram, P; Pizzolo, G; Sarris, AH; Vassilakopoulos, TP; Visco, C; Viviani, S; Witzig, TE | 1 |
| Gospodarowicz, MK; Heaton, R; Hodgson, DC; Koh, ES; Pintilie, M; Sun, A; Tran, TH; Tsang, R; Wells, W | 1 |
| Carrato Mena, A; Guillén Ponce, C; Maciá Escalante, S; Rodríguez Lescure, A; Ull Laita, M | 1 |
| Guadagnolo, BA; Kuntz, KM; Mauch, PM; Ng, AK; Punglia, RS | 1 |
| Fu, XH; Huang, HQ; Huang, Y; Lin, TY; Sun, XF; Wang, B; Wang, SS; Xu, RH; Zhang, L | 1 |
| Beishuizen, A; de Man, R; Lam, KH; Pieters, R; van den Heuvel-Eibrink, MM; van Grotel, M | 1 |
| Corrado, C; Greco, M; Niccodemi, C; Presas, J; Valsecchi, M; Winkel, M | 1 |
| Fayad, L; Goy, A; Pro, B; Romaguera, J; Wang, M; Younes, A | 1 |
| Dunlap, N; Parkhie, S | 1 |
| Ahmed, S; Buckley, CA; Crump, M; Dewitt, B; Gitterman, L; Gospodarowicz, MK; Hodgson, DC; Pintilie, M; Schwartz, A; Smith, K; Sun, A; Tsang, RW; Wells, W | 1 |
| Aoki, S; Hirano, M; Miura, I; Niitsu, N; Okamoto, M; Tamaru, J; Tomita, N | 1 |
| Armanda, V; Culić, S; Jankovic, S; Kuljis, D; Kuzmic, I; Pranic-Kragic, A | 1 |
| Boissevain, F; Diehl, V; Dühmke, E; Eich, HT; Engert, A; Haverkamp, H; Klimm, B; Koch, P; Lohri, A; Müller, RP; Müller-Hermelink, K; Pfistner, B; Trenn, G; Worst, P | 1 |
| Boleti, E; Mead, GM | 1 |
| Dotsenko, PV; Dudarova, RG; Efimov, IV; Gemdzhian, EG; Kolosova, LIu; Kozhurin, SV; Lutsenko, IN; Melikian, AL; Moiseeva, TN; Nechistiuk, AV; Pan'shin, GA; Pivnik, AV; Rastrigin, NA; Shavlokhov, VS; Shitareva, IV; Skidan, NI; Sotnikov, VM; Tsyba, NN | 1 |
| Arora, M; Burns, LJ; Defor, TE; MacMillan, ML; Majhail, NS; McGlave, PB; Miller, JS; Orchard, PJ; Ramsay, NK; Slungaard, A; Weisdorf, DJ | 1 |
| Arcaini, L; Baio, A; Brusamolino, E; Casagrande, W; Franchini, P; Griva, V; Lazzarino, M; Orlandi, E; Pascutto, C; Passamonti, F | 1 |
| Cataldi, A; Fava, C; Priola, AM; Priola, SM | 1 |
| Datsenko, PV; Kharchenko, VP; Mel'nik, IuD; Panyshin, GA; Sotnikov, VM | 1 |
| Balasch, J; Camus, A; Castelo-Branco, C; Martínez de Osaba, MJ; Mercadal, S; Nomdedeu, B | 1 |
| Capla, R; Farnen, J; Kulkarni, A; Zlabek, J | 1 |
| Ribatti, D | 1 |
| Mandal, AK; Mandal, S | 1 |
| Gergely, L; Illés, A; Keresztes, K; Miltényi, Z; Ress, Z; Simon, Z; Vadász, G; Váróczy, L | 1 |
| Arya, LS; Dawar, R; Dinand, V; Malik, A; Pandey, RM; Unni, R | 1 |
| Bartlett, NL; Canellos, GP; Cheson, BD; Friedberg, JW; Johnson, JL; Johnson, KB; Niedzwiecki, D; van Besien, K; Zelenetz, AD | 1 |
| Attilio, G; Cristina, L; Edoardo, DN; Giuseppe, L; Loredana, G; Vincenzo, L | 1 |
| Augustyniak, C; Bennett, CL; Catsaros, K; Cilley, J; Evens, AM; Gordon, LI; Gounder, M; Hou, N; Miyata, S; Ortiz, T; Rademaker, A; Tallman, MS; Variakojis, D; Winter, JN | 1 |
| Alba, E; Jurado, JM; Olmos, D; Rueda, A | 1 |
| Aspillaga, A; Cabrera, ME; Cerda, B; García, H; Hales, C; León, A; Lois, V; Meneses, P; Merino, C; Oliva, J; Peña, K; Rojas, H; Rosas, J; Rossle, A; Vittini de, C | 1 |
| Angus, B; Hoye, NA; Jones, GL; Lucraft, H; Proctor, SJ; Taylor, PR; Windebank, KP; Wood, K | 1 |
| Buccheri, V; Calore, EE; Chamone, DA; Pessoa, VP; Pracchia, LF; Tanaka, PY | 1 |
| Irie, T; Mori, A; Morioka, M; Saito, M; Tanaka, S; Toyoshima, N | 1 |
| Brillant, C; Cartoni, C; de Wit, M; Diehl, V; Dühmke, E; Eich, HT; Engert, A; Franke, A; Franklin, J; Hasenclever, D; Herrmann, R; Koch, P; Loeffler, M; Müller, RP; Müller-Hermelink, HK; Paulus, U; Pfreundschuh, M; Sehlen, S; Sieber, M; Tesch, H | 1 |
| Bogdanovic, AD; Bumbasirevic, VZ; Jakovic, LR; Jovanovic, MD; Kravic, TK; Martinovic, VM; Mihaljevic, BS | 1 |
| Akioka, T; Hanafusa, T; Hara, S; Hiraoka, N; Hirata, Y; Kobayashi, K; Miyoshi, T; Oka, S; Tsuji, M; Yokote, T | 1 |
| Al-Ali, HK; Niederwieser, D; Wittekind, C | 1 |
| Diehl, V; Fuchs, M | 1 |
| de Jong, FH; de Muinck Keizer-Schrama, SM; Hakvoort-Cammel, FG; Laven, JS; Pieters, R; Themmen, AP; van Beek, RD; van den Berg, H; van den Bos, C; van den Heuvel-Eibrink, MM | 1 |
| Connors, JM; Ding, K; Djurfeldt, MS; Gospodarowicz, MK; Horning, SJ; Macdonald, DA; Meyer, RM; Pearcey, RG; Shepherd, LE; Wells, WA; Winter, JN | 1 |
| Aird, EG; Diez, P; Hoskin, PJ | 1 |
| de Jong, FH; de Muinck Keizer-Schrama, SM; Hakvoort-Cammel, FG; Pieters, R; Smit, M; van Beek, RD; van den Berg, H; van den Bos, C; van den Heuvel-Eibrink, MM; Weber, RF | 1 |
| Atipo Galiba, FO; Elira Dokekias, A; Koko, I; Martin, A | 1 |
| Beard, J; Elmahy, H; Hawley, I | 1 |
| Bomanji, J; Buchler, T; Lee, SM | 1 |
| Horning, SJ | 1 |
| Andrieu, JM; Berthou, C; Casassus, P; Colonna, P; Delwail, V; Desablens, B; Gastinne, T; Jais, JP; Moles, MP; Sénécal, D | 1 |
| Bomanji, J; Buchler, T; Edwards, SG; Lee, SM; Ramsay, A | 1 |
| Filatova, LV; Gershanovich, ML | 1 |
| Ayedi, H; Ayoub, A; Ketata, W; Msaad, S; Yangui, I | 1 |
| Eich, HT; Müller, RP | 1 |
| Angelucci, E; Baldini, L; Federico, M; Gavarotti, P; Gobbi, P; Iannitto, E; Levis, A; Liberati, M; Luminari, S; Marcheselli, L; Orsucci, L; Pavone, V; Ricardi, U; Ucci, G | 1 |
| Crippa, C; Facchetti, F; Ferrari, S; Frata, P; Grazioli, L; Magrini, SM; Pizzocaro, C; Re, A; Rossi, G; Tucci, A | 1 |
| Subbiah, V | 1 |
| Wedgwood, A; Younes, A | 1 |
| Barada, WM; Bazarbachi, A; Beydoun, A; Hourani, R; Masroujeh, R; Otrock, ZK | 1 |
| Beppu, T; Fuke, H; Shiraki, K; Sugimoto, K; Takei, Y; Tanaka, J; Yamamoto, N; Yoneda, K | 1 |
| Amorim, CA; Carneiro, AS; Lima, I; Santiago, MB | 1 |
| Anderlini, P; Bueso-Ramos, C; Champlin, RE; Macapinlac, HA; Rashid, A; Swanston, N | 1 |
| Gerber, HP; Grewal, IS; Kissler, KM; Oflazoglu, E; Sievers, EL | 1 |
| Bonadonna, G; Lombardi, C; Ragni, G; Santoro, A; Viviani, S | 1 |
| Bladé, J; Carreras, E; Cervantes, F; Feliu, E; Gardella, S; Grañena, A; Marín, P; Montserrat, E; Olivé, T; Rozman, C | 1 |
| Bakács, T; Molnár, Z; Süss, J | 1 |
| Grebe, G; Lira, P | 1 |
| Arlin, Z; Clarkson, BD; Gee, T; Kempin, S; Koziner, B; Lee, BJ; Myers, J; Nisce, LZ; Passe, S; Straus, DJ; Young, CW | 1 |
| Amiel, JL; Ayed, FB; Brule, CH; Droz, JP; Tursz, T | 1 |
| Gamble, JF; Loh, KK; Rodgers, RW; Shullenberger, CC | 1 |
| Calavrezos, A; Hausmann, K; Hinrichs, A; Kuse, R | 1 |
| Clarkson, BD; Koziner, B; Lee, BJ; Nisce, LZ; Straus, DJ; Young, CW | 1 |
| Armata, J; Balwierz, W; Borkowski, W; Depowska, T | 1 |
| Bonadonna, G; Bonfante, V; Santoro, A | 1 |
| Banfi, A; Bonadonna, G; Fossati Bellani, F; Franchi, F; Santoro, A; Valagussa, P | 1 |
| Bonadonna, G; Bonfante, V; Santoro, A; Valagussa, P | 2 |
| Mayer, RJ | 1 |
| Bonadonna, G; Santoro, A | 2 |
| Amiel, JL; Ben Ayed, F; Droz, JP; Spielmann, M; Tursz, T | 1 |
| Bertino, JR; Farber, LR; Kapp, DS; Lawrence, R; Nordlund, M; Prosnitz, LR | 1 |
| Gassmann, W; Löffler, H; Schmitz, N | 1 |
| Klastersky, J | 1 |
| Armata, J; Legutko, L | 1 |
| Bartual, J; Bascuas, JL; Gil, M; Magro, E; Roquette, J | 1 |
| Bonadonna, G | 2 |
| Amadori, S; Anselmo, AP; Biagini, C; De Luca, AM; Mandelli, F; Maurizienrici, R; Mauro, F; Papa, G; Testi, AM | 1 |
| Bond, WH; Chenoweth, L; Einhorn, LH; Stevens, EE; Williams, SD | 1 |
| DeVita, VT; Hubbard, SM; Moxley, JH | 1 |
| Canellos, GP; Come, SE; Skarin, AT | 1 |
| Amadori, S; Anselmo, AP; Biagini, C; Fidani, P; Mandelli, F; Papa, G | 1 |
| Diehl, V; Peters, HD; Schmoll, HJ; von Roemeling, R; Weiss, J | 1 |
| Battista, R; Capnist, G; Cappellari, F; Chisesi, T; Cortelazzo, S; D'Emilio, A; Dal Fior, S; Pozza, F; Ricciardi, O; Rodeghiero, F | 1 |
| Anselmo, AP; Cimino, G; Mandelli, F; Marzullo, A; Maurizi Enrici, R; Mauro, F; Papa, G | 1 |
| Banfi, A; Zanini, M; Zucali, R | 1 |
| Arlin, Z; Gee, T; Kempin, S; Koziner, B; Lee, BJ; McCormick, B; Mertelsmann, R; Myers, J; Nisce, LZ; Straus, DJ | 1 |
| Guarga, A; Rey-Joly, C; Urrutia, A | 1 |
| Cabanillas, F; Hagemeister, F; Tannir, N; Velasquez, W | 1 |
| Harker, WG; Kushlan, P; Rosenberg, SA | 1 |
| Andres, J; Anger, G; Herold, M; Höche, D; Ihle, R; Kästner, R; Raderecht, C; Schleusner, A; Stobbe, H; Wutke, K | 1 |
| Dalal, BI; Heyman, M; Horsman, D; Kidd, P; Kingreen, D; Loughran, TP; Phillips, GL | 1 |
| Carde, P | 2 |
| Cleary, SF; Donaldson, SS; Link, MP | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Guzmán, R; Talavera, A | 2 |
| Abboud, J; Chahine, G; Nasnas, R; Nasrallah, T | 1 |
| al-Katib, A; Andersen, J; Bishop, CR; Hussein, ME; Karanes, C; Khanuja, PS; Smith, MR | 1 |
| Braban, LE; Hao, Y; Keane, TJ; Mah, K; Poon, PY; Van Dyk, J | 1 |
| Breed, WP; Carde, P; de Pauw, BE; Hagenbeek, A; Henry-Amar, M; Monconduit, M; Somers, R; Tarayre, M; Thomas, J; Verdonck, L | 1 |
| Bourdin, S; Dupas, B; Harousseau, JL; Le Tortorec, S; Mahe, B; Mechinaud-Lacroix, F; Milpied, N; Moreau, P; Rapp, MJ | 1 |
| Alessandrino, EP; Astori, C; Brusamolino, E; Canevari, A; Castelli, G; Lazzarino, M; Livraghi, A; Morra, E; Orlandi, E; Pagnucco, G | 1 |
| Astori, C; Bernasconi, C; Brusamolino, E; Castelli, G; Lazzarino, M; Livraghi, A; Morra, E; Orlandi, E; Pagnucco, G; Santagostino, A | 1 |
| Allen, PK; Besa, P; Cabanillas, F; Cox, JD; Hagemeister, FB; McLaughlin, P; Preti, A; Rodriguez, A; Swan, F | 1 |
| Filippa, DA; Merchant, TE; Yahalom, J | 1 |
| Alessandrino, EP; Astori, C; Bernasconi, P; Brusamolino, E; Canevari, A; Castelli, G; Lazzarino, M; Morra, E; Orlandi, E; Pagnucco, G | 1 |
| Andrac, L; Horschowski, N; Koeppel, MC; Sayag, J; Signoret, R; Stoppa, AM; Terrier, G | 1 |
| Dölken, G; Fuchs, R; Gerhartz, H; Hagen-Aukamp, U; Hiller, E; Löffler, M; Petsch, S; Pflüger, KH; Pfreundschuh, M; Rühl, U | 2 |
| Donaldson, SS; Hunger, SP; Link, MP | 1 |
| Bohndorf, W; Freitag, EM; Ganser, D; Mjaaland, I | 1 |
| Bonfante, V; Castellani, MR; Devizzi, L; Negretti, E; Santoro, A; Soncini, F; Villani, F; Viviani, S; Zanini, M; Zucali, R | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Guzmán, R; Nambo, MJ; Soto, B | 1 |
| Flores, E; Gómez-Campderá, FJ; Jofre, R; López-Gómez, JM | 1 |
| Balzarini, L; Bonadonna, G; Bonfante, V; Devizzi, L; Santoro, A; Valagussa, P; Viviani, S | 1 |
| Baccarani, M; Barillari, G; Fanin, R; Russo, D; Silvestri, F; Velisig, M; Virgolini, L; Zaja, F | 1 |
| Bockenstedt, P; Krishnan, K | 1 |
| Bruni, R; Carella, AM; Frassoni, F; Giordano, D; Pollicardo, N; Pungolino, E; Rossi, E; Spriano, M | 1 |
| Aversa, S; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Mazzarotto, R; Pappagallo, GL; Salvagno, L; Scarzello, G; Sorarù, M; Sotti, G | 1 |
| Andrieu, JM; Brice, P; Colonna, P; Gastaut, JA; Lévy, R; Raphaël, M; Taillan, B; Tourani, JM | 1 |
| Boiocchi, M; Carbone, A; Dolcetti, R; Errante, D; Franceschi, S; Gloghini, A; Serraino, D; Tirelli, U; Vaccher, E | 1 |
| Barnett, MJ; Fairey, RN; Hogge, DE; Klasa, RJ; Klingemann, HG; Nantel, SH; Reece, DE; Shepherd, JD; Sutherland, HJ; Voss, NJ | 1 |
| Elomaa, I; Franssila, K; Jekunen, A; Laurila, P; Maiche, A | 1 |
| Tobinai, K | 1 |
| Cooper, JS; Sullivan, JW | 1 |
| Anchisi, S; Baur, A; Pugin, P | 1 |
| Behles, C; Kreuser, ED; Schröder, K; Schröder, R; Thiel, E; Uhrig, A; Völler, H | 1 |
| Aisenberg, AC | 2 |
| Brunet, S; Martino, R; Nomdedeu, J | 1 |
| Chemnitius, JM; Helmchen, U; Herrmann, C; Kreuzer, H; Scholz, KH; Tebbe, U | 1 |
| Carrol, CL; Chintagumpala, MM; Dreyer, ZE; Fishman, MA; Mahoney, DH; McClain, K; Steuber, CP | 1 |
| Behar, RA; Hoppe, RT; Horning, SJ | 1 |
| Canellos, G; Coleman, CN; Mauch, P; Rosenthal, DS; Shulman, LN; Silver, B; Tarbell, NJ; Uematsu, M; Weinstein, H | 1 |
| Bader, SB; Mauch, P; Silver, B; Tarbell, NJ; Weinstein, H | 1 |
| Brice, P; Castaigne, S; D'Agay, MF; Fermand, JP; Fermé, C; Frija, J; Gisselbrecht, C; Lepage, E; Marty, M; Miot, C | 1 |
| McKendrick, J; Silberstein, M; Simmonds, P | 1 |
| Beykirch, M; Gerhartz, HH; Hiller, E; Wilmanns, W | 1 |
| Bontempi, N; Burnelli, R; Carli, M; Comelli, A; Di Tullio, MT; Pileri, S; Rosati, D; Sotti, G; Testi, AM; Vecchi, V | 1 |
| Wang, H; Yong, WB; Zhu, XM | 1 |
| Hryniewicz, A; Rosłan, K; Wójtowicz, J | 1 |
| Matthews, JH | 1 |
| Burgers, MJ; Carde, P; Hagenbeek, A; Hayat, M; Le Fur, R; Meerwaldt, JH; Monconduit, M; Noordijk, EM; Tanguy, A; Thomas, J | 1 |
| Aversa, SM; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Pappagallo, GL; Salvagno, L; Sorarù, M | 1 |
| Adkins, DR; Boldt, D; Freytes, CO; Irvin, R; Kuhn, J; LeMaistre, CF; Lyons, R; Roodman, GD; Salzman, D; Smith, L | 1 |
| Boussiotis, VA; Kyrtopoulos, SA; Pangalis, GA; Souliotis, VL; Valavanis, C | 2 |
| Akasaka, T; Fukuhara, S; Haga, H; Hayashi, T; Kadowaki, N; Ohno, H; Okuma, M; Yamabe, H | 1 |
| Cohen, IJ; Goshen, Y; Loven, D; Saab, A; Stark, B; Tamary, H; Yaniv, I; Zaizov, R | 1 |
| Clarke, K; Grigg, A | 1 |
| Behrendt, H; Brinkhuis, M; Van Leeuwen, EF | 1 |
| Gospodarowicz, M; Lipton, JH; Reingold, S | 1 |
| Bonadonna, G; Bonfante, V; Devizzi, L; Santoro, A; Soncini, F; Valagussa, P; Viviani, S; Zanini, M | 1 |
| Axdorph, U; Björkholm, M; Grimfors, G; Holm, G; Johansson, B; Landgren, O; Mellstedt, H; Merk, K; Svedmyr, E | 1 |
| Diehl, V; Geilen, W; Hasenclever, D; Loeffler, M; Nisters-Backes, H; Pfreundschuh, M; Ruehl, U; Sieber, M; Smith, K; Tesch, H | 1 |
| Gomez, EG; Hirsch, A; Leung, D; Portlock, CS; Straus, DJ; Vander Els, N; Yahalom, J | 1 |
| Carella, AM; Clò, V; Federico, M | 1 |
| Andrieu, JM; Boasson, M; Brière, J; Casassus, P; Colonna, P; Desablens, B; Ghandour, C; Guilhot, F; Harousseau, JL; Jais, JP; Le Prisé, PY; Lejeune, F; Lemevel, A | 1 |
| Abdallah, JM; Kirsch, IR; Lombardi, DP | 1 |
| Auger, J; Bendahmane, B; Decaudin, D; Koscielny, S; Munck, JN; Naccache, P | 1 |
| Prosnitz, LR; Wu, JJ; Yahalom, J | 1 |
| Babini, L; Barbieri, E; Battista, G; Bendandi, M; Canini, R; Fanti, S; Frezza, G; Gherlinzoni, F; Gozzetti, A; Merla, E; Monetti, N; Pisi, P; Rimondi, MR; Tura, S; Zinzani, PL; Zompatori, M | 1 |
| García Sanz, R; Ramos Ortega, FJ; Rodríguez García, J; Sandoval Guerra, V | 1 |
| Briones, J; Bruguera, M; Cervantes, F; Font, C; Grau, JM; Montserrat, E; Rozman, C | 1 |
| Bozeman, PM; Fairclough, DL; Greenwald, CA; Hudson, MM; Mackert, PW; Marina, NM; Stokes, DC; Thompson, EI; Wilimas, JA | 1 |
| Horning, SJ; Yuen, AR | 1 |
| Bruni, R; Carella, AM; Congiu, M; Federico, M; Frassoni, F; Gatti, AM; Giordano, D; Lerma, E; Nati, S; Occhini, D; Pierluigi, D; Prencipe, E; Pungolino, E; Ravetti, JL; Rossi, E; Spriano, M; Vimercati, R | 1 |
| Andrieu, JM; Briere, J; Casassus, P; Desablens, B; Hunault, M; Ifrah, N; Jais, JP; Le Maignan, C; Moreau, P | 1 |
| Bjorkholm, M; Branehog, I; Enblad, G; Glimelius, B; Gustavsson, A; Jakobsson, M; Kalkner, M; Lenner, P | 1 |
| Esteban, F; Hierro, C; Jimenez, JM; López-Lacomba, D; Solanellas, J; Soldado, L | 1 |
| Sarris, AH | 1 |
| Benchekroun, S; Benchemsi, N; Harif, M; Quessar, A; Sehraoui, S; Trachli, A | 1 |
| Goldberg, SL; Klumpp, TR; Mangan, KF; Ming, PL; Mullaney, MT; Rao, PN; Redei, I | 1 |
| Balzarotti, M; Bonadonna, G; Bonfante, V; Devizzi, L; Santoro, A; Soncini, F; Valagussa, P; Viviani, S; Zanini, M | 1 |
| Abrahamsen, AF; Hannisdal, E; Holte, H; Mella, O; Telhaug, R; Wist, E | 1 |
| Dubowik, R; Gabryś, K; Urbaniak-Kujda, D | 1 |
| Keinànen, S; Laine, P; Lindqvist, C; Meurman, JH; Pyrhönen, S; Teerenhovi, L | 1 |
| Behrendt, H; Stuve, W; van den Berg, H | 1 |
| André, M; Brice, P; Cazals, D; Fermé, C; Gisselbrecht, C; Hennequin, C; Kerneis, Y; Lepage, E; Rousselot, P; Zini, JM | 1 |
| Behrendt, H; van den Berg, H; Zsiros, J | 1 |
| Arico, M; Baio, A; Bossi, G; Cerveri, I; Corbella, F; Corsico, A; Klersy, C; Volpini, E | 1 |
| Adams, G; Burns, BF; Connors, JM; Cooper, I; Klimo, P; Meyer, RM; O'Reilly, SE; Pater, J; Quirt, I; Sadura, A; Shustik, C; Skillings, J; Sutcliffe, S; Verma, S; Yoshida, S; Zee, B | 1 |
| Bartels, H; Cartoni, C; Diehl, V; Dölken, G; Enzian, J; Franklin, J; Fuchs, R; Gassmann, W; Geilen, W; Gerhartz, H; Hagen-Aukamp, U; Hasenclever, D; Hiller, E; Hinkelbein, H; Hinterberger, W; Kirchner, H; Koch, P; Krüger, B; Loeffler, M; Nisters-Backes, H; Pfreundschuh, M; Rühl, U; Schwarze, EW; Sieber, M; Tesch, H | 1 |
| Kamieńska, E | 1 |
| Byrnes, JJ; Kanzaki, T; Kerdel, FA; Setoyama, M | 1 |
| Colwill, R; Crump, M; Danish, R; Imrie, KR; Keating, A; McCrae, J; Romeyer, F; Sheridan, B; Stewart, AK; Sutton, D | 1 |
| Behm, FG; Brecher, ML; Cantor, A; Chauvenet, AR; Gieser, PW; Leventhal, B; Marcus, RB; Ternberg, JL; Weiner, MA; Wharam, MD | 1 |
| Advani, SH; Gopal, R; Kulkarni, SS; Parikh, PM; Saikia, TK; Sastry, PS | 1 |
| Gustavsson, A | 1 |
| Corry, J; Laidlaw, C; Liew, KH; Matthews, J; Wirth, A | 1 |
| Ariad, S; Benharroch, D; Geffen, DB; Hatskelzon, L | 1 |
| Bastian, AW; DeVita, VT; Duffey, PL; Glatstein, E; Hubbard, SM; Ihde, DC; Jaffe, ES; Longo, DL; Wilson, WH; Wittes, RE; Young, RC | 1 |
| Brizel, DM; Light, KL; Prosnitz, LR | 1 |
| Hasebe, T; Mukai, K; Sasaki, Y; Sekine, I; Umeda, T | 1 |
| Ziółko, E | 1 |
| Beck, T; Fisher, RI; Glick, JH; Harrington, D; Neiman, R; Oken, MM; Peterson, BA; Schilsky, RL; Young, ML | 1 |
| Fleischmann, T; Molnár, Z; Schneider, T; Várady, E | 1 |
| Collins, RD; Davis, PC; Fryer, CJ; Gilchrist, GS; Hutchinson, RJ; Krailo, MD; Nachman, J; O'Brien, RT; Reardon, D; Trigg, ME; Whalen, T | 1 |
| Constine, LS | 1 |
| Balzarotti, M; Bonadonna, G; Bonfante, V; Camerini, E; Devizzi, L; Fornier, M; Santoro, A; Valagussa, P; Verderio, P; Viviani, S | 1 |
| Nakamura, S | 1 |
| Andrieu, JM; Brière, J; Casassus, P; Colonna, P; Desablens, B; François, S; Ghandour, C; Guilhot, F; Harousseau, JL; Jais, JP; Le Prisé, PY; Lejeune, F; Lemevel, A | 1 |
| Hesseling, PB; Van Jaarsveld, D; Van Riet, FA; Wessels, G | 1 |
| Beckstead, JH; Braziel, RM; Dailey, RA; Gross, ND; Wilson, DJ | 1 |
| Andrieu, JM; Colonna, P | 1 |
| Bienvenu, J; Coiffier, B; Dumontet, C; Moullet, I; Neidhardt-Berard, EM; Ribeiro, P; Salles, G; Warzocha, K | 1 |
| Amendola, A; Bendandi, M; Bocchia, M; Cantonetti, M; De Renzo, A; Falini, B; Gherlinzoni, F; Gobbi, M; Magagnoli, M; Mandelli, F; Marra, R; Martelli, M; Mazza, P; Moretti, L; Pavone, E; Pileri, SA; Ronconi, F; Sabattini, E; Tura, S; Zaccaria, A; Zinzani, PL | 1 |
| Aviles, A; Delgado, S | 1 |
| Acevedo, A; Arranz, R; Fernández-Rañada, JM; Gil-Fernández, JJ; Muñoz, E; Sobrino, MP | 1 |
| Joensuu, H; Muhonen, T; Nyandoto, P | 1 |
| Bonadonna, G; Valagussa, P | 1 |
| Bischoff, H; Diehl, V; Duehmke, E; Engert, A; Franklin, J; Georgii, A; Glunz, A; Haedicke, C; Hasenclever, D; Hermann, R; Holmer, L; Krause, S; Lathan, B; Loeffler, M; Paulus, U; Pfreundschuh, M; Rueffer, JU; Sextro, M; Sieber, M; Stappert-Jahn, U; Tesch, H; von Kalle, K; Winnerlein-Trump, E; Wolf, J; Wulf, G | 1 |
| Shimoyama, M; Tsushita, K; Utsumi, M | 1 |
| Bischoff, H; Diehl, V; Dühmke, E; Engert, A; Franklin, J; Georgii, A; Glunz, A; Haedicke, C; Hasenclever, D; Hermann, R; Holmer, L; Krause, S; Lathan, B; Loeffler, M; Paulus, U; Pfreundschuh, M; Rüffer, JU; Sextro, M; Sieber, M; Stappert-Jahn, U; Tesch, H; von Kalle, K; Winnerlein-Trump, E; Wolf, J; Wulf, G | 1 |
| Albertini, P; Babini, L; Barbieri, E; Bendandi, M; Frezza, G; Galuppi, A; Gherlinzoni, F; Magagnoli, M; Merla, E; Tura, S; Zinzani, PL | 1 |
| Aparicio, M; Blanco, P; Deminière, C; Denisi, R; Leng, B; Pellegrin, JL; Rispal, P | 1 |
| Iwase, O; Katagiri, T; Kimura, Y; Miyazawa, K; Nakano, M; Nishimaki, J; Suzuki, A; Syoji, N; Toyama, K | 1 |
| Andrieu, JM; Colonna, P; Yilmaz, U | 1 |
| Cooper, DL; Hu, GL; Salloum, E; Tanoue, LT; Wackers, FJ; Zelterman, D | 1 |
| Chim, CS; Ho, FC; Kwong, YL; Lee, CK; Liang, R; Lie, AK | 1 |
| Armata, J; Balwierz, W; Bogusławska-Jaworska, J; Janik-Moszant, A; Kaczmarek-Kanold, M; Kowalczyk, J; Kołakowska-Mrozowska, B; Kołecki, P; Matysiak, M; Moryl-Bujakowska, A; Newecka-Samól, T; Pisarek, J; Rokicka-Milewska, R; Skomra, S; Soñta-Jakimczyk, D; Sopyło, B | 1 |
| Anselmo, AP; Donato, V; Enrici, RM; Falchetto Osti, M; Mandelli, F; Santoro, M; Tombolini, V | 1 |
| Horning, SJ; Horwitz, SM; Lucas, JB; Sayegh, A | 1 |
| Foss, HD; Keilholz, U; Knauf, W; Siehl, J; Szelényi, H; Thiel, E | 1 |
| Avishay, AE; Kitay-Cohen, Y; Lishner, M; Manor, Y | 1 |
| Calvo Villas, J; Ramírez Sánchez, M; Sicilia Guillén, F | 1 |
| Aglietta, M; Amadori, S; Botto, B; Cantonetti, M; Castoldi, GL; Dammacco, F; Fagioli, F; Ferrara, R; Levis, A; Montemurro, F; Racanelli, V; Teofili, L; Volta, C | 1 |
| Farah, RA; Geara, F; Hajjar, T; Khogali, M; Muwakkit, S; Nabbout, B; Shabb, NS | 1 |
| Angelopoulou, MK; Boussiotis, VA; Kittas, C; Kontopidou, FN; Pangalis, GA; Papavassiliou, C; Siakantaris, MP; Vassilakopoulos, TP | 1 |
| Bertrand, Y; Coze, C; Donadieu, J; Habrand, JL; Landman-Parker, J; Leblanc, T; Lemerle, J; Leverger, G; Oberlin, O; Pacquement, H; Perel, Y; Robert, A; Schaison, G; Terrier-Lacombe, MJ; Thuret, I | 1 |
| Takagi, T; Yokota, A | 1 |
| Dohi, H; Fukuda, H; Fukuhara, S; Hirano, M; Hotta, T; Kozuru, M; Mikuni, C; Miura, A; Mukai, K; Nasu, K; Niimi, M; Sasaki, T; Shimoyama, M; Sugiyama, H; Suzuki, H; Tajima, K; Takenaka, T; Tomonaga, M | 1 |
| Bolger, MJ; Kaleem, Z; O'Sullivan, MJ; Swanson, PE; Zutter, MM | 1 |
| Bergonzi, C; Morandi, S; Spedini, P | 1 |
| Bosković, D; Colović, M; Elezović, I; Tomin, D | 1 |
| Botchan, A; Hauser, R; Paz, G; Tal, R; Yavetz, H; Yogev, L | 1 |
| Sauter, C | 1 |
| Allen, PK; Choe, JG; Cox, JD; Edmund, E; Ha, CS; Kong, JS; Oh, YK | 1 |
| Chott, A; Dieckmann, K; Geissler, K; Gisslinger, H; Jäger, U; Knöbl, P; Lechner, K; Pötter, R; Sperr, W; Valent, P | 1 |
| Astori, C; Baio, A; Baraté, C; Bernasconi, C; Brusamolino, E; Franchini, P; Lazzarino, M; Lunghi, F; Orlandi, E; Pagnucco, G; Passamonti, F | 1 |
| Cheung, T; Levine, AM; Li, P; Nathwani, BN; Ratner, L; Tulpule, A; Von Roenn, J | 1 |
| Avigdor, A; Ben-Bassat, I; Grotto, I; Hardan, I; Raanani, P; Shpilberg, O | 1 |
| Clough, RW; Dodge, RK; Elconin, JH; Kim, C; Prosnitz, LR; Rizzieri, DA; Roberts, KB; Vermont, C | 1 |
| Blumental, R; Ducach, A; Lugassy, G; Maslovsky, I; Volchek, L | 1 |
| Carbone, A; Spina, M; Tirelli, U; Vaccher, E | 1 |
| Kamma, JJ; Kattamis, A; Moschovi, M; Moshovi, M; Nicolatou-Galitis, O; Papadaki, T; Tsoumakas, C; Tzortzatou-Stathopoulou, F; van Vliet-Constantinidou, C | 1 |
| Borowitz, MJ; Li, S | 1 |
| Apak, H; Celkan, T; Ozbay, G; Ozkan, A; Yildiz, I; Yoruk, A | 1 |
| Diehl, V; Sieber, M; Tesch, H | 1 |
| Ben-Arie, Y; Ben-Shahar, M; Cohen, Y; Epelbaum, R; Faraggi, D; Haim, N; Sharabi-Nov, A; Valtuch, I | 1 |
| Berinstein, N; Cowan, DH; Franssen, E; MacKenzie, RG; Poldre, P; Sawka, C; Senn, J; Wong, R | 1 |
| Alba, E; De Las Nieves, MA; Gumà, J; Márquez, A; Miramón, J; Ribelles, N; Rueda, A; Sevilla, I | 1 |
| el Omri, H; Ennabli, S; Korbi, S; Kraiem, I; Skouri, H; Sriha, B; Youssef, YB | 1 |
| Ebsen, M; Kirchner, EM; Kirchner, J; Theegarten, D; Voigtmann, R | 1 |
| Ansén, S; Bischoff, S; Bohlen, H; Diehl, V; Dietlein, M; Re, D; Scheidhauer, K; Schicha, H; Tesch, H; Weihrauch, MR; Wolf, J | 1 |
| Enblad, G; Glimelius, B; Molin, D; Sundström, C; Venge, P | 1 |
| D'Orazio, AI | 1 |
| Avilés, A; Neri, N | 1 |
| Bethe, U; Cornely, OA; Pels, H; Ritzkowsky, A; Seibold, M; Soehngen, D; Toepelt, K | 1 |
| Anselmo, AP; Brosteanu, O; Diehl, V; Doelken, G; Duehmke, E; Engert, A; Franklin, J; Georgii, A; Greil, R; Hasenclever, D; Herrmann, R; Josting, A; Kirchner, H; Koch, P; Koch, T; Lathan, B; Loeffler, M; Munker, R; Paulus, U; Pfistner, B; Pfreundschuh, M; Rueffer, U; Schalk, KP; Sieber, M; Tesch, H; Wolf, J | 1 |
| Altundag, MK; Arpaci, F; Celasun, B; Kömürcü, S; Ozet, A; Oztürk, B; Tezcan, Y | 1 |
| Ananthanarayan, C; Haley, S; Solow, HL; Tsang, RW | 1 |
| Angelopoulou, MK; Bonadonna, G; Bonfante, V; Cabanillas, F; Chilosi, M; Gianni, AM; Giardini, R; Herling, M; Kittas, C; McLaughlin, P; Medeiros, LJ; Mesina, O; Nadali, GP; Pangalis, GA; Pizzolo, G; Rassidakis, GZ; Rodriguez, MA; Romaguera, J; Sarris, AH; Vassilakopoulos, TP; Viviani, S | 1 |
| Cataldi, A; Guerrasio, A; Pilatrino, C; Saglio, G | 1 |
| Carde, P; Cavalli, F; Diehl, V; Franklin, J | 1 |
| Fung, HC; Nademanee, AP | 1 |
| Hagihara, R; Imanishi, K; Kitazawa, S; Morita, M; Ryu, Y; Tani, S; Yagi, N; Yamashita, J | 1 |
| Bos, LP; Erdkamp, FL; Knibbeler-van Rossum, CT; Peters, FJ | 1 |
| Chisesi, T; Deliliers, GL; Federico, M; Gobbi, PG; Levis, A; Linfomi, MB; Luminari, S; Santini, G | 1 |
| Hutchinson, RJ; Kelly, KM; Lones, MA; Massey, V; Perkins, SL; Sposto, R; Weiner, MA | 1 |
| Andrieu, JM; Colonna, P; Delwail, V; Jais, JP | 1 |
| Bruntsch, U; Gallmeier, WM; Osieka, R; Schmidt, CG; Seeber, S | 1 |
| Frei, E; Jaffe, N; Lokich, JJ; Tullis, J | 1 |
| Abele, R; Alberto, P; Germano, G; Obrecht, JP; Wagenknecht, L | 1 |
| Case, DC; Clarkson, BD; Lee, BJ; Nisce, L; Young, CW | 1 |
| Donner, L; Klener, P | 1 |
| Case, DC; Lee, BJ; Young, CW | 1 |
| Alberto, P; Walser, A | 1 |
| Bonadonna, G; De Lena, M; Valagussa, P; Zucali, R | 1 |
| Amare, M; Peterson, J | 1 |
| Dold, U | 1 |
| Clamon, GH; Corder, MP | 1 |
| Krikorian, JG; Portlock, CS; Rosenberg, SA | 1 |
| De Lena, M; Santoro, A | 1 |
| Karrer, K | 1 |
| Grünewald, K; Huber, H | 1 |
| Houghton, AN; Rickles, FR; Shafi, N | 1 |
| Baumgartner, G; Höcker, P; Lutz, D; Waldner, R | 1 |
| Costanzi, JJ | 1 |
| Azzarelli, A; Bajetta, E; Beretta, G; Bonadonna, G; De Lena, M; Tancini, G; Veronesi, U | 1 |
| Klepp, O | 1 |
| Behles, C; Dahmen, E; Diehl, V; Felsenberg, D; Kreuser, ED; Mielcarek, M; Seibt-Jung, H; Thiel, E | 1 |
| Diehl, V; Hasenclever, D; Lathan, B; Löffler, M; Pfreundschuh, M; Rüffer, U | 1 |
| Coleman, CN; Diehl, V; Fischer, RI; Lister, TA; Meerwaldt, JH | 1 |
| Polliack, A; Putterman, C | 1 |
| Averous, M; Chevallier, P; Grasset, D; Guiter, J; Iborra, F; Lavabre-Bertrand, T; Rebillard, X; Robert, M | 1 |
| Laine, P; Lindqvist, C; Meurman, JH; Murtomaa, H; Pyrhönen, S; Teerenhovi, L; Tenovuo, J | 1 |
| D'Angio, GJ; Goldwein, JW; Lange, B; Maity, A | 1 |
| Auguet Quintillá, T; Gallén Castillo, M; Pedro-Botet Montoya, J; Planas Domingo, J | 1 |
| Capua, A; Pompili, E; Tombolini, V | 1 |
| Arnott, S; D'Ardenne, J; Ganesan, TS; Lister, TA; Oza, A; Perry, N; Shand, WS; Stansfeld, AG; Wrigley, PF | 1 |
| Erner, SM; Keller, SM; Langer, CJ | 1 |
| Bertrand, Y; Bey, P; Chompret, A; Habrand, JL; Leverger, G; Oberlin, O; Pacquement, H; Raquin, MA; Rubie, H; Terrier-Lacombe, MJ | 1 |
| Anderson, JR; Canellos, GP; Cooper, MR; Gottlieb, A; Green, MR; Henderson, ES; Nissen, N; Peterson, BA; Propert, KJ | 1 |
| Fleischmann, T; Molnár, Z | 1 |
| Kiss, A; Rák, K; Telek, B; Ujj, G | 1 |
| Brice, P; Brouet, JC; Castaigne, S; D'Agay, MF; Fermand, JP; Fermé, C; Frija, J; Lepage, E; Marty, M; Miot, C | 1 |
| Bonadonna, G; Bonfante, V; Santoro, A; Valagussa, P; Viviani, S | 3 |
| Bosly, A; Doyen, C; Ferrant, A; Machiels, JP; Martiat, P; Michaux, JL | 1 |
| Anderson, J; Canellos, GP; Cella, DF; Cherin, E; Cooper, MR; Henderson, ES; Kornblith, AB; Kosty, MP; Tross, S; Zuckerman, E | 1 |
| Bailey, NM; Hagemeister, FB; Liang, JC; Sen, P | 1 |
| Bezwoda, MA; Bezwoda, WR; Dansey, R | 1 |
| Diehl, V; Gerhartz, H; Hiller, E; Kirchner, H; Löffler, M; Pfreundschuh, M; Rühl, U | 1 |
| Lokich, JJ | 1 |
| Caravelli, J; Chapman, D; Clarkson, BD; Gaynor, JJ; Merke, DP; Myers, J; Straus, DJ; Yahalom, J | 1 |
| Audebert, AA; Blanc, CM; Bonichon, F; David, B; Eghbali, H; Hoerni, B; Najman, A; Rojouan, J; Zittoun, R | 1 |
| Calavrezos, A; Heilmann, HP; Küchler, R; Kuse, R | 1 |
| Aeppli, D; Day, DL; Heise, R; Lee, CK; McClain, KL; Woods, WG | 1 |
| Lerud, KS; Luetkehans, TJ; Shanley, DJ | 1 |
| Kaaden, R; Klotz, E; Wienbeck, M; Zwack, K | 1 |
| Collins, RD; Constine, LS; Davis, PC; Fryer, CJ; Hays, DM; Heller, RM; Hutchinson, RJ; Krailo, M; Nachman, J; O'Brien, RT | 1 |
| Boussiotis, VA; Kyrtopoulos, SA; Pangalis, GA; Souliotis, VL | 1 |
| Avilés, A; Díaz-Maqueo, JC; Guzman, R; Torras, V | 1 |
| Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S | 1 |
| al-Idrissi, HY; Ibrahim, EM | 1 |
| Bonadonna, G; Bonfante, V; Bregni, M; Gianni, AM; Gianni, L; Lombardi, F; Santoro, A; Siena, S; Viviani, S; Zucali, R | 1 |
| Foà, R; Gavosto, F; Monfardini, S; Tirelli, U; Vaccher, E | 1 |
| Bonadonna, G; Negretti, E; Santoro, A; Valagussa, P; Viviani, S; Zanini, M; Zucali, R | 1 |
| Breed, WP; Burgers, JM; Carde, P; de Pauw, BE; Hagenbeek, A; Henry-Amar, M; Monconduit, M; Somers, R; Tarayre, M; Thomas, J | 1 |
| Boiron, M; Brice, P; Ferme, C; Frija, J; Gisselbrecht, C; Hennequin, C; Marolleau, JP; Monsuez, JJ; Tredaniel, J | 1 |
| Copplestone, JA; Daniel, F; Goodrick, MJ; Prentice, AG; Tyrrell, CJ | 1 |
| Caggana, M; Coleman, CN; Kelsey, KT; Liber, HL; Mauch, PM | 1 |
| Behm, FG; Brecher, M; Cantor, A; Chauvenet, A; Leventhal, BG; Marcus, R; Ternberg, J; Weiner, MA; Wharam, M | 1 |
| Bacigalupo, A; Carella, AM; Carlier, P; Congiu, A; Damasio, E; Giordano, D; Nati, S; Occhini, D; Pierluigi, D; Santini, G | 1 |
| Bastion, Y; Coiffier, B; Tigaud, JD | 1 |
| Blanc, AP; Jacquème, P; Magnan, A; Poirier, R; Redding, E; Sudan, N | 1 |
| Avilés, A; Cruz, J; Zepeda, G | 1 |
| Brosteanu, O; Diehl, V; Gause, A; Hasenclever, D; Pfreundschuh, M; Roschansky, V; Schmits, R; Tschiersch, A; Verpoort, K | 1 |
| Armata, J; Balwierz, W; Depowska, T; Kaczmarek, M; Moryl-Bujakowska, A; Najbar, A; Ochocka, M; Radwańska, U; Sońta-Jakimczyk, D; Stańczak, E | 1 |
| Flaherty, LE; Redman, BG; Schwert, R | 1 |
| Rosenberg, SA | 2 |
| Emerson, JD; Moses, LE | 1 |
| Bestetti, O; Bonadonna, G; Bonfante, V; Ragni, G; Santoro, A; Viviani, S | 1 |
| McDermed, JE; Rosen, VJ; Strum, SB; Weiss, A | 1 |
| Appelbaum, FR; Buckner, CD; Clift, RA; Deeg, HJ; Neiman, PE; Sanders, JE; Stewart, P; Storb, R; Sullivan, KM; Thomas, ED | 1 |
| Jestrimski, KW; Lowenthal, RM | 1 |
| Dumont, J; Teillet, F | 1 |
| Bonadonna, G; Bonfante, V; Delfino, A; Santoro, A; Valagussa, P; Villarreal, CJ; Viviani, S | 1 |
| LaMonte, CS; Straus, DJ; Yeh, SD | 1 |
| Kholin, AV | 1 |
| Bonadonna, G; Santoro, A; Valagussa, P | 2 |
| Glick, JH; Tsiatis, A | 1 |
| Gabryś, K; Kotlarek-Haus, S; Sciborski, R | 2 |
| Beutner, KR; Markowitch, W; Packman, CH | 1 |
| Rusthoven, JJ | 1 |
| Joensuu, H; Nikkanen, V; Söderström, KO | 1 |
| Anselmo, AP; Biagini, C; Cartoni, C; Cimino, G; Mandelli, F; Maurizi Enrici, R | 1 |
| Armata, J; Borkowski, W; Depowska, T | 1 |
| Berner, J; Chmielowska, E; Dowgier-Witczak, I; Kowalczyński, M; Płuzańska, A; Woźniak, L | 1 |
| Bonadonna, G; Bonfante, V; Crippa, F; Musumeci, R; Pagnoni, AM; Santoro, A; Valagussa, P; Villani, F; Viviani, S; Zucali, R | 1 |
| Barbot, A; Le Fur, R; Menard, JF; Monconduit, M; Piguet, H; Tilly, H | 1 |
| Baccarani, M; Bandini, G; Emiliani, E; Fiacchini, M; Gobbi, M; Lauria, F; Mazza, P; Tura, S; Verlicchi, F; Zinzani, PL | 1 |
| Chojnowski, K; Drzewoski, J; Krykowski, E; Olszańska-Skorek, T | 1 |
| Coiffier, B | 1 |
| Behrendt, H; Van Bunningen, BN; Van Leeuwen, EF | 1 |
| Vicente, J | 1 |
| Diehl, V; Georgii, A; Gerhartz, H; Hiller, E; Löffler, M; Pfreundschuh, M; Rühl, U; Smith, K | 1 |
| Lemerle, J; Leverger, G; Oberlin, O; Schaison, G | 1 |
| Koziner, B; Zori Comba, A | 1 |
| Abgrall, J; Chatelain, JD; Hauteville, D; Jan, P; Jaubert, D; Verdier, M | 1 |
| Audebert, A; Blanc, CM; David, B; Debray, J; Eghbali, H; Hoerni, B; Rojouan, J; Zittoun, R | 1 |
| Buzaid, AC; Lippman, SM; Miller, TP | 1 |
| Diehl, V; Fuchs, R; Loeffler, M; Pflüger, KH; Pfreundschuh, MG; Schoppe, WD | 1 |
| Goshen, Y; Kalinsky, H; Pecht, M; Umiel, T; Zaizov, R | 1 |
| Bertino, JR; Cadman, EC; Farber, LR; Fischer, JJ; Kapp, DS; Prosnitz, LR; Scott, J | 1 |
| Habrand, JL; Lemerle, J; Leverger, G; Oberlin, O; Olive, D; Schaison, G; Zucker, JM | 1 |
| Bartels, H; Gerhartz, H; Hiller, E; Kirchner, H; Löffler, M; Petsch, S; Pfreundschuh, M; Rühl, U; Schoppe, W; Wilmanns, W | 1 |
| Karrison, T; Larson, R; Meier, P; Sagher, D; Schwartz, JL; Strauss, B | 1 |
| Armata, J; Balwierz, W; Moryl-Bujakowska, A; Pekacki, A | 1 |
| Fuchs, R; Gerhartz, H; Hasenclever, D; Hiller, E; Kühn, G; Loeffler, M; Pfreundschuh, M; Rohloff, R; Rühl, U; Wilmanns, W | 1 |
| Hayabuchi, N; Hirata, H; Ishii, E; Jingu, K; Kikuchi, M; Komiyama, S; Masuda, K; Miyoshi, M; Nishimura, J; Shibuya, T | 1 |
| Brice, P; Gerota, I; Gisselbrecht, C; Lepage, E; Trédaniel, J | 1 |
| Bey, P; Dionet, C; Dutou, L; Habrand, JL; Le Floch, O; Lefur, R; Madelain, M; Oberlin, O; Thierry, P; Vilcoq, J | 1 |
| Carrión Galindo, R; Cosín Ochaita, J; Flores Sañudo, E; García Alfonso, P; Jara Sánchez, C | 1 |
| Herrmann, G; Hübner, K | 1 |
| Carella, AM; Cimino, G; Congiu, AM; Coser, P; Gaozza, E; Mangoni, L; Mazza, P; Meloni, G; Ricci, P; Visani, G | 1 |
| Bladé, J; Cervantes, F; Montserrat, E; Reverter, JC; Rozman, C | 1 |
| Bensadoun, JR; Caldani, C; Héry, M; Lagrange, JL; Schneider, M; Thyss, A | 1 |
| Baker, JR; Douglas, DM; Giguere, JK; Lupton, GP; Weiss, RB | 1 |
| Burgers, JM; Carde, P; Hayat, M; Henry-Amar, M; Meerwaldt, JH; Noordijk, EM; Tanguy, A; Thomas, J; Tubiana, M; Van der Schueren, E | 1 |
| Donaldson, SS; Link, MP; Mefferd, JM | 1 |
| Albisinni, U; Ammendolia, I; Barbieri, E; Sciascia, R; Tondi, L | 1 |
| Diehl, V; Gerhartz, H; Hiller, E; Kirchner, H; Löffler, M; Petsch, S; Pfreundschuh, M; Rühl, U; Schoppe, W; Wilmanns, W | 1 |
| Kulus, M; Matysiak, M; Milanowski, A; Ochocka, M | 1 |
| Bey, P; Conroy, T; Lederlin, P; Peiffert, D; Witz, F | 1 |
| Barnett, MJ; Connors, JM; Fay, JW; Herzig, GP; Herzig, RH; Klingemann, HG; Phillips, GL; Reece, DE; Shepherd, JD; Wolff, SN | 1 |
| Armata, J; Balwierz, W; Depowska, T; Moryl-Bujakowska, A; Strzeszyński, J | 1 |
| Clarkson, B; Fuks, Z; Gulati, S; Shank, B; Yahalom, J | 1 |
| Brière, J; Casassus, P; Desablens, B; Gandhour, C; Guilhot, F; Harousseau, JL; Ifrah, N; Le Prise, PY; Lemevel, A; Tourani, JM | 1 |
| Banfi, A; Bonadonna, G; Bonfante, V; Santoro, A; Valagussa, P; Viviani, S | 1 |
| Caravelli, J; Chapman, D; Clarkson, BD; Gaynor, J; Lee, BJ; Merke, D; Myers, J; Nisce, LZ; Straus, DJ | 1 |
| Bonnet, M; de Lumley, L; Dufillot, D; Lemerle, J; Leverger, G; Oberlin, O; Olive, D; Schaison, G | 1 |
| Diehl, V; Pfreundschuh, M; Schaadt, M | 1 |
| Armata, J; Balwierz, W | 1 |
| Donaldson, SS; Link, MP; McDougall, IR; Parker, BR; Shochat, SJ | 1 |
| Binon, J; Ferrant, A; Hamoir, V; Michaux, JL; Sokal, G | 1 |
| Suon, SZ | 1 |
| Hatae, Y; Hattori, T; Ishikawa, Y; Nakadate, H; Nishi, M; Takeda, T | 1 |
129 review(s) available for dacarbazine and Hodgkin Disease
| Article | Year |
|---|---|
[Initial treatment strategy for classical Hodgkin lymphoma in adults].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Vinblastine | 2021 |
Estimating the global burden of Epstein-Barr virus-related cancers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Dacarbazine; Doxorubicin; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large B-Cell, Diffuse; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasms; Stomach Neoplasms; Vinblastine | 2022 |
Treatment Strategies for Advanced Classical Hodgkin Lymphoma in the Times of Dacarbazine Shortage.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Vinblastine | 2022 |
Extranodal classical Hodgkin lymphoma involving the spinal cord: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Spinal Cord; Vinblastine; Vincristine | 2022 |
Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immune Checkpoint Inhibitors; Mechlorethamine; Nivolumab; Prednisolone; Procarbazine; Renal Dialysis; Vinblastine; Vincristine; Vinorelbine | 2022 |
Lymphomas in pregnancy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Pregnancy; Vinblastine | 2023 |
Cost-effectiveness of brentuximab vedotin in Hodgkin lymphoma: a systematic review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cost-Benefit Analysis; Dacarbazine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Transplantation, Autologous; Vinblastine | 2023 |
Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Randomized Controlled Trials as Topic; Vinblastine | 2023 |
An evaluation of brentuximab vedotin as a treatment option for stage III/IV Hodgkin lymphoma.
Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Clinical Trials as Topic; Cost-Benefit Analysis; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunotoxins; Male; Middle Aged; Neoplasm Staging; Practice Guidelines as Topic; Survival Analysis; Vinblastine | 2019 |
Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine | 2020 |
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Progression-Free Survival; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Vinblastine; Vincristine; Young Adult | 2020 |
ABVD and BEACOPP regimens' effects on fertility in young males with Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fertility; Hodgkin Disease; Humans; Infertility, Male; Male; Prednisone; Procarbazine; Vinblastine; Vincristine | 2021 |
[Treatment strategy for newly diagnosed classical Hodgkin lymphoma: current achievements using interim PET-guided therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prospective Studies; Vinblastine | 2020 |
Stem Cell as Vehicles of Antibody in Treatment of Lymphoma: a Novel and Potential Targeted Therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphoma; Stem Cells; Vinblastine | 2021 |
Current treatment options for nodular lymphocyte-predominant Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphocytes; Retrospective Studies; Transplantation, Autologous; Vinblastine | 2021 |
Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging | 2017 |
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Middle Aged; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Young Adult | 2017 |
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Radiotherapy; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Vinblastine | 2017 |
Emerging role of novel therapies in Hodgkin lymphoma: proceed with caution.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Immunoconjugates; Neoplasm Proteins; Nivolumab; Programmed Cell Death 1 Receptor; Recurrence; Vinblastine | 2017 |
Nodular lymphocyte-predominant Hodgkin lymphoma: a unique disease deserving unique management.
Topics: Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Gene Expression Regulation, Neoplastic; Hodgkin Disease; Humans; Ki-1 Antigen; Neoplasm Proteins; Radiotherapy; Vinblastine | 2017 |
Balancing risk and benefit in early-stage classical Hodgkin lymphoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Risk Assessment; Sex Factors; Survival Rate; Vinblastine; Vincristine | 2018 |
Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors.
Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Resistance, Neoplasm; Hodgkin Disease; Humans; Immunoconjugates; Immunomodulation; Molecular Targeted Therapy; Neoplasm Staging; Positron-Emission Tomography; Retreatment; Salvage Therapy; Treatment Outcome; Vinblastine | 2018 |
Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Brentuximab Vedotin; Carboplatin; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Male; Vinblastine | 2018 |
Determining the sequence of novel therapies in the treatment of relapsed Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoconjugates; Male; Recurrence; United States; Vinblastine | 2018 |
Therapeutic recommendations for early stage Hodgkin lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Chemoradiotherapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Immunoconjugates; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Vinblastine | 2019 |
Risk-adapted therapy for advanced-stage Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Immunoconjugates; Neoplasm Staging; Risk Adjustment; Vinblastine | 2018 |
[Acute sensory neuropathy associated with Hodgkin's lymphoma: a case study].
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Paraneoplastic Polyneuropathy; Paresthesia; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2019 |
Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapy.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Neoplasm Staging; Neoplasms, Second Primary; Patient Selection; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine | 2013 |
Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vinblastine; Vincristine | 2013 |
Classical Hodgkin's lymphoma: past, present and future perspectives.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Chemoradiotherapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Immunoconjugates; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sex Factors; Stem Cell Transplantation; Vinblastine | 2013 |
Early intensification treatment approach in advanced-stage Hodgkin lymphoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Staging; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine | 2014 |
Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Decision Making; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Practice Guidelines as Topic; Risk Assessment; Treatment Outcome; Vinblastine | 2014 |
Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autologous stem cell transplant only for those who relapse).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Induction Chemotherapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine | 2014 |
Chemotherapy only in early-stage Hodgkin lymphoma: more relapses but "same" (or possibly worse) survival--reconsidering the misguided trend to omit radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Positron-Emission Tomography; Salvage Therapy; Vinblastine | 2014 |
[Treatment strategy of Hodgkin lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immunoconjugates; Mechlorethamine; Melphalan; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Rituximab; Vinblastine; Vincristine | 2014 |
How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus.
Topics: Adult; Anti-Retroviral Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; HIV Infections; HIV-1; Hodgkin Disease; Humans; Lymphatic Metastasis; Male; Vinblastine | 2015 |
Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Molecular Targeted Therapy; Prednisone; Procarbazine; Programmed Cell Death 1 Receptor; Vinblastine; Vincristine | 2016 |
Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Evidence-Based Medicine; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Vinblastine | 2016 |
Risk-Adapted Treatment of Advanced Hodgkin Lymphoma With PET-CT.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Retrospective Studies; Vinblastine | 2016 |
Current developments in the treatment of early-stage classical Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Staging; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine | 2016 |
Comparison of the efficiency of ABVD versus BEACOPP for Hodgkin lymphoma treatment: a meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2016 |
Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glucose-6-Phosphate; Hodgkin Disease; Humans; Positron-Emission Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine | 2016 |
FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine | 2017 |
[Primary osseous Hodgkin's lymphoma of the sacrum: A diagnostic and therapeutic challenge].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Diagnosis, Differential; Doxorubicin; Etoposide; False Negative Reactions; Female; Hodgkin Disease; Humans; Infertility, Female; Low Back Pain; Magnetic Resonance Imaging; Organ Sparing Treatments; Osteomyelitis; Ovary; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Conformal; Remission Induction; Sacrum; Spinal Neoplasms; Vinblastine; Vincristine; Young Adult | 2017 |
Treatment of lymphocyte-predominant Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphocytes; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy; Retrospective Studies; Treatment Outcome; Vinblastine | 2008 |
Treatment of Hodgkin lymphoma: the past, present, and future.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine | 2008 |
Breast cancer after treatment of Hodgkin's lymphoma: general review.
Topics: Adolescent; Adult; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Child; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Radionuclide Imaging; Radiotherapy; Risk Factors; Splenectomy; Vinblastine; Vincristine; Young Adult | 2008 |
[Primary multifocal osseous Hodgkin lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasms, Multiple Primary; Positron-Emission Tomography; Remission Induction; Tomography, X-Ray Computed; Vinblastine | 2009 |
HIV-associated Hodgkin lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; B-Lymphocytes; Bleomycin; Clinical Trials, Phase II as Topic; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Risk Factors; T-Lymphocytes; Vinblastine; Viral Matrix Proteins | 2009 |
Primary cutaneous Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Skin Neoplasms; Treatment Outcome; Vinblastine | 2009 |
Standard therapy of advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Melphalan; Methylprednisolone; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2009 |
Is BEACOPP better than ABVD?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Forecasting; Hodgkin Disease; Humans; Infertility; Male; Multicenter Studies as Topic; Neoplasms, Second Primary; Patient Selection; Prednisone; Procarbazine; Remission Induction; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Does rituximab have a place in treating classic hodgkin lymphoma?
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Rituximab; Vinblastine | 2010 |
The unique characteristics and management of patients over 60 years of age with classic Hodgkin lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Comorbidity; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Middle Aged; Recurrence; Vinblastine | 2011 |
Chemotherapy only for localized Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachial Plexus; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fibrosis; Gemcitabine; Heart; Hodgkin Disease; Humans; Hypothyroidism; Lung; Lymphedema; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 2011 |
The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Histiocytes; Hodgkin Disease; Humans; Immunophenotyping; Lymph Node Excision; Lymphatic Irradiation; Lymphocytes; Prognosis; Recurrence; Rituximab; Salvage Therapy; Vinblastine | 2012 |
Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Middle Aged; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Young Adult | 2011 |
Lymphoma study group of JCOG.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Approval; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Japan; Kaplan-Meier Estimate; Lymphoma; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Molecular Targeted Therapy; Multiple Myeloma; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Vincristine | 2012 |
Treatment of newly diagnosed advanced stage Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Prospective Studies; Retrospective Studies; Vinblastine; Vincristine | 2012 |
Autoimmune hemolytic anemia and classical Hodgkin lymphoma: a case report and literature review.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Erythrocyte Transfusion; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Rituximab; Vinblastine | 2012 |
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Cyclophosphamide; Dacarbazine; Disseminated Intravascular Coagulation; Doxorubicin; Etoposide; Evidence-Based Medicine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Prednisone; Procarbazine; Purpura, Thrombocytopenic, Idiopathic; Randomized Controlled Trials as Topic; Receptors, Thrombopoietin; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Viral Vaccines | 2012 |
Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Mediastinal Neoplasms; Phenotype; Prednisone; Procarbazine; Vinblastine; Vincristine | 2012 |
Lymphocyte-depleted Hodgkin lymphoma complicating hemophagocytic lymphohistiocytosis as an initial manifestation: a case report and review of the literature.
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphocytes; Lymphohistiocytosis, Hemophagocytic; Male; Prednisone; Thrombomodulin; Vinblastine; Vincristine | 2012 |
[Dropped Head Syndrome after whiplash injury in a patient treated for a Hodgkin's lymphoma by mantle field radiotherapy].
Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cervical Plexus; Cervical Vertebrae; Combined Modality Therapy; Dacarbazine; Dose Fractionation, Radiation; Doxorubicin; Electromyography; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Mechlorethamine; Middle Aged; Muscle Weakness; Neck Muscles; Osteoarthritis; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, High-Energy; Remission Induction; Vinblastine; Vincristine; Whiplash Injuries | 2013 |
Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine | 2003 |
Spontaneous regression of Hodgkin's disease: two case reports and a review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Regression, Spontaneous; Remission Induction; Tomography, X-Ray Computed; Vinblastine | 2003 |
[Hematologic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Doxorubicin; Hematologic Neoplasms; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 2003 |
The impact of conventional and high-dose therapy for lymphoma on fertility.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fertility; Hodgkin Disease; Hormone Replacement Therapy; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Prednisolone; Treatment Outcome; Vinblastine; Vincristine | 2004 |
[Primary treatment of early stage Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Risk Factors; Vinblastine | 2005 |
Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Transfusion; Child; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Recurrence; South Africa; Time Factors; Vinblastine; Vincristine | 2005 |
[Primary treatment of advanced Hodgkin's disease].
Topics: Age Factors; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Meta-Analysis as Topic; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Risk Factors; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine | 2005 |
ABVD, the Stanford V regimen, and BEACOPP for Hodgkin's lymphoma: what should an oncologist do?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Survival Analysis; Vinblastine; Vincristine | 2005 |
Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Neoplasm Staging; Radiotherapy; Randomized Controlled Trials as Topic; Retrospective Studies; Vinblastine | 2005 |
Clinical trials in North America.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; North America; Radiotherapy; Remission Induction; Salvage Therapy; Treatment Outcome; Vinblastine | 2005 |
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Heart Diseases; Hodgkin Disease; Humans; Infertility; Lung Diseases; Mechlorethamine; Multicenter Studies as Topic; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Risk; Survival Rate; Vinblastine; Vincristine | 2007 |
Risk, cure and complications in advanced hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Positron-Emission Tomography; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Risk; Vinblastine; Vincristine | 2007 |
Prophylactic use of filgrastim with ABVD and BEACOPP chemotherapy regimens for Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Prednisone; Procarbazine; Recombinant Proteins; Vinblastine; Vincristine | 2007 |
ABVD chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1982 |
[The practice of chemotherapy with the DeVita protocol].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine | 1982 |
Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Mutation; Prednisone; Procarbazine; Vinblastine; Vincristine | 1982 |
The cure of Hodgkin's disease with drugs.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisolone; Prednisone; Procarbazine; Radiotherapy Dosage; Vinblastine; Vincristine | 1983 |
Chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1983 |
Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cobalt Radioisotopes; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Particle Accelerators; Prednisolone; Prednisone; Procarbazine; Radioisotope Teletherapy; Radiotherapy, High-Energy; Vinblastine; Vincristine | 1984 |
[Hodgkin disease: should high-risk patients be selected and chemotherapy be intensified?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Patient Selection; Prednisone; Procarbazine; Prognosis; Risk Assessment; Sex Factors; Survival Rate; Vinblastine; Vincristine | 1995 |
[Hodgkin's disease and pregnancy. 3 case reports and a review of the literature].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Marrow Examination; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Incidence; Mechlorethamine; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, First; Pregnancy Trimester, Second; Procarbazine; Tomography, X-Ray Computed; Vinblastine; Vincristine | 1993 |
Sarcoidosis following chemotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Mediastinal Diseases; Models, Biological; Sarcoidosis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Vinblastine; Vincristine | 1994 |
Lymphomatoid papulosis and Hodgkin's disease: report of a case.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphomatoid Papulosis; Male; Mechlorethamine; Precancerous Conditions; Prednisone; Procarbazine; Reed-Sternberg Cells; Time Factors; Vinblastine; Vincristine | 1994 |
Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cohort Studies; Combined Modality Therapy; Comorbidity; Dacarbazine; Disease Progression; Doxorubicin; Female; France; Herpesviridae Infections; Herpesvirus 4, Human; HIV Infections; Hodgkin Disease; Homosexuality, Male; Humans; Life Tables; Lymphoma, AIDS-Related; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radioisotope Teletherapy; Registries; Remission Induction; Risk Factors; Substance Abuse, Intravenous; Survival Analysis; Tumor Virus Infections; Vinblastine; Vincristine | 1995 |
[High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Salvage Therapy; Vinblastine; Vincristine | 1995 |
Myocardial infarction in young patients with Hodgkin's disease--potential pathogenic role of radiotherapy, chemotherapy, and splenectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Coronary Vessels; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Myocardial Infarction; Postoperative Complications; Prednisone; Procarbazine; Radiation Injuries; Radioisotope Teletherapy; Splenectomy; Thrombocytosis; Vinblastine; Vincristine | 1993 |
The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy; Treatment Outcome; Vinblastine; Vincristine | 1996 |
The case for adjuvant radiation therapy in advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy; Radiotherapy Dosage; Radiotherapy, Adjuvant; Vinblastine | 1996 |
Hodgkin's disease: management of first relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Prognosis; Recurrence; Salvage Therapy; Time Factors; Transplantation, Autologous; Vinblastine; Vincristine | 1996 |
Radiation techniques for the treatment of Hodgkin's disease with combined modality therapy or radiation alone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immobilization; Male; Middle Aged; Neoplasm Staging; Radiation Oncology; Radiation Protection; Radiotherapy Dosage; Vinblastine | 1997 |
Coxalgia as the initial symptom in Hodgkin's disease: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Hip Joint; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Pain, Intractable; Pelvis; Vinblastine | 1997 |
[Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Life Tables; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Prednisone; Procarbazine; Radioisotope Teletherapy; Remission Induction; Retrospective Studies; Salvage Therapy; Spain; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 1998 |
[The management of Hodgkin's disease with chemotherapy or combined modality treatment].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1998 |
Problems in Hodgkin's disease management.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cardiomyopathies; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infections; Laparotomy; Lung Diseases, Interstitial; Lymphography; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Radiation Injuries; Radiotherapy; Remission Induction; Salvage Therapy; Vinblastine; Vincristine | 1999 |
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 1998 |
[Treatment for Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Prognosis; Radiotherapy; Transplantation, Autologous; Vinblastine | 2000 |
Hodgkin's disease: clinical presentation and treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Epstein-Barr Virus Infections; Europe; HIV Infections; Hodgkin Disease; Homosexuality, Male; Humans; Incidence; Lymph Nodes; Male; Mechlorethamine; Opportunistic Infections; Prednisone; Procarbazine; Prognosis; Reed-Sternberg Cells; United States; Vinblastine; Vincristine | 2001 |
The vanishing bile duct syndrome in a child with Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Diseases; Bleomycin; Child, Preschool; Dacarbazine; Doxorubicin; Fatal Outcome; Hodgkin Disease; Humans; Jaundice; Male; Syndrome; Vinblastine | 2001 |
Treatment of advanced stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Vinblastine; Vincristine | 2001 |
Daily general anaesthesia for radiotherapy in unco-operative patients: ingredients for successful management.
Topics: Adolescent; Anesthesia, Intravenous; Anesthetics, Intravenous; Antineoplastic Combined Chemotherapy Protocols; Autistic Disorder; Bleomycin; Combined Modality Therapy; Dacarbazine; Dose Fractionation, Radiation; Doxorubicin; Female; Health Planning Guidelines; Hodgkin Disease; Humans; Mediastinal Neoplasms; Propofol; Treatment Refusal; Vinblastine | 2001 |
Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hodgkin Disease; Humans; Infertility; Mechlorethamine; Prednisolone; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Safety; Treatment Outcome; Vinblastine; Vincristine | 2000 |
Approach to Hodgkin's lymphoma in the new millennium.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Forecasting; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Treatment Failure; Vinblastine | 2002 |
[Pharmacology of DTIC (author's transl)].
Topics: Animals; Chemical Phenomena; Chemistry; Dacarbazine; Hodgkin Disease; Humans; Melanoma; Sarcoma; Soft Tissue Neoplasms; Triazenes | 1978 |
[Dacarbacine (DTIC) in the therapy of a malignant disease. A review (author's transl)].
Topics: Antineoplastic Agents; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Gastrointestinal Neoplasms; Hodgkin Disease; Humans; Melanoma; Sarcoma; Soft Tissue Neoplasms; Triazenes | 1978 |
Late cardiovascular and pulmonary complications of therapy in Hodgkin's disease: report of three unusual cases, with a review of relevant literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lung Diseases; Middle Aged; Radiation Injuries; Radiotherapy; Splenectomy; Vinblastine; Vincristine | 1992 |
Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Remission Induction; Thymus Hyperplasia; Vinblastine; Vincristine | 1992 |
[Comparative study of advanced-stage Hodgkin's lymphoma patients treated with either COPP or ABVD drug combinations].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Evaluation; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vinblastine; Vincristine | 1992 |
ABVD in the treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Italy; Vinblastine; Vincristine | 1992 |
Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1990 |
Chemotherapy of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; Doxorubicin; Drug Administration Schedule; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1990 |
Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Minnesota; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, High-Energy; Retrospective Studies; Survival Rate; Vinblastine; Vincristine | 1990 |
Is there an effective salvage therapy for advanced Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Prognosis; Remission Induction; Vinblastine; Vincristine | 1991 |
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Italy; Mechlorethamine; Prednisone; Procarbazine; Remission Induction; Survival Rate; Transplantation, Autologous; Vinblastine; Vincristine | 1991 |
[Treatment of relapses and failures in disseminated Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Mechlorethamine; Melphalan; Methotrexate; Mitoguazone; Prednisone; Procarbazine; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine | 1991 |
[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunocompromised Host; Leishmaniasis, Visceral; Mechlorethamine; Meglumine; Meglumine Antimoniate; Opportunistic Infections; Organometallic Compounds; Prednisone; Procarbazine; Vinblastine; Vincristine | 1991 |
Corticosteroid drugs: their role in oncological practice.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Dyspnea; Fluorouracil; Hodgkin Disease; Humans; Hypercalcemia; Leukemia; Leukemia, Lymphoid; Lymphoma; Mechlorethamine; Melphalan; Methotrexate; Multiple Myeloma; Palliative Care; Prednisone; Procarbazine; Receptors, Glucocorticoid; Vinblastine; Vincristine; Vomiting | 1986 |
Chemotherapy of malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Hodgkin Disease; Humans; Leukemia; Lymphoma; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine | 1985 |
[Results of the treatment of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1986 |
Current approaches to the treatment of advanced-stage Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Recurrence; Vinblastine; Vincristine | 1986 |
[Rescue treatment in Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1987 |
Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potential.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy; Remission Induction; Vinblastine; Vincristine | 1987 |
[The place of bone marrow autografts in the treatment of Hodgkin's and non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Transplantation, Autologous; Vinblastine; Vincristine | 1988 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine | 1989 |
[Immediate hematological toxicity during combination chemotherapy-radiotherapy of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cell Count; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hematologic Diseases; Hodgkin Disease; Humans; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Retrospective Studies; Vinblastine; Vincristine | 1989 |
[A suggested program of combined treatment of Hodgkin's disease in children].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Dihydroxyphenylalanine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisolone; Prednisone; Procarbazine; Radiotherapy, High-Energy; Vinblastine; Vincristine | 1988 |
281 trial(s) available for dacarbazine and Hodgkin Disease
| Article | Year |
|---|---|
Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Vinblastine | 2021 |
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma.
Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Disease-Free Survival; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Staging; Survival Analysis; Treatment Outcome; Vinblastine | 2022 |
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Middle Aged; Neoplasm Staging; Treatment Outcome; Vinblastine; Young Adult | 2023 |
Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neutropenia; Vinblastine | 2023 |
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Neoplasm Staging; Nivolumab; Prednisone; Quality of Life; Stroke Volume; Ventricular Function, Left; Vinblastine | 2023 |
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Reproducibility of Results; Treatment Outcome; Vinblastine | 2023 |
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Prospective Studies; Quality of Life; Vinblastine | 2023 |
Estimating long-term outcomes in classic Hodgkin lymphoma: a United States population-based oncology simulation model based on overall survival from the ECHELON-1 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Neoplasms, Second Primary; United States; Vinblastine | 2023 |
Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Consolidation Chemotherapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Survival Rate; Vinblastine | 2019 |
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Clinical Decision-Making; Dacarbazine; Disease Progression; Doxorubicin; Europe; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Progression-Free Survival; Radiotherapy Dosage; Time Factors; Vinblastine; Young Adult | 2019 |
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Registries; Survival Rate; Vinblastine | 2020 |
Validation of a simplified international prognostic score (IPS-3) in patients with advanced-stage classic Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; British Columbia; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Predictive Value of Tests; Survival Rate; Vinblastine | 2020 |
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Autografts; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Prospective Studies; Stem Cell Transplantation; Survival Rate; Vinblastine | 2020 |
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Autografts; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Stem Cell Transplantation; Survival Rate; Vinblastine | 2020 |
The prognostic significance of ΔSUV
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Survival Rate; Vinblastine | 2020 |
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Intention to Treat Analysis; Male; Middle Aged; Neoplasm Staging; Survival Analysis; Treatment Outcome; Vinblastine | 2020 |
Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Cost-Benefit Analysis; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine | 2020 |
[Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: final results of the international randomized phase III HD16 trial conducted by the German Hodgkin Study Group].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiotherapy, Adjuvant; Risk Factors; Survival Rate; Vinblastine; Young Adult | 2020 |
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.
Topics: Adolescent; Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Germany; Hodgkin Disease; Humans; Immune Checkpoint Inhibitors; Male; Middle Aged; Nivolumab; Programmed Cell Death 1 Receptor; Progression-Free Survival; Remission Induction; Vinblastine; Young Adult | 2020 |
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Italy; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine | 2020 |
ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Vinblastine; Young Adult | 2020 |
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Progression-Free Survival; Prospective Studies; Vinblastine; Young Adult | 2020 |
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Treatment Outcome; Vinblastine | 2021 |
Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immune Checkpoint Inhibitors; Male; Middle Aged; Nivolumab; Outcome Assessment, Health Care; Positron-Emission Tomography; Prospective Studies; Survival Analysis; Vinblastine | 2021 |
Expression of the novel tumour suppressor sterile alpha motif and HD domain-containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Line, Tumor; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Hodgkin Disease; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; SAM Domain and HD Domain-Containing Protein 1; Survival Rate; Vinblastine | 2021 |
A Ukrainian multicenter prospective study of the value of PET/ CT prognostic role in primary patients with Hodgkins lymphoma in a real-life cohort.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Ukraine; Vinblastine; Vincristine; Young Adult | 2020 |
Treating early-stage Hodgkin lymphoma in resource-limited settings: InPOG-HL-15-01 experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Prospective Studies; Treatment Outcome; Vinblastine | 2021 |
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Female; Hodgkin Disease; Humans; Italy; Male; Middle Aged; Progression-Free Survival; Prospective Studies; Treatment Outcome; Vinblastine; Young Adult | 2021 |
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Chemoradiotherapy; Clinical Decision-Making; Dacarbazine; Doxorubicin; Female; Heart Disease Risk Factors; Hodgkin Disease; Humans; Incidence; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiation Dosage; Radiation Injuries; Risk Assessment; Time Factors; Treatment Outcome; United Kingdom; Vinblastine; Young Adult | 2021 |
Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chronic Disease; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Recurrence; Vinblastine | 2021 |
Treatment outcomes of children with Hodgkin lymphoma between 2000 and 2010: First report by the South African Children's Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; South Africa; Survival Rate; Vinblastine | 2017 |
Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Germany; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy; Radiotherapy Dosage; Survival Rate; Time Factors; Vinblastine; Vincristine; Young Adult | 2017 |
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Monitoring; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Vinblastine; Vincristine; Young Adult | 2017 |
ABVD or BEACOPP
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy; Risk Factors; Survival Analysis; Vinblastine; Vincristine; Young Adult | 2017 |
Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Interactions; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoconjugates; Kaplan-Meier Estimate; Lung Diseases; Male; Middle Aged; Molecular Targeted Therapy; Remission Induction; Treatment Outcome; Vinblastine; Young Adult | 2017 |
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoconjugates; Immunologic Factors; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival Rate; Vinblastine; Young Adult | 2018 |
Excellent Outcomes Following Response-based Omission of Radiotherapy in Children and Adolescents With Intermediate or High-risk Hodgkin Lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Prednisolone; Retrospective Studies; Risk Factors; Vinblastine; Vincristine | 2018 |
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Tria
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Prospective Studies; Radiotherapy; Rituximab; Survival Analysis; Vinblastine; Vincristine; Young Adult | 2018 |
ABVD Without Radiation for Newly Diagnosed Pediatric and Young Adult Patients With Hodgkin Lymphoma: A Single Center Retrospective Analysis of 28 Consecutive Patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Vinblastine | 2018 |
Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Survival Rate; Vinblastine | 2018 |
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Prednisone; Procarbazine; Progression-Free Survival; Treatment Outcome; Vincristine; Young Adult | 2018 |
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine | 2018 |
Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoconjugates; Male; Middle Aged; Vinblastine | 2018 |
ABVD plus rituximab
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Metastasis; Neoplasm Staging; Rituximab; Treatment Outcome; Vinblastine | 2019 |
Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cost-Benefit Analysis; Dacarbazine; Doxorubicin; Female; Health Expenditures; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunoconjugates; Male; Markov Chains; Models, Econometric; Quality-Adjusted Life Years; Survival Analysis; Vinblastine | 2019 |
Circulating dendritic cells deficiencies as a new biomarker in classical Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Blood Cell Count; Dacarbazine; Dendritic Cells; Doxorubicin; Female; Flow Cytometry; Hodgkin Disease; Humans; Male; Middle Aged; Vinblastine | 2019 |
Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lenalidomide; Male; Middle Aged; Neoplasm Staging; Prognosis; Treatment Outcome; Vinblastine | 2019 |
Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Canada; Chemotherapy-Induced Febrile Neutropenia; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Injury; Male; Middle Aged; Neoplasm Staging; Peripheral Nervous System Diseases; Progression-Free Survival; United States; Vinblastine | 2019 |
Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiotherapy; Remission Induction; Risk Assessment; Risk Factors; Treatment Outcome; United Kingdom; Vinblastine; Young Adult | 2019 |
Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Survival Analysis; Vinblastine; Young Adult | 2019 |
Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical Hodgkin lymphoma treated with ABVD with or without radiotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Proteins; Predictive Value of Tests; Receptors, Interleukin-2; Retrospective Studies; Vinblastine | 2019 |
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine; Young Adult | 2019 |
ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Feasibility Studies; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Remission Induction; Survival Rate; Vinblastine; Young Adult | 2013 |
Treatment-related mortality in patients with advanced-stage hodgkin lymphoma: an analysis of the german hodgkin study group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Mass Index; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Retrospective Studies; Risk Factors; Vinblastine; Vincristine | 2013 |
A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Biomarkers, Tumor; Bleomycin; Cohort Studies; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Maximum Tolerated Dose; Middle Aged; Treatment Outcome; Ventricular Function, Left; Vinblastine; Young Adult | 2013 |
Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Immunoconjugates; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Neutropenia; Treatment Outcome; Vinblastine | 2013 |
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Prospective Studies; Vinblastine; Vincristine; Young Adult | 2014 |
A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI ) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Young Adult | 2014 |
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2014 |
Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Confidence Intervals; Dacarbazine; Diaphragm; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphatic Irradiation; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden; Vinblastine; Young Adult | 2014 |
Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiation Injuries; Radiotherapy, Adjuvant; Risk Factors; Survival Rate; Vinblastine; Young Adult | 2014 |
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Treatment Outcome; Vinblastine | 2015 |
Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; India; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Prospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2015 |
Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; North America; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Risk Factors; Treatment Outcome; Vinblastine; Vincristine | 2015 |
Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease Progression; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Recurrence; Survival Analysis; Vinblastine; Young Adult | 2015 |
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2016 |
Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Mitoxantrone; Neoplasm Staging; Procarbazine; Treatment Outcome; Vinblastine | 2016 |
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Middle Aged; Neoplasm Staging; Remission Induction; Vinblastine | 2016 |
Brentuximab Vedotin in Combination With Dacarbazine or Bendamustine for Frontline Treatment of Hodgkin Lymphoma in Patients Aged 60 Years and Above: Interim Results of a Multi-Cohort Phase 2 Study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Brentuximab Vedotin; Cohort Studies; Dacarbazine; Female; Hodgkin Disease; Humans; Immunoconjugates; Male; Middle Aged; Neoplasm Recurrence, Local | 2016 |
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Vinblastine; Vincristine; Young Adult | 2016 |
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Male; Medication Adherence; Middle Aged; Prednisone; Procarbazine; Risk Factors; Vinblastine; Vincristine | 2016 |
[No general recommendation for waiving consolidated radiotherapy in Hodgkin lymphoma and negative PET results after completion of chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease Progression; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Proportional Hazards Models; Recurrence; Survival Analysis; Survival Rate; Treatment Outcome; United Kingdom; Vinblastine; Young Adult | 2016 |
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Young Adult | 2016 |
Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; HIV Seropositivity; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Treatment Outcome; Vinblastine | 2017 |
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Young Adult | 2017 |
Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablativ
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphatic Irradiation; Male; Methylprednisolone; Prednisone; Treatment Outcome; Vinblastine; Vincristine | 2008 |
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine | 2009 |
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine | 2009 |
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Vinblastine; Young Adult | 2009 |
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Procarbazine; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2010 |
Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Hodgkin Disease; Humans; Middle Aged; Neoplasm Staging; Prospective Studies; Survival Rate; Treatment Outcome; Vinblastine | 2010 |
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine | 2009 |
Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Treatment Outcome; Vinblastine; Young Adult | 2009 |
Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Radiotherapy, High-Energy; Remission Induction; Risk Factors; Salvage Therapy; Survival Analysis; Vinblastine; Vincristine; Young Adult | 2009 |
Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma: survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Radiation; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Radiotherapy, Adjuvant; Vinblastine | 2010 |
Risk-adapted therapy with three or six cycles of doxorubicin/bleomycin/vinblastine/dacarbazine plus involved-field radiation therapy in Hodgkin lymphoma, based on prognosis at diagnosis and early response: results from the GATLA study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy; Radiotherapy Dosage; Remission Induction; Risk Factors; Vinblastine; Young Adult | 2010 |
Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Radiotherapy Dosage; Vinblastine | 2010 |
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Europe; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prednisone; Procarbazine; Radiation Dosage; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2010 |
18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Vinblastine; Young Adult | 2010 |
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Prognosis; Proportional Hazards Models; Radiotherapy Dosage; Survival Rate; Vinblastine; Young Adult | 2010 |
Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305).
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Endpoint Determination; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Young Adult | 2010 |
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Substitution; Epidemiologic Methods; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine | 2011 |
Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Recurrence; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vinblastine | 2011 |
Radionuclide ventriculography detects early anthracycline cardiotoxicity in children with Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Early Diagnosis; Echocardiography, Doppler, Color; Female; Heart Diseases; Hodgkin Disease; Humans; Male; Radionuclide Ventriculography; Stroke Volume; Vinblastine | 2011 |
Clinical outcome in children and adolescents with Hodgkin lymphoma after treatment with chemotherapy alone - the results of the United Kingdom HD3 national cohort trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Chlorambucil; Cohort Studies; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Prednisolone; Procarbazine; Prognosis; Salvage Therapy; Survival Analysis; Treatment Outcome; United Kingdom; Vinblastine | 2012 |
Treatment of Hodgkin lymphoma with adriamycin, bleomycin, vinblastine and dacarbazine without routine granulocyte-colony stimulating factor support does not increase the risk of febrile neutropenia: a prospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cost-Benefit Analysis; Dacarbazine; Doxorubicin; Female; Fever; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Risk Factors; Treatment Outcome; Vinblastine; Young Adult | 2012 |
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Proportional Hazards Models; Remission Induction; Salvage Therapy; Vinblastine; Vincristine; Young Adult | 2011 |
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2012 |
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 2011 |
Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Interferons; Middle Aged; Prognosis; Treatment Outcome; Vinblastine; Young Adult | 2012 |
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Heart Diseases; Hodgkin Disease; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Radiotherapy; Survival Analysis; Treatment Outcome; Vinblastine | 2012 |
Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2012 |
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocyte Subsets; Bleomycin; Clone Cells; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Epstein-Barr Virus Infections; Fatigue; Female; Gastrointestinal Diseases; Herpesvirus 4, Human; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Middle Aged; Neutropenia; Remission Induction; Rituximab; Survival Rate; Vinblastine; Young Adult | 2012 |
Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Alopecia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Fatigue; Female; Gastrointestinal Diseases; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Middle Aged; Neutropenia; Remission Induction; Rituximab; Survival Rate; Vinblastine; Young Adult | 2012 |
A randomized trial of brief treatment of early- stage Hodgkin lymphoma: Is it effective?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Neoplasm Staging; Radiotherapy; Radiotherapy Dosage; Vinblastine; Young Adult | 2012 |
Treatment of newly diagnosed advanced stage Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Prospective Studies; Retrospective Studies; Vinblastine; Vincristine | 2012 |
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Middle Aged; Survival Rate; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vinblastine; Young Adult | 2012 |
Intermediate stage Hodgkin lymphoma in partial remission after three or four courses of doxorubicin, bleomycin, vinblastine dacarbazine: no benefit of one course of intensive chemotherapy before irradiation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Remission Induction; Treatment Outcome; Vinblastine; Young Adult | 2013 |
Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Treatment Outcome; Vinblastine; Young Adult | 2013 |
ABVD vs. radiotherapy in early stage Hodgkin's lymphoma: A critical look at the NCIC HD.6 trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Chemoradiotherapy; Cohort Studies; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Lymphatic Irradiation; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Risk Factors; United States; Vinblastine | 2012 |
Treatment of advanced stage Hodgkin lymphoma--it's all about risk-benefit.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Staging; Prednisone; Procarbazine; Risk Assessment; Vinblastine; Vincristine | 2012 |
Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cohort Studies; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoenzyme Techniques; In Situ Hybridization; Macrophages; Male; Middle Aged; Prognosis; Receptors, Cell Surface; RNA, Viral; Survival Rate; Tissue Array Analysis; Vinblastine | 2012 |
Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2012 |
Is cerebral glucose metabolism affected by chemotherapy in patients with Hodgkin's lymphoma?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Bleomycin; Brain; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Vinblastine | 2013 |
Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2013 |
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Hematologic Diseases; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2013 |
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; DNA, Viral; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoadjuvant Therapy; North America; Prednisone; Prognosis; Sensitivity and Specificity; Vinblastine; Vincristine; Young Adult | 2013 |
Stanford V and radiotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Middle Aged; Prospective Studies; Radiotherapy Dosage; Vinblastine | 2002 |
Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy: long-term results of the Groupe Ouest et Est des
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Prospective Studies; Radiotherapy Dosage; Treatment Outcome | 2002 |
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome; Up-Regulation; Vinblastine; Vincristine | 2002 |
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Confidence Intervals; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine | 2003 |
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Leukemia; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Survival Analysis; Vinblastine; Vincristine | 2003 |
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine | 2003 |
Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized tria
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Female; France; Hodgkin Disease; Humans; Male; Methotrexate; Middle Aged; Survival Rate; Time Factors; Vinblastine | 2004 |
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymph
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy; Recurrence; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2003 |
Treatment of advanced Hodgkin's disease: EBVD versus intensive brief chemotherapy.
Topics: Actuarial Analysis; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Epirubicin; Female; Hodgkin Disease; Humans; Infections; Male; Middle Aged; Survival Analysis; Treatment Outcome; Vinblastine | 2003 |
Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need?
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Staging; Treatment Outcome; Vinblastine | 2004 |
Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Recurrence; Salvage Therapy; Vinblastine; Vincristine | 2004 |
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Prednimustine; Prednisone; Procarbazine; Prognosis; Sex Factors; Treatment Outcome; Vinblastine; Vincristine | 2004 |
Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Netherlands; Prednisone; Procarbazine; Statistics, Nonparametric; Survival Rate; Vinblastine; Vincristine | 2004 |
ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease Progression; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiotherapy; Remission Induction; Time Factors; Treatment Outcome; Vinblastine | 2004 |
Consolidation radiotherapy may improve outcomes in people with Hodgkin's disease achieving complete remission after combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prognosis; Treatment Outcome; Vinblastine | 2004 |
Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukopenia; Lung Diseases; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Remission Induction; Survival Analysis; Vinblastine | 2004 |
Phase II study of PEND chemotherapy in patients with refractory/relapsed Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mitoxantrone; Prednisone; Remission Induction; Salvage Therapy; Survival Analysis | 2004 |
Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Recurrence; Treatment Outcome; Vinblastine | 2004 |
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).
Topics: Administration, Oral; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Prednisone; Procarbazine; Prospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2005 |
Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Survival Rate; Vinblastine | 2005 |
Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Gastrointestinal Tract; Hodgkin Disease; Humans; Neoplasm Staging; Prednisone; Procarbazine; Radiation Injuries; Vinblastine; Vincristine | 2005 |
Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Echocardiography; Epirubicin; Female; Gated Blood-Pool Imaging; Heart; Heart Diseases; Hodgkin Disease; Humans; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Remission Induction; Survival Rate; Treatment Outcome; Vinblastine | 2005 |
Hodgkin's disease in Indian children: outcome with chemotherapy alone.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; India; Male; Multivariate Analysis; Prednisone; Procarbazine; Proportional Hazards Models; Survival Rate; Vinblastine; Vincristine | 2006 |
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2005 |
Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisolone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine | 2005 |
Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cryopreservation; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunohistochemistry; Infertility, Female; Oocytes; Ovarian Follicle; Reproductive Techniques, Assisted; Retrospective Studies; Tissue Preservation; Vinblastine | 2006 |
Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine | 2006 |
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Female; Germany; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiation Injuries; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 2007 |
[Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisolone; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Retrospective Studies; Time Factors; Treatment Outcome; Vinblastine; Vincristine | 2006 |
[Five-year outcome of a new combination chemotherapy with CEA/ABVD for advanced Hodgkin's disease with poor prognosis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Analysis; Treatment Outcome; Vinblastine | 2006 |
Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Density; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Norpregnenes; Ovary; Prednisone; Primary Ovarian Insufficiency; Procarbazine; Triptorelin Pamoate; Vinblastine; Vincristine | 2007 |
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Gemcitabine; Hodgkin Disease; Humans; Middle Aged; Neutropenia; Patient Selection; Polyethylene Glycols; Salvage Therapy; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 2007 |
Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Topics: Adolescent; Adult; Amenorrhea; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Female; Follicle Stimulating Hormone; Glycoproteins; Hodgkin Disease; Humans; Infertility, Female; Inhibins; Luteinizing Hormone; Mechlorethamine; Ovarian Follicle; Ovary; Predictive Value of Tests; Prednisolone; Prednisone; Primary Ovarian Insufficiency; Procarbazine; Sensitivity and Specificity; Survivors; Testicular Hormones; Time Factors; Triptorelin Pamoate; Ultrasonography; Vinblastine; Vincristine | 2007 |
Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Radiation Oncology; Time Factors; Treatment Outcome; Vinblastine | 2007 |
The expression of Ki-67 and Bcl-2 in Hodgkin's lymphoma: correlation with the International Prognostic Score and bulky disease: a study by the Serbian Lymphoma Study Group (SLG).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Eosinophilia; Female; Hodgkin Disease; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Middle Aged; Prognosis; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Survival Rate; Vinblastine | 2007 |
Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease Progression; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Treatment Outcome; Vinblastine | 2007 |
Treatment planning and delivery of involved field radiotherapy in advanced Hodgkin's disease: results from a questionnaire-based audit for the UK Stanford V regimen vs ABVD clinical trial quality assurance programme (ISRCTN 64141244).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Quality Assurance, Health Care; United Kingdom; Vinblastine; Vincristine | 2007 |
[Dicarbamin--an effective protector of myelodepression in combined treatment for Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Caproates; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Granulocytes; Hodgkin Disease; Humans; Imidazoles; Infusions, Intravenous; Leukocyte Count; Male; Middle Aged; Neutropenia; Protective Agents; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine | 2007 |
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Heart Diseases; Hodgkin Disease; Humans; Infections; Italy; Leukopenia; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Severity of Illness Index; Treatment Outcome; Vinblastine | 2008 |
Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Citrates; Combined Modality Therapy; Dacarbazine; Disease Management; Disease-Free Survival; Doxorubicin; Female; Gallium; Gallium Radioisotopes; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Risk; Tomography, X-Ray Computed; Vinblastine | 2008 |
The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report.
Topics: Adolescent; Adult; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Nausea; Neuritis; Prednisone; Procarbazine; Prognosis; Time Factors; Vinblastine; Vincristine; Vomiting | 1980 |
Alternating drug combinations in the treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Random Allocation; Vinblastine; Vincristine | 1982 |
More than MOPP for advanced Hodgkin's disease?
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Random Allocation; Vinblastine; Vincristine | 1982 |
ABVD chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1982 |
[Salvage chemotherapy in resistant malignant lymphomas (author's transl)].
Topics: Adolescent; Adult; Bleomycin; Cisplatin; Clinical Trials as Topic; Dacarbazine; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Vinblastine; Vindesine | 1982 |
Combined modality therapy for advanced Hodgkin's disease: long-term followup data.
Topics: Adult; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Vincristine | 1982 |
Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
Topics: Adult; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1982 |
Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Thrombocytopenia; Vinblastine; Vincristine | 1983 |
The cure of Hodgkin's disease with drugs.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisolone; Prednisone; Procarbazine; Radiotherapy Dosage; Vinblastine; Vincristine | 1983 |
Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1984 |
[Comparative study of the efficacy of the DBVCy protocol (daunoblastin, bleomycin, vincristine, cytostasan) and the ABVD protocol in advanced Hodgkin's lymphoma. A prospective inter-clinic study within the framework of the Hauptforschungsrichtung Geschwul
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Daunorubicin; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Nitrogen Mustard Compounds; Prospective Studies; Random Allocation; Vinblastine; Vincristine | 1984 |
Hodgkin's disease in the very young.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Infant; Male; Mechlorethamine; Multivariate Analysis; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Retrospective Studies; Survival Rate; Vinblastine; Vincristine | 1994 |
Randomized study for the treatment of adult advanced Hodgkin's disease: epirubicin, vinblastine, bleomycin, and dacarbazine (EVBD) versus mitoxantrone, vinblastine, bleomycin, and dacarbazine (MVBD).
Topics: Actuarial Analysis; Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemical and Drug Induced Liver Injury; Dacarbazine; Epirubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Mitoxantrone; Prospective Studies; Thrombocytopenia; Treatment Outcome; Ventricular Function, Left; Vinblastine | 1994 |
Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage: a prospective clinical study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Esophageal Neoplasms; Fluorouracil; Hodgkin Disease; Humans; Incidence; Lung Neoplasms; Mechlorethamine; Prednisone; Procarbazine; Prospective Studies; Radiation Pneumonitis; Tomography, X-Ray Computed; Vinblastine; Vincristine | 1994 |
A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie cont
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Regression Analysis; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1994 |
Early intensive therapy with autotransplantation for high-risk Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Vinblastine; Vincristine | 1993 |
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Failure; Vinblastine; Vincristine; Vindesine | 1994 |
ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy Dosage; Survival Rate; Vinblastine; Vincristine | 1994 |
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Risk Factors; Salvage Therapy; Vinblastine; Vincristine | 1994 |
Results of a randomized study of early stage Hodgkin's disease using ABVD, EBVD, or MBVD.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Hodgkin Disease; Humans; Male; Mitoxantrone; Neoplasm Staging; Remission Induction; Survival Rate; Vinblastine; Vincristine | 1995 |
Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy; Remission Induction; Salvage Therapy; Survival Rate; Vinblastine; Vincristine; Vinorelbine | 1994 |
The role of granulocyte colony-stimulating factor (filgrastim) in maintaining dose intensity during conventional-dose chemotherapy with ABVD in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Infection Control; Male; Middle Aged; Neutropenia; Recombinant Proteins; Treatment Outcome; Vinblastine; Vincristine | 1994 |
Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cohort Studies; Combined Modality Therapy; Comorbidity; Dacarbazine; Disease Progression; Doxorubicin; Female; France; Herpesviridae Infections; Herpesvirus 4, Human; HIV Infections; Hodgkin Disease; Homosexuality, Male; Humans; Life Tables; Lymphoma, AIDS-Related; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radioisotope Teletherapy; Registries; Remission Induction; Risk Factors; Substance Abuse, Intravenous; Survival Analysis; Tumor Virus Infections; Vinblastine; Vincristine | 1995 |
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leucovorin; Male; Mechlorethamine; Methotrexate; Prednisolone; Prednisone; Procarbazine; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1995 |
Optimal treatment of early-stage Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1993 |
[Late cardiac toxicity in Hodgkin's disease. A study with pulsed Doppler echocardiography].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Echocardiography, Doppler; Female; Follow-Up Studies; Heart; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy Dosage; Remission Induction; Time Factors; Vinblastine; Vincristine | 1993 |
Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Survival Analysis; Survival Rate; Vinblastine; Vincristine | 1993 |
Chemotherapy dose and survival in advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Female; Germany, West; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Remission Induction; Vinblastine; Vincristine | 1993 |
Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Infant; Male; Mechlorethamine; Mediastinal Neoplasms; Prednisone; Procarbazine; Prognosis; Sex Factors; Treatment Outcome; Vinblastine; Vincristine | 1993 |
Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Decision Trees; Doxorubicin; Female; Hodgkin Disease; Humans; Laparotomy; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Research Design; Treatment Outcome; Vinblastine; Vincristine | 1993 |
Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hypocalcemia; Hypotension; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Remission Induction; Transplantation, Autologous | 1994 |
Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Remission Induction; Salvage Therapy; Vinblastine; Vincristine | 1996 |
Fixed versus response-adapted MOPP/ABVD chemotherapy in Hodgkin's disease. A prospective randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 1995 |
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 1995 |
Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lung; Male; Middle Aged; Prospective Studies; Treatment Outcome; Vinblastine | 1996 |
High-dose therapy autologous stem cell transplantation vs conventional therapy for patients with advanced Hodgkin's disease responding to first-line therapy: analysis of clinical characteristics of 51 patients enrolled in the HD01 protocol. EBMT/ANZLG/Int
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Patient Selection; Vinblastine | 1996 |
ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Recurrence; Remission Induction; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine | 1996 |
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Gallium Radioisotopes; Hodgkin Disease; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prednisone; Radioimmunodetection; Radiotherapy; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 1996 |
[The whole dose at once?].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Leukocytosis; Male; Middle Aged; Neutropenia; Premedication; Recombinant Proteins; Vinblastine | 1996 |
Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Pilot Projects; Prednisone; Procarbazine; Prognosis; Remission Induction; Risk Factors; Vinblastine; Vincristine | 1996 |
Treatment of Hodgkin's disease: the Swedish National Care Programme experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Sweden; Vinblastine; Vincristine | 1996 |
ChlVPP is as effective as alternating ChlVPP/ABOD in advanced stage Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisolone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine | 1996 |
Results of three courses of adriamycin, bleomycin, vindesine, and dacarbazine with subtotal nodal irradiation in 189 patients with nodal Hodgkin's disease (stage I, II and IIIA).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Gonads; Heart; Hodgkin Disease; Humans; Lung; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prospective Studies; Radiotherapy; Survival Rate; Thyroid Gland; Treatment Outcome; Vinblastine; Vindesine | 1997 |
Treatment of childhood Hodgkin's disease without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasms, Second Primary; Prednisone; Procarbazine; Vinblastine; Vincristine | 1997 |
Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1997 |
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Radiation; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Proportional Hazards Models; Recurrence; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1997 |
A phase I study of interleukin-6 after autologous bone marrow transplantation for patients with poor prognosis Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cytokines; Dacarbazine; Doxorubicin; Female; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Interleukin-6; Male; Mechlorethamine; Pilot Projects; Prednisone; Procarbazine; Prognosis; Recombinant Proteins; Transplantation, Autologous; Vinblastine; Vincristine | 1997 |
Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphatic Irradiation; Male; Mechlorethamine; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine | 1997 |
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vinblastine; Vincristine | 1997 |
[A trial of applying an oily suspension of bleomycin endolymphatically in patients with Hodgkin's disease of the extraperitoneal lymph nodes].
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Cancer, Regional Perfusion; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Injections, Intralymphatic; Lymph Nodes; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine | 1997 |
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vinblastine; Vincristine | 1998 |
ABVD chemotherapy of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Treatment Outcome; Vinblastine | 1997 |
MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Multivariate Analysis; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Proportional Hazards Models; Survival Analysis; Vinblastine; Vincristine | 1998 |
Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin's disease at advanced stages.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Multivariate Analysis; Prospective Studies; Survival Analysis; Vinblastine | 1998 |
Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasms, Second Primary; Oligospermia; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 1998 |
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leucovorin; Lymphoma, Large-Cell, Anaplastic; Male; Mediastinum; Methotrexate; Middle Aged; Prednisone; Remission Induction; Survival Analysis; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vinblastine; Vincristine | 1998 |
A prospective clinical trial comparing chemotherapy, radiotherapy and combined therapy in the treatment of early stage Hodgkin's disease with bulky disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Life Tables; Lymphoma; Neoplasms, Second Primary; Nervous System Diseases; Prospective Studies; Pulmonary Fibrosis; Radiation Injuries; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine | 1998 |
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Cyclophosphamide; Czech Republic; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Germany; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Switzerland; Treatment Outcome; Vinblastine; Vincristine | 1998 |
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 1998 |
ABVD and radiation therapy as first-line treatment in advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Vinblastine | 1999 |
[A trial for peripheral blood stem cell harvest by combination of G-CSF with ABVD regimen in the management of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Component Removal; Dacarbazine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Male; Vinblastine | 1999 |
MOPP versus ABVD and low-dose versus high-dose irradiation in Hodgkin's disease at intermediate and advanced stages: analysis of a meta-analysis by clinicians.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1999 |
Assessment of cardiac and pulmonary function in adult patients with Hodgkin's disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Dose-Response Relationship, Radiation; Doxorubicin; Evaluation Studies as Topic; Female; Follow-Up Studies; Heart; Hodgkin Disease; Humans; Lung; Male; Mechlorethamine; Middle Aged; Physical Exertion; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Remission Induction; Respiratory Function Tests; Vinblastine; Vincristine | 1999 |
Childhood stage IV Hodgkin disease: therapeutic results of the Polish pediatric leukemia/lymphoma study group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Poland; Prednisolone; Prednisone; Procarbazine; Recurrence; Time Factors; Treatment Outcome; Vinblastine; Vincristine | 1999 |
Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Middle Aged; Recurrence; Survival Rate; Vinblastine | 1999 |
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Dose-Response Relationship, Drug; Double-Blind Method; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hodgkin Disease; Humans; Injections, Subcutaneous; Male; Mechlorethamine; Middle Aged; Neutropenia; Prednisone; Procarbazine; Prospective Studies; Recombinant Proteins; Vinblastine; Vincristine | 2000 |
EBVD combination chemotherapy plus low dose involved field radiation is a highly effective treatment modality for early stage Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Epirubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Remission Induction; Survival Analysis; Vinblastine | 2000 |
Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisone; Radiotherapy Dosage; Treatment Outcome; Vinblastine | 2000 |
Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymph
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisolone; Procarbazine; Survival Rate; Vinblastine; Vincristine | 2000 |
Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Citrates; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Gallium; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphography; Male; Mechlorethamine; Methotrexate; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 2000 |
Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome; Vinblastine | 2000 |
Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; HIV Infections; Hodgkin Disease; Humans; Karnofsky Performance Status; Male; Middle Aged; Prospective Studies; Vinblastine | 2000 |
Secondary prophylactic G-CSF (filgrastim) administration in chemotherapy of stage I and II Hodgkin's lymphoma with ABVD.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Dacarbazine; Doxorubicin; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Recombinant Proteins; Treatment Outcome; Vinblastine | 2001 |
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine | 2002 |
ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 2002 |
Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine | 2002 |
Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Vinblastine; Vincristine | 1976 |
Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Bleomycin; Child; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vinblastine; Vincristine | 1977 |
ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.
Topics: Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1978 |
Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine | 1979 |
DTIC (NSC-45388) studies in the southwest oncology group.
Topics: Carmustine; Chlorpromazine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Melanoma; Nausea; Neoplasm Metastasis; Remission, Spontaneous; Thrombocytopenia; Triazenes; Vincristine; Vomiting | 1976 |
Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Melanoma; Sarcoma; Skin Neoplasms; Soft Tissue Neoplasms; Triazenes | 1976 |
Role of additional radiotherapy in advanced stages of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Germany, West; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy Dosage; Vinblastine; Vincristine | 1992 |
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine | 1992 |
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy Dosage; Recurrence; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1992 |
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine | 1992 |
[Comparative study of advanced-stage Hodgkin's lymphoma patients treated with either COPP or ABVD drug combinations].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Evaluation; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vinblastine; Vincristine | 1992 |
Hodgkin's disease, clinical stages I, II A-B and IIIA. Results of brief chemotherapy followed by irradiation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Procarbazine; Prospective Studies; Recurrence; Survival Rate; Vinblastine; Vincristine | 1992 |
ABVD in the treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Italy; Vinblastine; Vincristine | 1992 |
A prospective randomized study of two alternating, non cross-resistant chemotherapies for advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mitoguazone; Prednisone; Procarbazine; Prospective Studies; Survival Rate; Vinblastine; Vincristine | 1992 |
Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adaptation, Psychological; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Psychological Tests; Self-Assessment; Sexual Dysfunctions, Psychological; Social Adjustment; Vinblastine; Vincristine | 1992 |
Cooperative trials of Hodgkin's lymphoma in the Federal Republic of Germany.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy Dosage; Risk Factors; Vinblastine; Vincristine | 1990 |
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hematocrit; Hodgkin Disease; Humans; Lomustine; Lymphatic Metastasis; Male; Mechlorethamine; Melphalan; Middle Aged; Models, Biological; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Analysis; Vinblastine; Vincristine; Vindesine | 1990 |
Chemotherapy of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; Doxorubicin; Drug Administration Schedule; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1990 |
Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Children's Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Lung; Male; Pilot Projects; Radiotherapy Dosage; Survival Rate; Vinblastine; Vincristine | 1990 |
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphatic Metastasis; Male; Mechlorethamine; Neoplasms, Multiple Primary; Patient Compliance; Prednisone; Procarbazine; Prospective Studies; Radiotherapy Dosage; Recurrence; Remission Induction; Survival Rate; Vinblastine; Vincristine | 1991 |
Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Recurrence; Remission Induction; Survival Rate; Vinblastine; Vincristine | 1991 |
Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Transplantation, Autologous; Vinblastine; Vincristine | 1991 |
The clinical significance of serum CD8 antigen levels in adult patients with Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD8 Antigens; Cyclophosphamide; Dacarbazine; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Vinblastine; Vincristine | 1991 |
A note on the Wilcoxon-Mann-Whitney test for 2 X kappa ordered tables.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biometry; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1985 |
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Luteinizing Hormone; Male; Mechlorethamine; Middle Aged; Oligospermia; Prednisone; Procarbazine; Prospective Studies; Testosterone; Vinblastine; Vincristine | 1985 |
Autologous bone marrow transplantation in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Transplantation, Autologous; Vinblastine; Vincristine | 1985 |
Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine | 1986 |
Long-term follow-up of cardiac function in patients with Hodgkin's disease treated with mediastinal irradiation and combination chemotherapy including doxorubicin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Pressure; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart; Hodgkin Disease; Humans; Mechlorethamine; Middle Aged; Physical Exertion; Prednisone; Procarbazine; Radiography; Radiotherapy Dosage; Stroke Volume; Vinblastine; Vincristine | 1986 |
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednimustine; Prednisone; Procarbazine; Prospective Studies; Random Allocation; Recurrence; Vinblastine; Vincristine | 1986 |
MOPP/ABVD chemotherapy for advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Research Design; Statistics as Topic; Vinblastine; Vincristine | 1986 |
[Intermediate results of the German Hodgkin's disease therapy study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Germany, West; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine; Vindesine | 1986 |
Evaluation of therapeutic modalities in the control of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Prognosis; Random Allocation; Vinblastine; Vincristine | 1986 |
[Treatment of Hodgkin's disease in children. Results of the Polish Group for the Treatment of Leukemia and Neoplastic Diseases in Children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clinical Trials as Topic; Cobalt Radioisotopes; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Poland; Prednisolone; Prednisone; Procarbazine; Vinblastine; Vincristine | 1986 |
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Genital Diseases, Female; Genital Diseases, Male; Heart Diseases; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Random Allocation; Statistics as Topic; Vinblastine; Vincristine | 1987 |
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Pilot Projects; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine; Vindesine | 1987 |
[Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Radiation Dosage; Random Allocation; Vinblastine; Vincristine | 1987 |
Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Risk Factors; Vinblastine; Vincristine | 1988 |
[Therapy of Hodgkin's lymphomas. Results of the German Hodgkin's Disease Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Germany, West; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Random Allocation; Vinblastine; Vincristine | 1988 |
Prognostic risk factors in advanced Hodgkin's lymphoma. Report of the German Hodgkin Study Group.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Germany, West; Hodgkin Disease; Humans; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Prospective Studies; Risk Factors; Vinblastine; Vincristine | 1988 |
Initial chemotherapy and low-dose radiation in limited fields in childhood Hodgkin's disease: results of a joint cooperative study by the French Society of Pediatric Oncology (SFOP) and Hôpital Saint-Louis, Paris.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine | 1988 |
Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Europe; Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Random Allocation; Recurrence; Vinblastine; Vincristine | 1989 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine | 1989 |
Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Germany, West; Hodgkin Disease; Humans; Middle Aged; Prednisone; Procarbazine; Random Allocation; Remission Induction; Risk Factors; Vinblastine; Vincristine | 1989 |
Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine | 1989 |
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine | 1989 |
Hodgkin's disease in children: adaptation of treatment to risk factors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Prognosis; Risk Factors; Vinblastine; Vincristine | 1989 |
[Controversy regarding the treatment of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Poland; Prednisone; Procarbazine; Radiotherapy Dosage; Remission Induction; United States; Vinblastine; Vincristine | 1989 |
Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1989 |
719 other study(ies) available for dacarbazine and Hodgkin Disease
| Article | Year |
|---|---|
In male Hodgkin lymphoma patients, impaired fertility may be improved by non-gonadotoxic therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease Management; Disease Susceptibility; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infertility, Male; Male; Neoplasm Staging; Public Health Surveillance; Semen Analysis; Sperm Motility; Treatment Outcome; Vinblastine; Young Adult | 2022 |
Ability of final PET/CT to predict response to first-line treatment in real patients with classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiotherapy; Retrospective Studies; Survival Rate; Treatment Failure; Vinblastine; Young Adult | 2022 |
[Prevalence and associated factors of frailty in adults over 70 years in the community].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Frail Elderly; Frailty; Geriatric Assessment; Hodgkin Disease; Humans; Male; Prevalence; Quality of Life; Social Status; Vinblastine | 2021 |
Evaluation of the Relapse Risk and Survival Rate in Patients with Hodgkin Lymphoma: A Monocentric Experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Middle Aged; Recurrence; Survival Rate; Treatment Outcome; Vinblastine; Young Adult | 2021 |
[Development of classical Hodgkin lymphoma in a patient receiving tocilizumab for rheumatoid arthritis].
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Methotrexate; Vinblastine | 2021 |
Whole-body MRI radiomics model to predict relapsed/refractory Hodgkin Lymphoma: A preliminary study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Vinblastine; Young Adult | 2022 |
Risk based and response adapted radiation therapy for children and adolescents with newly diagnosed advanced stage Hodgkin lymphoma treated with ABVD chemotherapy: a report from the Indian pediatric oncology group study InPOG-HL-15-01.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Prospective Studies; Treatment Outcome; Vinblastine | 2022 |
Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein-Barr Virus in Classical Hodgkin Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Bleomycin; Dacarbazine; Doxorubicin; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Male; Membrane Proteins; Middle Aged; Prognosis; Reed-Sternberg Cells; Survival Analysis; Vinblastine; Young Adult | 2021 |
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asthma; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Morbidity; Neoplasm Recurrence, Local; Neoplasm Staging; Venous Thromboembolism; Vinblastine | 2022 |
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Positron-Emission Tomography; Vinblastine | 2022 |
Successful Treatment for Isolated Bone Marrow Hodgkin Lymphoma in an Human Immunodeficiency Virus (HIV)-Negative Patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Dacarbazine; Doxorubicin; HIV; HIV Infections; Hodgkin Disease; Humans; Male; Vinblastine | 2022 |
Bleomycin-induced Pneumonitis in a Child Treated With Nintedanib: Report of the First Case in a Childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Male; Pneumonia; Prednisone; Vinblastine; Vincristine | 2022 |
Rare Case of Hodgkin Lymphoma Transformation into Diffuse Large B-Cell Lymphoma with Atypical Spread Epidurally, Intradurally and Intramedullary: A Case Report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Rituximab; Vinblastine | 2022 |
A new prognostic model including platelet/lymphocyte ratio and International Prognostic Score 3 for freedom from progression in patients with previously untreated advanced classical Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Freedom; Hodgkin Disease; Humans; Lymphocytes; Neoplasm Staging; Prognosis; Vinblastine | 2022 |
The ABVD's of cooperative trials in pediatric Hodgkin lymphoma: The India experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphoma; Vinblastine | 2022 |
Late side effects of cancer treatment in childhood cancer survivors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Survivors; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Neoplasms; Quality of Life; Retrospective Studies; Vinblastine; Young Adult | 2023 |
Drug Shortages and Curative Cancer Therapy: The Problem of Dacarbazine and Classical Hodgkin's Lymphoma.
Topics: Dacarbazine; Hodgkin Disease; Humans | 2022 |
Outcomes of Hodgkin variant Richter transformation in chronic lymphocytic leukaemia and small lymphocytic lymphoma in British Columbia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; British Columbia; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prognosis; Vinblastine | 2022 |
Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Genomics; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Retrospective Studies; RNA; Vinblastine | 2022 |
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Tumor Burden; Vinblastine | 2022 |
Cost-Effectiveness of PET Directed Versus Combined Modality Therapy for Early-Stage Favorable Hodgkin's Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cost-Benefit Analysis; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Positron-Emission Tomography; Vinblastine | 2022 |
Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; China; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Vinblastine; Vincristine | 2023 |
Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; Fertility; Hodgkin Disease; Humans; Infant, Newborn; Pregnancy; Vinblastine; Young Adult | 2023 |
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Vinblastine; Vincristine | 2023 |
Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Vinblastine | 2022 |
The frequency of change in five-point scale score with a Bayesian penalised likelihood PET reconstruction algorithm on interim FDG PET-CT and its potential implications for therapy decisions in Hodgkin's lymphoma.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Vinblastine | 2023 |
Response assessment by positron emission tomography-computed tomography as compared with contrast-enhanced computed tomography in childhood Hodgkin lymphoma can reduce the need for radiotherapy in low- and middle-income countries.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Developing Countries; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Vinblastine | 2023 |
Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry.
Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Registries; Vinblastine | 2023 |
Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Vinblastine | 2023 |
The International Prognostic Score and HIV status predict red cell concentrate transfusion needs in Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; HIV Infections; Hodgkin Disease; Humans; Prognosis; Retrospective Studies; South Africa; Vinblastine | 2023 |
Combined use of pathological and genomic alteration analyses for the diagnosis of gray zone lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Genomics; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse | 2022 |
Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breath Holding; Cardiovascular Diseases; Dacarbazine; Doxorubicin; Female; Heart; Hodgkin Disease; Humans; Lymphoma; Mediastinal Neoplasms; Neoplasms, Second Primary; Organs at Risk; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Vinblastine | 2023 |
Cardiovascular and Thyroid Late Effects in Pediatric Patients With Hodgkin Lymphoma Treated With ABVD Protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiotoxicity; Child; Child, Preschool; Cross-Sectional Studies; Dacarbazine; Disease Progression; Doxorubicin; Hodgkin Disease; Humans; Hypertension; Vinblastine | 2023 |
Low B-cell content is associated with a CD73-low tumour microenvironment and unfavourable prognosis in classic Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Prognosis; Prospective Studies; Tumor Microenvironment; Vinblastine | 2023 |
[Our experience with the treatment of Hodgkin lymphoma patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Immunoconjugates; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Vinblastine | 2023 |
Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cohort Studies; Cyclophosphamide; Dacarbazine; Denmark; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisone; Reproduction; Sweden; Vinblastine; Vincristine | 2023 |
Real-World Patient Characteristics, Treatment Patterns, and Outcomes for Patients With Stage III or IV Classic Hodgkin Lymphoma Treated With Frontline ABVD: A Retrospective Database Review in the United States.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Retrospective Studies; United States; Vinblastine | 2023 |
Survival rates of adult patients with Hodgkin lymphoma who underwent ABVD versus escalated BEACOPP in a resource-limited country: An observational study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Retrospective Studies; Survival Rate; Thailand; Vinblastine; Vincristine | 2023 |
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Positron-Emission Tomography; Prednisone; Vinblastine; Vincristine | 2023 |
Cardiovascular and Thyroid Late Effects in Pediatric Patients With Hodgkin Lymphoma Treated With ABVD Protocol: Erratum.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Disease Progression; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Thyroid Gland; Vinblastine | 2023 |
[Frontline therapy for classical Hodgkin lymphoma patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Prednisone; Vinblastine | 2023 |
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Clinical Studies as Topic; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Middle Aged; Neoplasm Staging; Prospective Studies; Registries; Treatment Outcome; Vinblastine | 2023 |
On the challenges of predicting treatment response in Hodgkin's Lymphoma using transcriptomic data.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Transcriptome; Vinblastine | 2023 |
Rare complication of doxorubicin-induced complete heart block in a patient with Hodgkin's lymphoma: a case report.
Topics: Anthracyclines; Dacarbazine; Doxorubicin; Heart Block; Hodgkin Disease; Humans; Polyketides | 2023 |
Variant histology of pediatric nodular lymphocyte-predominant Hodgkin lymphoma with IgD and CD30 expression.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bleomycin; Child; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphoma, Follicular; Neoplasm Recurrence, Local; Vinblastine | 2023 |
Real-World Use of Positron Emission Tomography-Computed Tomography and Reported Deauville Scores in Advanced-Stage Classic Hodgkin Lymphoma: A Community Oncology Practice Perspective.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Vinblastine | 2023 |
[Brentuximab Vedotin, Doxorubicin, Vinblastine, Dacarbazine(A+AVD)Therapy for Classical Hodgkin Lymphoma- A Single-Institution Experience].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Middle Aged; Neoplasm Staging; Retrospective Studies; Vinblastine | 2023 |
Revisiting the predictive role of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography on treatment outcome in early-stage favorable Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Treatment Outcome; Vinblastine | 2023 |
Improved survival of children and adolescents with classical Hodgkin lymphoma treated on a harmonised protocol in South Africa.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; HIV Infections; Hodgkin Disease; Humans; Prednisone; South Africa; Vinblastine; Vincristine | 2024 |
Estimated impact of ECHELON-1 overall survival on productivity costs in stage III/IV classical Hodgkin lymphoma in the United States.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; United States; Vinblastine | 2023 |
Can We Predict Bleomycin Toxicity with PET-CT?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Pulmonary Fibrosis; Vinblastine | 2019 |
Retrospective analysis of clinical features and treatment outcomes of children with Hodgkin's Lymphoma treated with different chemotherapy protocols at a tertiary care center in Pakistan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Infant; Kaplan-Meier Estimate; Male; Neoplasm Staging; Pakistan; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Tertiary Care Centers; Treatment Outcome; Vinblastine; Vincristine | 2019 |
Bleomycin use in the treatment of Hodgkin lymphoma (HL): toxicity and outcomes in the modern era.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Retrospective Studies; Treatment Outcome; Vinblastine | 2020 |
Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Vinblastine | 2020 |
Mees' lines because of chemotherapy for Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Hypopigmentation; Male; Nail Diseases; Vinblastine; Young Adult | 2020 |
Predictive Value of Positron Emission Tomography/Computed Tomography After ABVD-Based Chemotherapy in Early-Stage Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Risk Assessment; United Kingdom; Vinblastine | 2019 |
Heart on the wrong side.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Dyspnea; Etoposide; Hematuria; Hepatomegaly; Hodgkin Disease; Humans; Lower Urinary Tract Symptoms; Lymphadenopathy; Male; Marfan Syndrome; Mediastinum; Neoplasm Staging; Pectus Carinatum; Pleural Effusion; Prednisone; Procarbazine; Splenomegaly; Tomography, X-Ray Computed; Vinblastine; Vincristine; Young Adult | 2019 |
Hodgkin's lymphoma with HLH and complete remission with brentuximab-based therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Epstein-Barr Virus Infections; Hodgkin Disease; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Remission Induction; Vinblastine; Viremia | 2019 |
Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Male; Middle Aged; Neutropenia; Vinblastine | 2020 |
Hepatitis B virus infection status is not associated with poor prognosis in classical Hodgkin lymphoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hodgkin Disease; Humans; Prognosis; Retrospective Studies; Vinblastine | 2020 |
Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; India; Infant; Infant, Newborn; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Survival Analysis; Treatment Outcome; Vinblastine; Young Adult | 2019 |
What to Do With Deauville 3 Interim Positron Emission Tomography/Computed Tomography Response in a Young Woman With Classic Unfavorable Hodgkin's Lymphoma: To Irradiate or Not to Irradiate?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymph Nodes; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine | 2020 |
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Comorbidity; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Italy; Male; Middle Aged; Prognosis; Prospective Studies; Survival Rate; Vinblastine | 2020 |
A Prolonged Activated Partial Thromboplastin Time in a Child With Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cell Count; Blood Coagulation; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Partial Thromboplastin Time; Vinblastine | 2021 |
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Circulating Tumor DNA; Dacarbazine; Doxorubicin; Genotype; Hodgkin Disease; Humans; Middle Aged; Mutation; Prospective Studies; Retrospective Studies; Vinblastine; Young Adult | 2021 |
Horner syndrome secondary to Hodgkin lymphoma.
Topics: Adult; Anisocoria; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Horner Syndrome; Humans; Mediastinal Neoplasms; Radiotherapy; Tomography, X-Ray Computed; Vinblastine | 2020 |
[Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: final results of the German Hodgkin Study Group].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Young Adult | 2020 |
Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Organs at Risk; Prednisone; Procarbazine; Radiotherapy Dosage; Recurrence; Retrospective Studies; Treatment Outcome; Tunisia; Vinblastine; Vincristine; Young Adult | 2020 |
Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Twin; Vinblastine | 2020 |
2-deoxy-2[F-18] fluoro-D-glucose positron emission tomography Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease Management; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Vinblastine; Young Adult | 2020 |
Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Betacoronavirus; Bleomycin; Coronavirus Infections; COVID-19; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Hydroxychloroquine; Idarubicin; Mediastinal Neoplasms; Pandemics; Pneumonia, Viral; Positron-Emission Tomography; Prednisone; Procarbazine; SARS-CoV-2; Treatment Outcome; Vinblastine; Vincristine | 2020 |
Hodkgin lymphoma concomitant of tuberculosis, a therapeutic challenge for multidisciplinary management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Bleomycin; Colonic Diseases; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lung; Lymph Nodes; Male; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiotherapy, Intensity-Modulated; Risk Assessment; Tomography, X-Ray Computed; Tuberculosis, Gastrointestinal; Tuberculosis, Pulmonary; Vinblastine | 2020 |
Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Positron-Emission Tomography; Vinblastine | 2020 |
Methotrexate-associated Hodgkin Lymphoma in a Patient with Rheumatoid Arthritis Successfully Treated with Brentuximab Vedotin in Combination with Doxorubicin, Vinblastine, and Dacarbazine (BV+AVD).
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Rheumatoid; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoconjugates; Male; Methotrexate; Middle Aged; Treatment Outcome; Vinblastine | 2020 |
Long-term outcomes of patients with unfavorable stage I-II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Vinblastine | 2020 |
Impact of ABVD chemotherapy on ovarian reserve after fertility preservation in reproductive-aged women with Hodgkin lymphoma.
Topics: Adult; Age Factors; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fertility Preservation; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Organ Preservation; Ovarian Follicle; Ovarian Reserve; Retrospective Studies; Vinblastine | 2020 |
Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis-a dangerous disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Dacarbazine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Treatment Outcome; Vinblastine; Young Adult | 2020 |
A Case of Paraneoplastic Cerebellar Degeneration that Preceded the Diagnosis of Classical Hodgkin's Lymphoma by 16 Months.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Paraneoplastic Cerebellar Degeneration; Vinblastine | 2020 |
Early interval and serial positron emission tomography-computed tomography (PET-CT) after an indeterminate response defined by a PET scored 4 on the Deauville scale in lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Retrospective Studies; Rituximab; Vinblastine; Vincristine | 2020 |
Treatment of Hodgkin Lymphoma With ABVD Chemotherapy in Rural Rwanda: A Model for Cancer Care Delivery Implementation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Retrospective Studies; Rwanda; Vinblastine | 2020 |
Sintilimab as salvage treatment in an HIV patient with relapsed/refractory Hodgkin: a case report.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; HIV Infections; Hodgkin Disease; Humans; Male; Positron Emission Tomography Computed Tomography; Salvage Therapy; Vinblastine | 2020 |
Primary gastric Hodgkin's lymphoma: A rare coincidence.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bleomycin; Dacarbazine; Diagnosis, Differential; Doxorubicin; Gastric Bypass; Gastric Outlet Obstruction; Hodgkin Disease; Humans; Immunohistochemistry; Jejunum; Male; Middle Aged; Stomach; Stomach Neoplasms; Treatment Outcome; Vinblastine | 2020 |
Polyostotic Fibrous Dysplasia Mimicking Bone Involvement in Hodgkin Lymphoma: A Pediatric Case and Literature Review.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone and Bones; Dacarbazine; Diagnosis, Differential; Doxorubicin; Female; Fibrous Dysplasia, Polyostotic; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Stem Cell Transplantation; Transplantation, Autologous; Vinblastine | 2021 |
Vinblastine for elderly and frail patients with Hodgkin lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Frail Elderly; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Vinblastine | 2020 |
Classical Hodgkin lymphoma-like post-transplant lymphoproliferative disease after allogeneic stem cell transplantation for primary myelofibrosis is successfully treated with nivolumab: A case report.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoproliferative Disorders; Nivolumab; Positron-Emission Tomography; Primary Myelofibrosis; Stem Cell Transplantation; Treatment Outcome; Vinblastine | 2021 |
[Marginal zone lymphoma associated with Reed-Sternberg cells: A challenge for the pathologist].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Pathologists; Reed-Sternberg Cells; Vinblastine | 2021 |
Localised multiple sclerosis-like disease after irradiation of the cervicothoracic spinal cord.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Encephalomyelitis, Autoimmune, Experimental; Hodgkin Disease; Humans; Leukocytes, Mononuclear; Male; Multiple Sclerosis; Neoplasm Recurrence, Local; Rats; Spinal Cord; Vinblastine | 2020 |
[A single-center retrospective analysis of 85 children and adolescents with limited-stage Hodgkin lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Vinblastine | 2020 |
Classical Hodgkin Lymphoma: Clinicopathologic Features, Prognostic Factors, and Outcomes From a 28-Year Single Institutional Experience.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Progression-Free Survival; Remission Induction; Retrospective Studies; Risk Factors; Vinblastine; Young Adult | 2021 |
Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Radiation; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Long Term Adverse Effects; Male; Neoplasm Staging; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiation Dosage; Radiotherapy; Vinblastine | 2020 |
Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Retrospective Studies; Vinblastine | 2021 |
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Progression-Free Survival; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Stem Cell Transplantation; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2021 |
Outcomes in Patients with Classic Hodgkin Lymphoma Treated with ABVD: A Single-center Retrospective Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Vinblastine | 2021 |
Post-transplant lymphoproliferative disorder after paediatric liver transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Liver Transplantation; Lymphoproliferative Disorders; Retrospective Studies; Vinblastine | 2021 |
Evaluation of ovarian reserve before and after chemotherapy.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Female; Fertility Preservation; Fluorouracil; Hodgkin Disease; Humans; Longitudinal Studies; Luminescent Measurements; Ovarian Reserve; Prednisone; Procarbazine; Vinblastine; Vincristine; Young Adult | 2021 |
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Risk Factors; Vinblastine | 2021 |
The presence of a bulky mediastinal mass of 7 cm or greater in diameter confers an adverse prognosis to patients with advanced Hodgkin lymphoma in case of negative interim PET/CT.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Vinblastine | 2021 |
IPS-3 Validation in 1012 cases with classical hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Risk Factors; Vinblastine | 2021 |
The patient experience of ABVD treatment in Hodgkin lymphoma: a retrospective cohort study of patient-reported distress.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Patient Outcome Assessment; Patient Reported Outcome Measures; Retrospective Studies; Vinblastine | 2021 |
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; England; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Procarbazine; Progression-Free Survival; Retrospective Studies; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2021 |
2 + 2 in the long term: informing a new standard of care in 2021 for early stage, unfavourable Hodgkin lymphoma.
Topics: Dacarbazine; Follow-Up Studies; Hodgkin Disease; Humans; Standard of Care; Vinblastine | 2021 |
Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin's lymphoma: A case report.
Topics: Adenosine Monophosphate; Adult; Alanine; Amides; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Brentuximab Vedotin; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; Dacarbazine; Disease Progression; Doxorubicin; Hodgkin Disease; Humans; Male; Pregnenediones; Pyrazines; Time Factors; Vinblastine | 2021 |
Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Chemoradiotherapy; Dacarbazine; Disease Progression; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Progression-Free Survival; Risk Assessment; Risk Factors; Time Factors; United States; Vinblastine; Young Adult | 2021 |
Hodgkin’s lymphoma-related vanishing bile duct syndrome
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bile Ducts; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Positron Emission Tomography Computed Tomography; Vinblastine | 2021 |
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Neutropenia; Peripheral Nervous System Diseases; Vinblastine | 2022 |
Small lymphocytic lymphoma secondary to young patient with a history of classical Hodgkin Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Neoplasms, Second Primary; Prednisone; Procarbazine; Vinblastine; Vincristine | 2022 |
Sequencing therapies in Hodgkin lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Carboplatin; Dacarbazine; Disease Management; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Vinblastine | 2021 |
Clinicopathologic features and therapy outcome in childhood Hodgkin's lymphoma: a report from tertiary care center in Saudi Arabia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Saudi Arabia; Tertiary Care Centers; Treatment Outcome; Vinblastine | 2021 |
Longitudinal study of AMH variations in 122 Adolescents and Young Adults (AYA) and non-AYA lymphoma patients to evaluate the chemo-induced ovarian toxicity to further personalise fertility preservation counselling.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Counseling; Dacarbazine; Doxorubicin; Female; Fertility Preservation; Hodgkin Disease; Humans; Longitudinal Studies; Prospective Studies; Vinblastine; Young Adult | 2021 |
Late effects in pediatric Hodgkin lymphoma survivors after uniform treatment with ABVD with or without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Survivors; Child; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Stroke Volume; Ventricular Function, Left; Vinblastine | 2021 |
Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphocytes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Vinblastine; Young Adult | 2021 |
Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Middle Aged; Retrospective Studies; Vinblastine | 2021 |
ABVD chemotherapy with reduced radiation therapy rates in children, adolescents and young adults with all stages of Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Child; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Retrospective Studies; Treatment Outcome; Vinblastine; Young Adult | 2017 |
Pharmacokinetic evaluation of anticancer drugs in Hodgkin's lymphoma patients after their simultaneous administration.
Topics: Administration, Intravenous; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biotransformation; Bleomycin; Child; Chromatography, High Pressure Liquid; Dacarbazine; Doxorubicin; Drug Dosage Calculations; Drug Monitoring; Half-Life; Hodgkin Disease; Humans; Male; Metabolic Clearance Rate; Middle Aged; Vinblastine; Young Adult | 2016 |
Severe hypokalemia due to a possible drug-drug interaction between vinblastine and antiretrovirals in a HIV-infected patient with Hodgkin's lymphoma.
Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Interactions; Emtricitabine; Female; HIV Infections; HIV Protease Inhibitors; Hodgkin Disease; Humans; Hypokalemia; Middle Aged; Ritonavir; Tenofovir; Treatment Outcome; Vinblastine | 2017 |
Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Middle Aged; Outcome Assessment, Health Care; Proportional Hazards Models; Retrospective Studies; Vinblastine; Young Adult | 2017 |
Clinical and subclinical cardiac late effects in pediatric Hodgkin's lymphoma survivors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Heart; Heart Diseases; Hodgkin Disease; Humans; Male; Retrospective Studies; Survivors; Vinblastine | 2017 |
Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease Progression; Doxorubicin; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Patient Selection; Positron Emission Tomography Computed Tomography; Radiotherapy; Radiotherapy Dosage; Recurrence; Retrospective Studies; Risk Factors; Salvage Therapy; Treatment Outcome; Vinblastine; Young Adult | 2017 |
[Response to ABVD chemotherapeutic protocol in patients with early stage Hodgkins lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Prognosis; Remission Induction; Retrospective Studies; Treatment Outcome; Vinblastine | 2017 |
Children and Adolescent Hodgkin Lymphoma in Argentina: Long-term Results After Combined ABVD and Restricted Radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Multimodal Imaging; Neoplasm Staging; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vinblastine | 2017 |
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Neoplasm Staging; Prednisone; Radiotherapy; Retrospective Studies; Survival Rate; Treatment Outcome; United States; Vinblastine; Vincristine; Young Adult | 2018 |
Brentuximab: is it time for a new "B" in ABVD?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Procarbazine; Vincristine | 2017 |
Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; In Vivo Dosimetry; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiation Dosage; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Young Adult | 2018 |
The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin's lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Vinblastine; Young Adult | 2017 |
Classic Hodgkin lymphoma in pelvis: A case report highlights diagnosis and treatment challenges.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Female; Fractures, Spontaneous; Hodgkin Disease; Humans; Limb Salvage; Pelvic Bones; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2017 |
Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemokine CCL17; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Vinblastine | 2017 |
The predictive value of interim FDG-PET in early-stage Hodgkin lymphoma is not well established.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Poland; Positron-Emission Tomography; Radiopharmaceuticals; Vinblastine | 2018 |
Endobronchial localization of Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bronchial Neoplasms; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymph Nodes; Tomography, X-Ray Computed; Vinblastine | 2017 |
Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Dacarbazine; Doxorubicin; Female; Glycolysis; Hodgkin Disease; Humans; Immunohistochemistry; Lymphocytes, Tumor-Infiltrating; Macrophages; Male; Membrane Transport Proteins; Middle Aged; Mitochondria; Mitochondrial Precursor Protein Import Complex Proteins; Monocarboxylic Acid Transporters; Muscle Proteins; Neoplasm Recurrence, Local; Oxidative Phosphorylation; Receptors, Cell Surface; Reed-Sternberg Cells; Remission Induction; Symporters; Tumor Microenvironment; Vinblastine | 2017 |
Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphoma: response to Adams and Kwee.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Vinblastine | 2019 |
Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Vinblastine | 2019 |
Strong Prolyl Hydroxylase Domain 1 Expression Predicts Poor Outcome in Radiotherapy-treated Patients with Classical Hodgkin's Lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Bleomycin; Cell Hypoxia; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Male; Middle Aged; Prolyl Hydroxylases; Retrospective Studies; Treatment Outcome; Vinblastine; Young Adult | 2018 |
Multiple Lung Cavities in Hodgkin's Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Doxorubicin; Fatal Outcome; Female; Hodgkin Disease; Humans; Lung; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Vinblastine | 2018 |
Pharmacokinetics of dacarbazine (DTIC) in pregnancy.
Topics: Administration, Intravenous; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Dacarbazine; Doxorubicin; Drug Monitoring; Female; Hodgkin Disease; Humans; Infant, Newborn; Neoplasm Staging; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Treatment Outcome; Vinblastine | 2018 |
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Circulating Tumor DNA; Clonal Evolution; Dacarbazine; Doxorubicin; Genotype; High-Throughput Nucleotide Sequencing; Hodgkin Disease; Humans; Immunotherapy; Mutation; Neoplasm Recurrence, Local; Neoplasm, Residual; Reed-Sternberg Cells; STAT6 Transcription Factor; Tumor Cells, Cultured; Vinblastine | 2018 |
Hodgkin Lymphoma Presentation With Extensive Chest Wall Muscle Involvement in an Adult.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Large-Core Needle; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Middle Aged; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography; Thoracic Wall; Tomography, X-Ray Computed; Vinblastine | 2018 |
Cold Agglutinins in Peripheral Blood with Atypical Cells with an Owl-Eye Appearance in Bone Trephine.
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cryoglobulins; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Sentinel Lymph Node Biopsy; Treatment Outcome; Vinblastine | 2018 |
Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplant.
Topics: Adolescent; Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunoconjugates; Kaplan-Meier Estimate; Male; Melphalan; Methylprednisolone; Middle Aged; Proportional Hazards Models; Remission Induction; Retrospective Studies; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Vinblastine; Young Adult | 2018 |
Low dose PD-1 inhibition in relapsed refractory Hodgkin lymphoma after allogeneic stem cell transplant with concomitant active GVHD.
Topics: Adult; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Graft vs Host Disease; Hodgkin Disease; Humans; Male; Nivolumab; Programmed Cell Death 1 Receptor; Stem Cell Transplantation; Vinblastine | 2019 |
Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Heart; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organs at Risk; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Vinblastine; Young Adult | 2018 |
Anterior mediastinal Hodgkin lymphoma presenting as an extremely hypervascular tumor on computed tomography: A case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diagnosis, Differential; Dissection; Doxorubicin; Hodgkin Disease; Humans; Lung; Male; Mediastinal Neoplasms; Mediastinum; Reed-Sternberg Cells; Regional Blood Flow; Tomography, X-Ray Computed; Vinblastine; Young Adult | 2018 |
Strikingly Heterogeneous Results Among Studies on Interim Fluorodeoxyglucose-Positron Emission Tomography-Adapted Treatment in Advanced-Stage Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Vinblastine | 2018 |
Reply to H.J.A. Adams et al and C. Mesguich et al.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Multimodal Imaging; Vinblastine | 2018 |
Additional Evidence That End-of-Treatment Fluorodeoxyglucose-Positron Emission Tomography Evaluation Is Necessary in Advanced Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Vinblastine | 2018 |
[Primary hodgkin lymphoma of thyroid: case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Middle Aged; Thyroid Neoplasms; Thyroidectomy; Vinblastine | 2017 |
[Toxic epidermal necrolysis during a hemophagocytic syndrome secondary to Hodgkin lymphoma. Report of one case].
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Imipenem; Lymphohistiocytosis, Hemophagocytic; Stevens-Johnson Syndrome; Treatment Outcome; Vinblastine | 2018 |
Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiotherapy Dosage; Vinblastine; Young Adult | 2018 |
Acute liver failure secondary to ABVD use.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Chemical and Drug Induced Liver Injury; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoconjugates; Syncope; Treatment Outcome; Vinblastine | 2018 |
Genomic chaos in peripheral blood lymphocytes of Hodgkin's lymphoma patients one year after ABVD chemotherapy/radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Chromosome Aberrations; Dacarbazine; DNA Damage; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphocytes; Male; Tumor Cells, Cultured; Vinblastine; Young Adult | 2018 |
Concomitant classic Hodgkin lymphoma and schistosomiasis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dacarbazine; Hodgkin Disease; Humans; Male; Prednisolone; Schistosoma mansoni; Schistosomiasis mansoni; Vincristine | 2019 |
Vinblastine-induced posterior reversible encephalopathy syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Posterior Leukoencephalopathy Syndrome; Vinblastine | 2019 |
Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fever; Hodgkin Disease; Humans; Hypotension; Male; Middle Aged; Vinblastine | 2019 |
Pruritic Rash in a Woman With Hodgkin Lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Pregnancy; Pruritus; Vinblastine | 2019 |
Prognostic Significance of IL-6 in Hodgkin Lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Interleukin-6; Male; Prognosis; Retrospective Studies; Vinblastine | 2019 |
PET-adapted therapy after three cycles of ABVD for all stages of Hodgkin lymphoma: results of the GATLA LH-05 trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Survival Analysis; Vinblastine; Young Adult | 2019 |
Pregnancy rate and outcome of pregnancies in long-term survivors of Hodgkin's lymphoma.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fertility; Hodgkin Disease; Humans; Live Birth; Menstrual Cycle; Middle Aged; Pregnancy; Pregnancy Rate; Remission Induction; Retrospective Studies; Survivors; Vinblastine | 2019 |
Apical periodontitis as potential source of infection in patients with lymphoma treated with chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Infections; Lymphoma; Male; Periapical Periodontitis; Prospective Studies; Retrospective Studies; Root Canal Therapy; Vinblastine | 2020 |
The Utility of PET/CT in Guiding Radiotherapy Reduction for Children With Hodgkin Lymphoma Treated With ABVD.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Infant; Male; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Radiotherapy, Image-Guided; Retrospective Studies; Survival Rate; Vinblastine; Young Adult | 2020 |
[Treatment of Hodgkin lymphoma. Analysis of 915 patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chile; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Time Factors; Treatment Outcome; Vinblastine; Young Adult | 2019 |
How can outcomes be improved for older patients with Hodgkin lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Vinblastine | 2013 |
International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Consensus; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Information Storage and Retrieval; Internationality; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Research Report; Tomography, X-Ray Computed; Vinblastine | 2013 |
Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carmustine; Chemoradiotherapy; Cisplatin; Cohort Studies; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Melphalan; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vinblastine; Young Adult | 2015 |
Granulocyte colony-stimulating factor as secondary prophylaxis of febrile neutropenia in the management of advanced-stage Hodgkin lymphoma treated with adriamycin, bleomycin, vinblastine and dacarbazine chemotherapy: a decision analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Decision Support Techniques; Decision Trees; Doxorubicin; Febrile Neutropenia; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Markov Chains; Neoplasm Staging; Premedication; Quality-Adjusted Life Years; Treatment Outcome; Vinblastine | 2014 |
Radiation in early-stage Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Research; Treatment Outcome; Vinblastine | 2013 |
[The optimal total focal radiotherapy dosage after first-line chemotherapy in patients with Hodgkin lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm, Residual; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Vincristine | 2012 |
Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Follow-Up Studies; HIV Infections; Hodgkin Disease; Humans; Survival Rate; Time Factors; Treatment Outcome; Vinblastine | 2013 |
[Treatment of advanced Hodgkin lymphoma].
Topics: Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cause of Death; Climacteric; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Immunoconjugates; Molecular Targeted Therapy; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine | 2013 |
Hodgkin lymphoma in pregnancy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Genetic Therapy; Hodgkin Disease; Humans; Neoplasm Staging; Pregnancy; Pregnancy Complications, Neoplastic; Vinblastine | 2013 |
Hodgkin's lymphoma preceded by haemophagocytic lymphohistiocytosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphohistiocytosis, Hemophagocytic; Prednisolone; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2013 |
[Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome; Vinblastine; Vincristine | 2013 |
Independent validation of a model using cell line chemosensitivity to predict response to therapy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Breast Neoplasms; Cell Line, Tumor; Dacarbazine; Doxorubicin; Epirubicin; Female; Gene Expression Regulation, Neoplastic; Hodgkin Disease; Humans; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; ROC Curve; Treatment Outcome; Vinblastine | 2013 |
Brentuximab vedotin: first-line agent for advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Immunoconjugates; Middle Aged; Multimodal Imaging; Prednisone; Procarbazine; Vinblastine; Vincristine | 2013 |
Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Brentuximab Vedotin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Resistance, Neoplasm; Hodgkin Disease; Humans; Immunoconjugates; Male; Nitrogen Mustard Compounds; Positron-Emission Tomography; Radiotherapy, Adjuvant; Recurrence; Salvage Therapy; Vinblastine; Young Adult | 2013 |
Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Vinblastine; Young Adult | 2013 |
Membranous glomerulonephritis in a patient with Hodgkin's lymphoma in remission.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Glomerulonephritis, Membranous; Hodgkin Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Prednisone; Remission Induction; Tacrolimus; Time Factors; Vinblastine | 2013 |
Diagnosis and treatment of Hodgkin's lymphoma: at times a challenge.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Jaundice, Obstructive; Lymphatic Diseases; Middle Aged; Postmenopause; Treatment Outcome; Vinblastine | 2013 |
An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Vinblastine | 2013 |
Pulmonary lymphocyte-rich classical Hodgkin lymphoma with early response to ABVD therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lung; Lymphocytes; Multimodal Imaging; Positron-Emission Tomography; Remission Induction; Tomography, X-Ray Computed; Vinblastine | 2014 |
Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Chemoradiotherapy; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Incidence; Lung Injury; Middle Aged; Prednisone; Radiation Pneumonitis; Retrospective Studies; ROC Curve; Vinblastine; Young Adult | 2014 |
Impact of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine resistance of Hodgkin's lymphoma cells.
Topics: Antineoplastic Agents, Alkylating; Azacitidine; Cell Line, Tumor; Cell Survival; Dacarbazine; DNA Methylation; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Hodgkin Disease; Humans; Immunoblotting; O(6)-Methylguanine-DNA Methyltransferase; Promoter Regions, Genetic; Purines; Reverse Transcriptase Polymerase Chain Reaction | 2014 |
Acquired Glanzmann thrombasthenia associated with Hodgkin lymphoma: rapid reversal of functional platelet defect with ABVD (adriamycin/bleomycin/vinblastine/dacarbazine) chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Thrombasthenia; Treatment Outcome; Vinblastine | 2014 |
Primary refractory Hodgkin lymphoma: limited options and poor survival--but not always.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoconjugates; Lymph Nodes; Salvage Therapy; Treatment Outcome; Vinblastine | 2014 |
Treatment of Hodgkin lymphoma: a 50-year perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Europe; History, 20th Century; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 2014 |
[Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?].
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Causality; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Male; Neoplasm Staging; Paraneoplastic Syndromes; Prednisone; Procarbazine; Recurrence; Remission Induction; Stevens-Johnson Syndrome; Vinblastine; Vincristine; Young Adult | 2014 |
Hodgkin lymphoma in pregnancy: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Pregnancy; Pregnancy Complications, Neoplastic; Radiography; Term Birth; Vinblastine | 2013 |
Hodgkin lymphoma in pregnancy: achieving the best outcome for both mother and infant.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Pregnancy; Pregnancy Complications, Neoplastic; Term Birth; Vinblastine | 2013 |
Thyroid malignancies in survivors of Hodgkin lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Databases, Factual; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Poisson Distribution; Prednisone; Procarbazine; Radiotherapy Dosage; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Survivors; Thyroid Neoplasms; Vinblastine; Vincristine; Young Adult | 2014 |
Factors affecting intrapatient liver and mediastinal blood pool ¹⁸F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma.
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Liver; Male; Mediastinum; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Vinblastine | 2014 |
Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Middle Aged; Radiotherapy, Conformal; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tumor Burden; Vinblastine; Young Adult | 2014 |
Comparison of dose-dense ABVD and standard ABVD in the treatment of early unfavorable and advanced Hodgkin's lymphoma: a retrospective analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Retrospective Studies; Vinblastine | 2014 |
Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Dacarbazine; Direct Service Costs; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Induction Chemotherapy; Male; Middle Aged; Population Surveillance; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; United States; Vinblastine | 2014 |
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Chlorambucil; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine | 2014 |
A single institution experience on 314 newly diagnosed advanced Hodgkin lymphoma patients: the role of ABVD in daily practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymph Nodes; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Randomized Controlled Trials as Topic; Survival Analysis; Vinblastine | 2014 |
Different clones of acute leukemia after successful treatment of Hodgkin's disease.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Azacitidine; Bleomycin; Bone Marrow; Clone Cells; Consolidation Chemotherapy; Dacarbazine; Doxorubicin; Fatal Outcome; Female; fms-Like Tyrosine Kinase 3; Hodgkin Disease; Humans; Immunophenotyping; Leukemia, Myelomonocytic, Acute; Neoplasm Proteins; Neoplasms, Second Primary; Neoplastic Stem Cells; Palliative Care; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Vinblastine | 2014 |
Chemotherapy only in early stage Hodgkin lymphoma: more relapses but the same survival--what to do?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Survival Analysis; Treatment Outcome; Vinblastine | 2014 |
Which Hodgkin's patients in the Unites States should be treated with BEACOPP?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immunoconjugates; Prednisone; Procarbazine; United States; Vinblastine; Vincristine | 2014 |
A rare case of septic pulmonary embolism caused by infection-associated catheter removal in a patient with Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Catheter-Related Infections; Catheters, Indwelling; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lung; Male; Pulmonary Embolism; Radiography; Vinblastine | 2014 |
Pruritus and hyperpigmented streaks. The diagnosis: flagellate hyperpigmentation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Hyperpigmentation; Male; Middle Aged; Pruritus; Vinblastine | 2014 |
[Flagellate erythema].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Eruptions; Erythema; Hodgkin Disease; Humans; Male; Middle Aged; Vinblastine | 2014 |
Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; DNA; DNA Damage; Doxorubicin; Hodgkin Disease; Humans; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Prednisone; Procarbazine; Semen Analysis; Sperm Count; Spermatogenesis; Spermatozoa; Vinblastine; Vincristine; Young Adult | 2014 |
In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Vinblastine; Young Adult | 2014 |
Risk of premature menopause after treatment for Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Child, Preschool; Cytarabine; Dacarbazine; Doxorubicin; England; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Infant; Melphalan; Menopause, Premature; Ovary; Poisson Distribution; Proportional Hazards Models; Radiotherapy Dosage; Risk Assessment; Surveys and Questionnaires; Vinblastine; Wales; Young Adult | 2014 |
Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Retrospective Studies; ROC Curve; Treatment Outcome; Vinblastine; Young Adult | 2014 |
Hodgkin lymphoma--a survey of children and adolescents treated in Sweden 1985-2009.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Incidence; Infant; Infant, Newborn; Male; Mechlorethamine; Prednisone; Procarbazine; Recurrence; Sex Distribution; Survival Analysis; Sweden; Vinblastine; Vincristine | 2015 |
Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
Topics: Adult; Anti-Retroviral Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Prognosis; Retrospective Studies; Vinblastine | 2015 |
Nodular sclerosis Hodgkin lymphoma with classic Reed-Sternberg cells.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chest Pain; Dacarbazine; Diagnosis, Differential; Doxorubicin; Hodgkin Disease; Humans; Lung Neoplasms; Male; Neoplasm Staging; Reed-Sternberg Cells; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2014 |
Hemoperfusion for Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytokines; Dacarbazine; Doxorubicin; Hemoperfusion; Hodgkin Disease; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Vinblastine | 2014 |
Efficacy and safety of first line vincristine with doxorubicin, bleomycin and dacarbazine (ABOD) for Hodgkin's lymphoma: a single institute experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Retrospective Studies; Risk Assessment; Survival Analysis; Time Factors; Treatment Outcome; Vincristine | 2014 |
Radiation therapy overcomes adverse prognostic role of cyclooxygenase-2 expression on Reed-Sternberg cells in early Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Child; Cyclooxygenase 2; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prognosis; Reed-Sternberg Cells; Retrospective Studies; Tissue Array Analysis; Tumor Burden; Vinblastine; Young Adult | 2015 |
Release the hounds! Activating the T-cell response to cancer.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Dacarbazine; Female; Hodgkin Disease; Humans; Immunotherapy; Male; Melanoma; Nivolumab; Programmed Cell Death 1 Receptor | 2015 |
Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barré syndrome: a case report.
Topics: Adult; Antineoplastic Agents; Autografts; Bleomycin; Dacarbazine; Doxorubicin; Guillain-Barre Syndrome; Hodgkin Disease; Humans; Male; Salvage Therapy; Stem Cell Transplantation; Vinblastine | 2014 |
Hodgkin's lymphoma: better outcomes with fewer drugs?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Vinblastine | 2015 |
When Hodgkin comes to a head: Hodgkin central nervous system involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomography; Radiography; Vinblastine | 2015 |
Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Dacarbazine; Diagnostic Imaging; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Vinblastine; Young Adult | 2015 |
Untreated Hodgkin Lymphoma With Skin Infiltration and Satellite Skin Nodule in a 15-Year-Old Female Adolescent.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed; Vinblastine | 2015 |
[Hodgkin lymphoma--ABVD regimen].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Vinblastine | 2015 |
Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Ferritins; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy; Retrospective Studies; ROC Curve; Survival Analysis; Treatment Outcome; Vinblastine; Young Adult | 2015 |
Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Hypothyroidism; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Radiotherapy Dosage; Retrospective Studies; Vinblastine; Young Adult | 2015 |
Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lung; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Middle Aged; Radiation Pneumonitis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Regression Analysis; Retrospective Studies; Salvage Therapy; Vinblastine; Young Adult | 2015 |
Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Vinblastine; Vincristine | 2015 |
Hodgkin lymphoma in childhood: clinicopathological features and therapy outcome at 2 centers from a developing country.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Child; Child, Preschool; Cross-Sectional Studies; Dacarbazine; Developing Countries; Doxorubicin; Egypt; Female; Hodgkin Disease; Humans; Incidence; Male; Neoplasm Staging; Residence Characteristics; Retrospective Studies; Vinblastine | 2015 |
Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lung Injury; Male; Middle Aged; Neoplasm Staging; Prognosis; Vinblastine | 2015 |
Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma: reply to D'Arco et al.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Vinblastine | 2015 |
On the prediction of Hodgkin lymphoma treatment response.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Inflammation; Iron Overload; Liver Diseases; Machine Learning; Male; Middle Aged; Neoplasm Staging; Prognosis; Remission Induction; Retrospective Studies; Vinblastine | 2015 |
Controversies in the treatment of early-stage Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Vinblastine | 2015 |
A case of Hodgkin lymphoma in a patient with a history of bone pain and an initial diagnosis of chronic osteomyelitis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Density Conservation Agents; Bone Marrow; Bone Neoplasms; Chronic Disease; Dacarbazine; Diagnosis, Differential; Diagnostic Errors; Diphosphonates; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Osteoblasts; Osteomyelitis; Pain; Pleural Effusion; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Sacrum; Tomography, X-Ray Computed; Treatment Failure; Vinblastine | 2015 |
Does interim PET increase the value of ABVD in advanced-stage Hodgkin lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Prednisone; Procarbazine; Tomography, X-Ray Computed; Vinblastine; Vincristine | 2015 |
[Hodgkin's lymphoma and radiotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy Dosage; Recurrence; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2015 |
Two Cases of Successful Autologous Hematopoietic Stem Cell Harvest after Treatment with Brentuximab Vedotin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Immunoconjugates; Male; Middle Aged; Vinblastine; Young Adult | 2015 |
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Regression Analysis; Remission Induction; Retrospective Studies; Time Factors; Vinblastine | 2015 |
Balancing Risks in Developing a Personalised Approach to the Treatment of Early Hodgkin Lymphoma: A Haematologist's Perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Precision Medicine; Radiation Injuries; Radiotherapy; Randomized Controlled Trials as Topic; Vincristine | 2015 |
[The effectiveness and toxicity of therapy in primary Hodgkin's lymphoma with extranodal lesions].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine | 2015 |
Balancing Risks in Developing a Personalised Approach to the Treatment of Early Hodgkin Lymphoma: Have We Got the Balance Right?
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Precision Medicine; Radiation Injuries; Radiotherapy; Risk; Vincristine | 2015 |
High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort.
Topics: Adult; Aged; Anti-Retroviral Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Doxorubicin; Female; France; HIV Infections; Hodgkin Disease; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Treatment Outcome; Vinblastine; Young Adult | 2015 |
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Immunohistochemistry; Macrophages; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome; Vinblastine; Young Adult | 2017 |
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Clinical Trials, Phase III as Topic; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Mechlorethamine; Multicenter Studies as Topic; Prednisone; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sample Size; Severity of Illness Index; Survival Analysis; Vinblastine; Vincristine | 2015 |
Central nervous system Hodgkin lymphoma developing during systemic chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Dacarbazine; Disease Progression; Doxorubicin; Fatal Outcome; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Tomography, X-Ray Computed; Vinblastine | 2016 |
[A analysis of the outcome and prognostic factors in 415 patients with Hodgkin lymphoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bleomycin; China; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Multivariate Analysis; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Survival Rate; Treatment Outcome; Vinblastine | 2015 |
Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lung Neoplasms; Male; Mechlorethamine; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Vinblastine; Vincristine; Young Adult | 2016 |
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prednisone; Procarbazine; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 2016 |
Fertility in young patients following treatment for Hodgkin's lymphoma: a single center survey.
Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Fertility; Fertility Preservation; Follow-Up Studies; Hodgkin Disease; Humans; Infertility, Female; Infertility, Male; Male; Pregnancy; Procarbazine; Surveys and Questionnaires; Vinblastine; Vincristine; Young Adult | 2016 |
Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Biomarkers, Tumor; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Staging; Prognosis; Programmed Cell Death 1 Ligand 2 Protein; Programmed Cell Death 1 Receptor; Retrospective Studies; Survival Rate; Tumor Microenvironment; Vinblastine; Young Adult | 2016 |
Rituximab-ABV(D) for patients with Nodular lymphocyte predominant Hodgkin lymphoma ineligible for radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphocytes; Male; Middle Aged; Rituximab; Vinblastine; Young Adult | 2016 |
Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Infertility, Male; Longitudinal Studies; Male; Prednisone; Procarbazine; Retrospective Studies; Semen Analysis; Spermatogenesis; Spermatozoa; Vinblastine; Vincristine | 2016 |
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Marrow; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Vinblastine | 2016 |
Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Chemotherapy-Induced Febrile Neutropenia; Cohort Studies; Cost-Benefit Analysis; Dacarbazine; Decision Support Systems, Clinical; Doxorubicin; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Markov Chains; Neoplasm Staging; Quality-Adjusted Life Years; Secondary Prevention; Treatment Outcome; Vinblastine | 2016 |
Kikuchi's Disease Masquerading As Refractory Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Diagnosis, Differential; Doxorubicin; Female; Histiocytic Necrotizing Lymphadenitis; Hodgkin Disease; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Vinblastine | 2016 |
Advanced Lymphocyte-rich Classical Hodgkin Lymphoma Complicated with Fatal Hemophagocytic Syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Neoplasms; Dacarbazine; Disease Progression; Doxorubicin; Hodgkin Disease; Humans; Lymphatic Metastasis; Lymphocytes; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Vinblastine | 2016 |
Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Armenia; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Developed Countries; Doxorubicin; Etoposide; Female; Hodgkin Disease; Hospitals; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Retrospective Studies; Vinblastine; Vincristine; Young Adult | 2016 |
ABVD-Based Therapy for Hodgkin Lymphoma in Children and Adolescents: Lessons Learnt in a Tertiary Care Oncology Center in a Developing Country.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Child; Child, Preschool; Dacarbazine; Developing Countries; Doxorubicin; Female; Hodgkin Disease; Humans; India; Kaplan-Meier Estimate; Male; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Vinblastine | 2016 |
Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Bleomycin; Chemotherapy-Induced Febrile Neutropenia; Combined Modality Therapy; Dacarbazine; Databases, Factual; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Medical Records; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome; Vinblastine; Young Adult | 2016 |
Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Biomarkers; Bleomycin; Dacarbazine; Disease-Free Survival; DNA, Viral; Doxorubicin; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Male; Middle Aged; Prognosis; Real-Time Polymerase Chain Reaction; Reed-Sternberg Cells; Republic of Korea; RNA, Viral; Tumor Virus Infections; Vinblastine; Viremia; Young Adult | 2016 |
Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Rituximab; Vinblastine; Young Adult | 2017 |
Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphocyte Count; Lymphocytes; Lymphopenia; Male; Middle Aged; Monocytes; Retrospective Studies; Vinblastine; Young Adult | 2016 |
History of ABVD alters the number of oocytes vitrified after in vitro maturation in fertility preservation candidates.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Dacarbazine; Doxorubicin; Female; Fertility Preservation; Hodgkin Disease; Humans; Oocytes; Retrospective Studies; Vinblastine; Vitrification; Young Adult | 2016 |
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Gene Frequency; Haplotypes; HLA Antigens; Hodgkin Disease; Homozygote; Humans; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Receptors, KIR; Vinblastine | 2016 |
Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Vinblastine; Young Adult | 2016 |
Clinical features and outcomes of 139 Japanese patients with Hodgkin lymphoma.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Retrospective Studies; Treatment Outcome; Vinblastine | 2016 |
Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Comorbidity; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prevalence; Radiation Injuries; Retrospective Studies; Risk Factors; Secondary Prevention; Survival Rate; Texas; Treatment Failure; Treatment Outcome; Vinblastine; Young Adult | 2016 |
Effect of Bleomycin Hydrolase Gene Polymorphism on Late Pulmonary Complications of Treatment for Hodgkin Lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Cysteine Endopeptidases; Dacarbazine; Doxorubicin; Female; Gene Frequency; Hodgkin Disease; Humans; Lung; Male; Middle Aged; Polymorphism, Single Nucleotide; Respiratory Function Tests; Vinblastine; Young Adult | 2016 |
Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Chemoradiotherapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoconjugates; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prognosis; Vinblastine; Young Adult | 2016 |
HD2000 Update in Hodgkin Lymphoma-ABVD or BEACOPP?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Procarbazine; Vinblastine; Vincristine | 2016 |
Hodgkin lymphoma: a negative interim-PET cannot circumvent the need for end-of-treatment-PET evaluation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease Management; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Treatment Failure; Treatment Outcome; Vinblastine; Young Adult | 2016 |
Strong KDM4B and KDM4D Expression Associates with Radioresistance and Aggressive Phenotype in Classical Hodgkin Lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytoplasm; Dacarbazine; Disease-Free Survival; Doxorubicin; Epigenesis, Genetic; Female; Follow-Up Studies; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hodgkin Disease; Humans; Immunohistochemistry; Jumonji Domain-Containing Histone Demethylases; Male; Middle Aged; Neoplasm Recurrence, Local; Phenotype; Protein Processing, Post-Translational; Vinblastine; Young Adult | 2016 |
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
Topics: Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Cohort Studies; Dacarbazine; Denmark; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Italy; Male; Multivariate Analysis; Poland; Positron-Emission Tomography; Programmed Cell Death 1 Receptor; Recurrence; Reed-Sternberg Cells; Retrospective Studies; STAT1 Transcription Factor; Treatment Failure; Tumor Microenvironment; Vinblastine | 2016 |
Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?
Topics: Adolescent; Adult; Analysis of Variance; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Incidence; Lung; Male; Middle Aged; Radiation Pneumonitis; Radiotherapy, Intensity-Modulated; Regression Analysis; Retrospective Studies; Risk Assessment; Salvage Therapy; Time Factors; Vinblastine; Young Adult | 2016 |
Presence of risk factors does not affect outcome in early stage pediatric Hodgkin lymphoma treated with ABVD.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cohort Studies; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Retrospective Studies; Risk Factors; Treatment Outcome; Vinblastine | 2017 |
Outcome of pediatric advanced Hodgkin lymphoma treated with ABVD and predictors of inferior survival: a multicenter study of 186 patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Treatment Outcome; Vinblastine | 2017 |
Fertility preservation before an ABVD protocol: no new evidence to support changing the recommendations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fertility; Fertility Preservation; Hodgkin Disease; Humans; Infertility; Oocyte Retrieval; Oocytes; Vinblastine | 2017 |
Non-growing follicle density is increased following adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult human ovary.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Ovarian Follicle; Ovary; Vinblastine; Young Adult | 2017 |
Letter in reply to "Fertility preservation before an ABVD protocol: no new evidence to support changing the recommendations".
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fertility; Fertility Preservation; Hodgkin Disease; Humans; Infertility; Oocyte Retrieval; Oocytes; Time Factors; Vinblastine | 2017 |
Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Confidence Intervals; Dacarbazine; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Glycolysis; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Recurrence; Risk; Treatment Outcome; Tumor Burden; Vinblastine | 2017 |
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoglobulin Heavy Chains; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Neoplasms, Second Primary; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Treatment Outcome; Vinblastine | 2017 |
[Features of clinical course of combination chemotherapy for liver involvement in Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Liver Neoplasms; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Radionuclide Imaging; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Vinblastine; Vincristine | 2008 |
Synchronous Hodgkin's disease and gastric adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Radiography; Reed-Sternberg Cells; Stomach Neoplasms; Treatment Outcome; Vinblastine | 2007 |
Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Azoospermia; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fertility; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Luteinizing Hormone; Male; Middle Aged; Prednisone; Procarbazine; Semen; Spermatozoa; Testosterone; Vinblastine; Vincristine | 2008 |
Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cryopreservation; Dacarbazine; Doxorubicin; Female; Follicle Stimulating Hormone; Follow-Up Studies; Gonadotropins; Hodgkin Disease; Humans; Middle Aged; Ovary; Surveys and Questionnaires; Ultrasonography; Vinblastine | 2008 |
Isolated neutropenia during ABVD chemotherapy for Hodgkin lymphoma does not require growth factor support.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoprevention; Cost-Benefit Analysis; Dacarbazine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Incidence; Leukocyte Count; Male; Middle Aged; Neutropenia; Retrospective Studies; Sepsis; Vinblastine | 2008 |
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Frequency; Glucuronosyltransferase; Hodgkin Disease; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine; Young Adult | 2009 |
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Hodgkin Disease; Hospitals, Urban; Humans; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Vinblastine; Vincristine; Young Adult | 2009 |
[Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Care Facilities; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Hungary; Male; Neoplasm Staging; Prednisone; Procarbazine; Recurrence; Retrospective Studies; Survival Analysis; Vinblastine; Vincristine; Young Adult | 2008 |
LED phototherapy to prevent mucositis: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Phototherapy; Radiotherapy Dosage; Stomatitis; Vinblastine | 2008 |
Limited-stage disease: optimal use of chemotherapy and radiation treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Radiotherapy; Risk Assessment; Vinblastine | 2008 |
Challenging problems: coincident pregnancy, HIV infection, and older age.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Doxorubicin; Female; HIV Infections; Hodgkin Disease; Humans; Middle Aged; Neoplasm Staging; Pregnancy; Pregnancy Complications; Survival Rate; Vinblastine | 2008 |
[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukopenia; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Proportional Hazards Models; Radiotherapy; Remission Induction; Retrospective Studies; Survival Rate; Vinblastine; Vincristine; Young Adult | 2008 |
Hodgkin's disease of appendix: report of a case.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Neoplasm Staging; Vinblastine | 2009 |
[Concomitant pulmonary Langerhans cell histiocytosis and malignant lymphoma: report of two cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Lung; Lymphoma, Follicular; Male; Mechlorethamine; Prednisone; Procarbazine; Radiography, Thoracic; Radiotherapy Dosage; Remission Induction; Smoking Cessation; Time Factors; Tomography, X-Ray Computed; Vinblastine; Vincristine | 2009 |
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Exercise; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radiation Injuries; Vinblastine; Vincristine; Young Adult | 2009 |
Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed; Vinblastine | 2009 |
Hodgkin lymphoma with cutaneous involvement.
Topics: Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Invasiveness; Reed-Sternberg Cells; Skin; Skin Ulcer; Vinblastine | 2009 |
Comparison of favorable early-stage hodgkin's lymphoma treatments: a single-institution review.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Radiation Injuries; Radiotherapy Dosage; Retrospective Studies; Sex Factors; Treatment Outcome; Vinblastine; Young Adult | 2010 |
Long-term survival of patients treated for Hodgkin's disease in 1971-1996 depending on the clinical stage of the disease, patient's fertility after therapy and cause of death analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fertility; Hodgkin Disease; Humans; Infant, Newborn; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Risk Factors; Survival Rate; Survivors; Time Factors; Treatment Outcome; Vinblastine; Vincristine | 2009 |
Nodular lymphocyte predominant Hodgkin lymphoma with clusters of LP Cells, acute inflammation, and fibrosis: a syncytial variant.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Fibrosis; Hodgkin Disease; Humans; Immunohistochemistry; Lymph Nodes; Lymphadenitis; Lymphocytes; Lymphoma, Follicular; Male; Neutrophils; Radiotherapy, Adjuvant; Sclerosis; Vinblastine | 2009 |
Limited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vinblastine; Young Adult | 2009 |
Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis; Retrospective Studies; Vinblastine; Young Adult | 2010 |
Epstein-Barr virus-positive Hodgkin lymphoma-like earlobe lymphoid infiltrate: case report.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Ear Diseases; Epstein-Barr Virus Infections; Female; Hodgkin Disease; Humans; Immunophenotyping; Lymphatic Metastasis; Middle Aged; Skin Neoplasms; Vinblastine | 2009 |
IRF4 is modulated by CD40L and by apoptotic and anti-proliferative signals in Hodgkin lymphoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Apoptosis; CD40 Ligand; Cell Proliferation; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Gene Expression Regulation, Neoplastic; Hodgkin Disease; Humans; Interferon Regulatory Factors; Reed-Sternberg Cells; Tumor Cells, Cultured | 2010 |
Second hematologic malignancies after ABVD: Two case reports and a retrospective study of 183 Hodgkin lymphoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasms, Second Primary; Vinblastine | 2010 |
Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Cohort Studies; Dacarbazine; Doxorubicin; Female; Germinal Center; Hodgkin Disease; Humans; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Male; Microfilament Proteins; Middle Aged; Neoplasm Proteins; Predictive Value of Tests; Prognosis; Survival Analysis; Tissue Array Analysis; Treatment Outcome; Vinblastine; Young Adult | 2009 |
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Organoplatinum Compounds; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Thalidomide; Topotecan; Transplantation, Autologous; Vidarabine; Vinblastine; Vincristine | 2010 |
The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine | 2009 |
Long-term follow-up of survival in Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Survival Analysis; Vinblastine; Vincristine | 2009 |
A case with Hodgkin lymphoma and fronto-temporal lobular degeneration (FTLD)-like dementia facilitated by chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Frontotemporal Lobar Degeneration; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Vinblastine | 2010 |
[Management of lymphoma with respect to pathologic classification: updates and controversies].
Topics: Anaplastic Lymphoma Kinase; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Prednisone; Receptor Protein-Tyrosine Kinases; Rituximab; Vinblastine; Vincristine | 2009 |
Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Young Adult | 2010 |
Multiple-cytokine-producing, mixed-cellularity, classical Hodgkin lymphoma with B symptoms and minimal-change nephrotic syndrome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; C-Reactive Protein; Dacarbazine; Doxorubicin; Edema; Fatigue; Fever; Hodgkin Disease; Humans; Immunosuppressive Agents; Interleukin-6; Male; Nephrosis, Lipoid; Paraneoplastic Syndromes; Recurrence; Reed-Sternberg Cells; Sweating; Tumor Necrosis Factor-alpha; Vinblastine | 2010 |
[Particularities of Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Prognosis; Vinblastine | 2010 |
A sinister itch: prurigo nodularis in Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dexamethasone; Doxorubicin; Female; Glucocorticoids; Hodgkin Disease; Humans; Paraneoplastic Syndromes; Prurigo; Vinblastine; Young Adult | 2009 |
Excessive neurotoxicity with ABVD when combined with protease inhibitor-based antiretroviral therapy in the treatment of AIDS-related Hodgkin lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; HIV Infections; Hodgkin Disease; Humans; Incidence; Lymphoma, AIDS-Related; Male; Neoplasms; Neurotoxicity Syndromes; Protease Inhibitors; Vinblastine | 2010 |
Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fever; Hodgkin Disease; Humans; Interleukin-6; Male; Seizures, Febrile; Tumor Lysis Syndrome; Unconsciousness; Vinblastine | 2010 |
Eleventh biannual report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin lymphoma.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bendamustine Hydrochloride; Bleomycin; Chlorambucil; Controlled Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Exercise; Hematinics; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Multicenter Studies as Topic; Myelodysplastic Syndromes; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Quality of Life; Randomized Controlled Trials as Topic; Vinblastine; Vincristine | 2010 |
Effect of oral itraconazole on the pharmacokinetics of tacrolimus in a hematopoietic stem cell transplant recipient with CYP3A5*3/*3.
Topics: Administration, Oral; Alleles; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Capsules; Combined Modality Therapy; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dacarbazine; Doxorubicin; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Graft vs Host Disease; Half-Life; Hodgkin Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Intestines; Itraconazole; Methotrexate; Tacrolimus; Transplantation, Homologous; Vinblastine; Young Adult | 2010 |
Cardiac sparing with proton therapy in consolidative radiation therapy for Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Heart; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Protons; Radiation Injuries; Radiotherapy Dosage; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2010 |
ABVD associated with imatinib for coexisting chronic myeloid leukaemia and relapsed Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines; Recurrence; Vinblastine | 2010 |
Doxorubicin, bleomycin, vinblastine, and dacarbazine alone in treatment of favorable, limited-stage Hodgkin's lymphoma: do we really have robust data?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Evidence-Based Medicine; Hodgkin Disease; Humans; Neoplasm Staging; Time Factors; Treatment Outcome; Vinblastine | 2010 |
Minimal-change nephrotic syndrome preceding Hodgkin lymphoma by 5 years with expression of tumor necrosis factor alpha in Hodgkin-Reed-Sternberg cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Nephrosis, Lipoid; Recurrence; Reed-Sternberg Cells; Tumor Necrosis Factor-alpha; Vinblastine | 2010 |
Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Treatment Outcome; Vincristine | 2010 |
Combination chemotherapy for Hodgkin's lymphoma during pregnancy: favorable outcome for mother and child.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Pregnancy; Pregnancy Complications, Neoplastic; Treatment Outcome; Vinblastine | 2010 |
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednimustine; Prednisone; Procarbazine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine | 2011 |
Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Vinblastine | 2010 |
Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease.
Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Chondrosarcoma; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Hyperparathyroidism, Primary; Male; Mechlorethamine; Neoplasms, Second Primary; Parathyroid Neoplasms; Prednisone; Procarbazine; Vinblastine; Vincristine | 2010 |
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Oxygen Consumption; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy; Vinblastine; Vincristine; Young Adult | 2010 |
Classical Hodgkin's lymphoma associated with Langerhans cell histiocytosis: multiagent chemotherapy resulted in histologic resolution of both the classical Hodgkin's lymphoma and Langerhans cell proliferation components.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cell Proliferation; Dacarbazine; Doxorubicin; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Reed-Sternberg Cells; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Vinblastine | 2011 |
[Diffuse large B-cell lymphoma following nodular lymphocyte predominant Hodgkin's lymphoma: report of a case].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD79 Antigens; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasms, Second Primary; Prednisone; Rituximab; Vinblastine; Vincristine | 2010 |
[Risk factors for hematologic toxicity and multifaceted analysis of blood in Hodgkin's disease: a model for hematologic toxicity].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Dacarbazine; Discriminant Analysis; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Hodgkin Disease; Humans; Male; Middle Aged; Models, Statistical; Prognosis; Risk Factors; Vinblastine | 2010 |
Primary Hodgkin's lymphoma of the rectum: an unusual presentation.
Topics: Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Colectomy; Colonoscopy; Dacarbazine; Doxorubicin; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Rectal Neoplasms; Treatment Outcome; Vinblastine | 2011 |
[ABVD chemotherapy for Hodgkin lymphoma at a single institute].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Japan; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Young Adult | 2010 |
Adolescent hodgkin lymphoma: are treatment results more favorable with pediatric than with adult regimens?
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Prednisone; Procarbazine; Vinblastine; Vincristine; Young Adult | 2011 |
[Fatal Bacillus cereus sepsis and rhabdomyolysis in a patient with Hodgkin's disease].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bacillus cereus; Bacteremia; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Diabetes Mellitus, Type 2; Disease Susceptibility; Doxorubicin; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Hodgkin Disease; Humans; Immunocompromised Host; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recurrence; Rhabdomyolysis; Shock, Septic; Vinblastine; Vincristine | 2011 |
Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Epidemiologic Methods; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Prognosis; Recurrence; Treatment Outcome; Vinblastine; Young Adult | 2011 |
Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Inhalation; Middle Aged; Neoplasm Staging; Radiation Injuries; Radiography; Radiotherapy; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Spirometry; Vinblastine; Young Adult | 2011 |
Consolidative radiation therapy for stage III Hodgkin lymphoma in patients who achieve complete response after ABVD chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Cohort Studies; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Vinblastine; Young Adult | 2011 |
Marathon running during chemotherapy: where are the limits?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Running; Vinblastine | 2011 |
Marathon run under chemotherapy: is it possible?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Running; Vinblastine | 2011 |
Low incidence of long-term respiratory impairment in Hodgkin lymphoma survivors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Dacarbazine; Disease-Free Survival; Doxorubicin; Dyspnea; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Prospective Studies; Respiratory Function Tests; Retrospective Studies; Risk Factors; Survivors; Treatment Outcome; Vinblastine; Young Adult | 2012 |
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Combined Modality Therapy; Confidence Intervals; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymph Node Excision; Mastectomy, Segmental; Mechlorethamine; Mediastinum; Middle Aged; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2012 |
Successful treatment of Hodgkin lymphoma in second trimester of pregnancy: feasibility of ABVD regimen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Hodgkin Disease; Humans; Infant, Newborn; Pregnancy; Pregnancy Trimester, Second; Treatment Outcome; Vinblastine | 2011 |
Single dose palonosetron and dexamethasone in preventing nausea and vomiting induced by high emetogenic ABVD regimen in Hodgkin Lymphoma patients.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Isoquinolines; Male; Middle Aged; Nausea; Palonosetron; Prospective Studies; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vinblastine; Vomiting; Young Adult | 2012 |
Hodgkin's lymphoma--the great teacher.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Salvage Therapy; Vinblastine; Vincristine | 2011 |
Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease Management; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Recurrence; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Vinblastine | 2012 |
Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Infant; Male; Neoplasm Staging; Registries; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Young Adult | 2011 |
Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Consolidation Chemotherapy; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Induction Chemotherapy; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Remission Induction; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine | 2011 |
Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Time Factors; Vinblastine; Young Adult | 2012 |
[Pulmonary Langerhans histiocytosis and Hodgkin's lymphoma].
Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchioles; Carmustine; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Female; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Ifosfamide; Incidental Findings; Lung Diseases; Lymphatic Diseases; Marijuana Smoking; Melphalan; Methylprednisolone; Mitoguazone; Remission Induction; Smoking; Tomography, X-Ray Computed; Vinblastine; Vindesine; Vinorelbine; Young Adult | 2011 |
Chemotherapy: Hodgkin lymphoma--absence of evidence not evidence of absence!
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Remission Induction; Research Design; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine | 2011 |
Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lung; Lung Transplantation; Male; Middle Aged; Radiation Pneumonitis; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Risk Assessment; Vinblastine; Young Adult | 2012 |
Progressive pericardial effusion during chemotherapy for advanced Hodgkin lymphoma.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiac Tamponade; Dacarbazine; Diagnosis, Differential; Diuretics; Doxorubicin; Edema; Electrocardiography; Furosemide; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Myocardial Infarction; Neoplasm Staging; Pericardial Effusion; Pericarditis; Positron-Emission Tomography; Serositis; Tomography, X-Ray Computed; Ultrasonography; Vinblastine | 2012 |
Chemotherapy alone for early-stage Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Vinblastine | 2012 |
Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial.
Topics: Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fertility; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Logistic Models; Menopause; Menstrual Cycle; Middle Aged; Multivariate Analysis; Ovary; Prednisone; Pregnancy; Procarbazine; Randomized Controlled Trials as Topic; Survivors; Vinblastine; Vincristine; Young Adult | 2012 |
ABVD as the treatment option in advanced Hodgkin's lymphoma patients older than 45 years.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Comorbidity; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Vinblastine | 2012 |
Hematuria--a rare presentation of Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cystoscopy; Dacarbazine; Doxorubicin; Hematuria; Hodgkin Disease; Humans; Lymph Nodes; Male; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Autologous; Urinary Bladder; Vinblastine | 2011 |
Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Dacarbazine; Doxorubicin; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Hodgkin Disease; Humans; Italy; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiation Tolerance; Remission Induction; Retrospective Studies; Tumor Burden; Vinblastine | 2012 |
Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphoma.
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Comorbidity; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Incidence; Male; Medical Oncology; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome; Vinblastine | 2012 |
Hematological cancer: Localized non-bulky Hodgkin lymphoma--future questions.
Topics: Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Hematologic Neoplasms; Hodgkin Disease; Humans; Radiotherapy; Survival Analysis; Treatment Outcome; United States; Vinblastine | 2012 |
Role of [18F]-FDG-PET/MDCT in evaluating early response in patients with Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2012 |
Paediatric Hodgkin lymphoma with Reed-Sternberg and mononuclear Hodgkin cells in the bone marrow aspirate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Bleomycin; Bone Marrow Cells; Child; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Reed-Sternberg Cells; Vinblastine | 2012 |
Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2012 |
[Classic Hodgkin's lymphoma in post-treatment hairy cell leukemia: report of a case].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Leukemia, Hairy Cell; Male; Mitoxantrone; Neoplasms, Multiple Primary; Rituximab; Splenectomy; Vidarabine; Vinblastine | 2011 |
[Sequential monitoring of plasma EBV-DNA level in a patient with EBV-positive Hodgkin lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Dacarbazine; DNA, Viral; Doxorubicin; Epstein-Barr Virus Infections; Female; Fever; Herpesvirus 4, Human; Hodgkin Disease; Humans; Lymphatic Diseases; Middle Aged; Vinblastine; Viral Load | 2012 |
Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma.
Topics: Abortion, Spontaneous; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Congenital Abnormalities; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Premature Birth; Procarbazine; Retrospective Studies; Vinblastine; Vincristine; Young Adult | 2012 |
Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Lung; Lymph Nodes; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Organs at Risk; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Survival Rate; Tumor Burden; Vinblastine; Young Adult | 2012 |
Expression of COX-2 on Reed-Sternberg cells is an independent unfavorable prognostic factor in Hodgkin lymphoma treated with ABVD.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Child; Cyclooxygenase 2; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Reed-Sternberg Cells; Retrospective Studies; Treatment Outcome; Vinblastine; Young Adult | 2012 |
Recommendations for fertility preservation in patients with lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cryopreservation; Dacarbazine; Doxorubicin; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Oocytes; Ovary; Primary Ovarian Insufficiency; Semen Preservation; Testis; Vinblastine | 2012 |
Positional periodic alternating vertical nystagmus with PCA-Tr antibodies in Hodgkin lymphoma.
Topics: Adult; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemoradiotherapy; Dacarbazine; Doxorubicin; Fluorescent Antibody Technique, Indirect; Head; Hodgkin Disease; Humans; Male; Nystagmus, Pathologic; Paraneoplastic Cerebellar Degeneration; Paraneoplastic Syndromes, Nervous System; Posture; Purkinje Cells; Remission Induction; Vinblastine | 2012 |
[First case in Spain of bacteremia by Methylobacterium thiocyanatum from Hickmann catheter in an immunosuppressed patient with Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Biofilms; Bleomycin; Carmustine; Catheter-Related Infections; Central Venous Catheters; Cisplatin; Cross Infection; Cytarabine; Dacarbazine; Deoxycytidine; Doxorubicin; Drug Resistance, Multiple, Bacterial; Equipment Contamination; Etoposide; Female; Gemcitabine; Gram-Negative Bacterial Infections; Hodgkin Disease; Humans; Immunocompromised Host; Melphalan; Methylobacterium; Prednisone; Ribotyping; Spain; Vinblastine | 2012 |
[The optimal radiation volume after first-line chemotherapy in Hodgkin lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Vincristine | 2012 |
[Role of response to first-line chemotherapy and of the primary lesion in Hodgkin lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Vincristine | 2012 |
[Primary refractory and relapsed Hodgkin lymphoma with unfavorable prognosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome; Vinblastine; Vincristine | 2012 |
Hodgkin lymphoma presenting with multifocal osseous lesions in a child.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Vinblastine | 2012 |
Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Doxorubicin; Female; Hematologic Diseases; HIV Infections; HIV Protease Inhibitors; Hodgkin Disease; Humans; Incidence; Kaplan-Meier Estimate; Lopinavir; Lung Diseases; Male; Mechlorethamine; Middle Aged; Nervous System Diseases; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Ritonavir; Vinblastine; Vincristine | 2012 |
Superior vena cava syndrome caused by Hodgkin's lymphoma in an adolescent girl.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Superior Vena Cava Syndrome; Tomography, X-Ray Computed; Vinblastine | 2012 |
[Retrospective analysis of 157 patients with pediatric Hodgkin lymphoma in Japan: investigation by four pediatric cancer study groups].
Topics: Adolescent; Age Factors; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Infant; Male; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Survival Rate; Vinblastine; Vincristine | 2012 |
Clinical characteristics of the patients with Hodgkin's lymphoma involving extranodal sites.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Retrospective Studies; Survival Rate; Vinblastine; Vincristine; Young Adult | 2012 |
An incidentally detected paraaortic mass diagnosed as bulky disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Doxorubicin; Drainage; Echocardiography; Electrocardiography; Hodgkin Disease; Humans; Incidental Findings; Male; Pericardial Effusion; Tachycardia, Sinus; Tomography, X-Ray Computed; Ventricular Dysfunction, Right; Ventricular Premature Complexes; Vinblastine | 2012 |
[Diagnostic difficulties caused by a pulmonary infiltrate].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bleomycin; Dacarbazine; Diagnosis, Differential; Doxorubicin; Fever of Unknown Origin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2012 |
[Relapse in Hodgkin lymphoma].
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prednisone; Procarbazine; Prognosis; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Serum Albumin; Treatment Outcome; Vinblastine; Vincristine | 2012 |
Cardiac lymphoma: ECG images pre-treatment and post-treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Heart Neoplasms; Heart Septum; Heart Ventricles; Hodgkin Disease; Humans; Middle Aged; Treatment Outcome; Tricuspid Valve; Ultrasonography; Vinblastine | 2010 |
Alopecia universalis, hypothyroidism and pituitary hyperplasia: polyglandular autoimmune syndrome III in a patient in remission from treated Hodgkin lymphoma.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Hyperplasia; Hypothyroidism; Induction Chemotherapy; Male; Pituitary Gland; Polyendocrinopathies, Autoimmune; Vinblastine | 2010 |
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Female; Gemcitabine; Graft vs Host Disease; Hodgkin Disease; Humans; Ifosfamide; Male; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Recurrence; Reoperation; Rituximab; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Vinorelbine; Young Adult | 2013 |
International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; British Columbia; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Reproducibility of Results; Survival Analysis; Vinblastine | 2012 |
Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Line, Tumor; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Immunohistochemistry; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Treatment Failure; Vinblastine; Young Adult | 2012 |
HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Treatment Outcome; Vinblastine; Young Adult | 2012 |
ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiation Monitoring; Radiography; Recurrence; Remission Induction; Treatment Outcome; Vinblastine; Young Adult | 2013 |
Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fertility; Fertility Preservation; Follicle Stimulating Hormone; Germany; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Inhibins; Male; Menstrual Cycle; Middle Aged; Oligospermia; Ovary; Prednisone; Pregnancy; Procarbazine; Randomized Controlled Trials as Topic; Survivors; Testis; Testosterone; Vinblastine; Vincristine; Young Adult | 2013 |
[Clinical analysis of childhood and adolescent Hodgkin's lymphoma: a report of 88 cases].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; L-Lactate Dehydrogenase; Male; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Retrospective Studies; Splenomegaly; Survival Rate; Vinblastine; Vincristine | 2012 |
Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Boronic Acids; Bortezomib; Combined Modality Therapy; Dacarbazine; Dexamethasone; Doxorubicin; Epstein-Barr Virus Infections; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Pyrazines; Salvage Therapy; Thalidomide; Transplantation Conditioning; Transplantation, Autologous; Vinblastine; Vincristine | 2013 |
Hodgkin's lymphoma with cutaneous involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymph Nodes; Positron-Emission Tomography; Skin; Skin Ulcer; Tomography, X-Ray Computed; Vinblastine; Young Adult | 2012 |
Pericardial effusion due to pericardium involvement by Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Pericardial Effusion; Pericardiocentesis; Pericardium; Remission Induction; Tomography, X-Ray Computed; Ultrasonography; Vinblastine; Young Adult | 2013 |
Involved node radiation therapy: an effective alternative in early-stage hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Heart Diseases; Hodgkin Disease; Humans; Lymphatic Irradiation; Male; Middle Aged; Neoplasm Staging; Radiation Injuries; Radiotherapy Dosage; Recurrence; Retrospective Studies; Treatment Outcome; Vinblastine; Young Adult | 2013 |
Bleomycin-induced Raynaud's phenomenon after single-dose exposure: risk factors and treatment with intravenous iloprost infusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fingers; Hodgkin Disease; Humans; Iloprost; Infusions, Intravenous; Male; Middle Aged; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Raynaud Disease; Remission Induction; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Vasodilator Agents; Vinblastine | 2013 |
Angiokeratoma corporis diffusum in a patient with Hodgkin lymphoma: a new paraneoplastic skin manifestation?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fabry Disease; Follow-Up Studies; Hodgkin Disease; Humans; Male; Paraneoplastic Syndromes; Skin Neoplasms; Vinblastine | 2013 |
Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
Topics: Academic Medical Centers; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; California; Chemotherapy, Adjuvant; Clinical Trials as Topic; Dacarbazine; Databases, Factual; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Melphalan; Methotrexate; Myelodysplastic Syndromes; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Risk; Vinblastine; Vincristine | 2013 |
[Sarcoidosis-like reaction after treatment with doxorubicin, bleomycin, vinblastine and dacarbazine in a patient with Hodgkin's lymphoma].
Topics: Acute-Phase Proteins; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diagnosis, Differential; Disease Progression; Doxorubicin; False Positive Reactions; Female; Granuloma; Hodgkin Disease; Humans; Lymphadenitis; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Vinblastine | 2013 |
Hodgkin's lymphoma mortality in the Americas, 1997-2008: achievements and persistent inadequacies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central America; Dacarbazine; Developing Countries; Doxorubicin; Female; Hodgkin Disease; Humans; Male; North America; South America; Vinblastine; World Health Organization; Young Adult | 2013 |
The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Procarbazine; Retrospective Studies; Sperm Count; Testis; Tomography, X-Ray Computed; Vinblastine; Vincristine; Young Adult | 2013 |
Hodgkin's disease in HIV-infected patients: report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony- stimulating factor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; HIV Infections; Hodgkin Disease; Humans; Infusions, Intravenous; Male; Prognosis; Risk Assessment; Sampling Studies; Survival Rate; Treatment Outcome; Vinblastine | 2002 |
Role of endothelin-1 in the development of a special type of cardiomyopathy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Echocardiography; Endothelin-1; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Stroke Volume; Vinblastine; Vincristine | 2002 |
[Endemic celiac sprue and Hodgkin's disease in a 72-year-old patient].
Topics: Aged; Anemia, Iron-Deficiency; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Celiac Disease; Dacarbazine; Diarrhea; Doxorubicin; Hodgkin Disease; Humans; Male; Paraproteinemias; Pulmonary Fibrosis; Vinblastine | 2002 |
Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Croatia; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Salvage Therapy; Vinblastine; Vincristine | 2002 |
[Hodgkin's disease presenting with progressive liver failure].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease Progression; Doxorubicin; Hodgkin Disease; Humans; Liver Failure; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Neck; Thrombocytopenia; Treatment Outcome; Vinblastine | 2002 |
BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunohistochemistry; Male; Middle Aged; Prognosis; Proto-Oncogene Proteins c-bcl-2; Reed-Sternberg Cells; Retrospective Studies; Survival Analysis; Survival Rate; Treatment Outcome; Vinblastine | 2002 |
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Needle; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; International Cooperation; Ki-1 Antigen; Male; Mechlorethamine; Middle Aged; Multivariate Analysis; Neoplasm Staging; Predictive Value of Tests; Prednisone; Procarbazine; Prognosis; Proportional Hazards Models; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Survival Rate; Vinblastine; Vincristine | 2002 |
Postpneumonectomy-like syndrome after chemoradiation therapy for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lung; Mechlorethamine; Pneumonectomy; Prednisone; Procarbazine; Prognosis; Radiography, Thoracic; Radiotherapy; Respiratory Distress Syndrome; Respiratory Function Tests; Risk Assessment; Severity of Illness Index; Syndrome; Tomography, X-Ray Computed; Vinblastine; Vincristine | 2002 |
[High-dose chemotherapy with autologous bone marrow transplantation in children with high-risk malignant neoformations].
Topics: Adolescent; Age Factors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carboplatin; Carmustine; Child; Child, Preschool; Cytarabine; Dacarbazine; Data Interpretation, Statistical; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Melphalan; Podophyllotoxin; Rhabdomyosarcoma; Sarcoma, Ewing; Sex Factors; Statistics, Nonparametric; Time Factors; Transplantation, Autologous; Vinblastine | 2002 |
[Foliculitis in a patient with Hodkins disease].
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cytarabine; Dacarbazine; Dermatomycoses; Dexamethasone; Doxorubicin; Etoposide; Folliculitis; Hodgkin Disease; Humans; Itraconazole; Malassezia; Male; Melphalan; Opportunistic Infections; Vinblastine | 2003 |
HIV-related Hodgkin's disease with central nervous system involvement and association with Epstein-Barr virus.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Biopsy; Bleomycin; Brain Neoplasms; Dacarbazine; Doxorubicin; Fatal Outcome; Herpesvirus 4, Human; HIV Infections; Hodgkin Disease; Homosexuality; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Neoplasm Staging; Reed-Sternberg Cells; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Vinblastine | 2003 |
Misleading Ga-67 uptake in a patient with Hodgkin's disease, mediastinal deviation, and pulmonary compression.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Citrates; Dacarbazine; Diagnosis, Differential; Doxorubicin; False Positive Reactions; Female; Gallium; Hodgkin Disease; Humans; Mediastinal Diseases; Mediastinum; Middle Aged; Pleural Effusion; Pneumonia; Pulmonary Atelectasis; Radionuclide Imaging; Radiopharmaceuticals; Vinblastine | 2002 |
[Relapse of Hodgkin disease after 17 years of complete remission. A case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Fatal Outcome; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Recurrence; Remission Induction; Time Factors; Treatment Failure; Vinblastine; Vincristine | 2003 |
Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Incidence; Mechlorethamine; Menopause, Premature; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Vinblastine; Vincristine | 2003 |
Hodgkin's disease associated cholestasis in a man with thymoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bile Ducts, Intrahepatic; Bleomycin; Cholestasis, Intrahepatic; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Liver; Male; Neoplasm Staging; Neoplasms, Multiple Primary; Thymoma; Thymus Neoplasms; Vinblastine | 2003 |
Chemotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vinblastine; Vincristine | 2003 |
Revascularization for acute coronary occlusion in a young woman following radiation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Coronary Artery Bypass; Coronary Stenosis; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy; Vinblastine; Vincristine | 2003 |
[Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Incidence; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Retrospective Studies; Risk Factors; Tunisia; Vinblastine; Vincristine | 2003 |
Treatment of early clinically staged Hodgkin's disease with a combination of ABVD chemotherapy plus limited field radiotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Treatment Outcome; Vinblastine | 2003 |
Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aza Compounds; Bleomycin; Chlamydophila Infections; Chlamydophila pneumoniae; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fluoroquinolones; Hodgkin Disease; Humans; Imipenem; Immunocompromised Host; Moxifloxacin; Neutropenia; Pneumonia, Bacterial; Quinolines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Vincristine | 2004 |
Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lung Neoplasms; Male; Mechlorethamine; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy; Recurrence; Retrospective Studies; Survival Analysis; Thoracic Wall; Vinblastine; Vincristine | 2003 |
[Asplenia in the Hodgkin's patient].
Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Immunosuppression Therapy; Prognosis; Radiotherapy; Radiotherapy Dosage; Recurrence; Risk Factors; Spleen; Splenectomy; Time Factors; Transplantation, Autologous; Vinblastine | 2003 |
Uncommon presentations of Hodgkin's disease. Case 2. Hodgkin's disease of the nasopharynx.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Daunorubicin; Hodgkin Disease; Humans; Immunohistochemistry; Male; Nasopharyngeal Neoplasms; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Vinblastine | 2004 |
Uncommon presentations of Hodgkin's disease. Case 3. Hodgkin's disease: rectal presentation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Immunohistochemistry; Male; Rectal Neoplasms; Vinblastine | 2004 |
Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Drug Administration Schedule; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Gonadal Disorders; Hodgkin Disease; Humans; Leydig Cells; Luteinizing Hormone; Male; Mechlorethamine; Prednisone; Procarbazine; Sertoli Cells; Survivors; Testosterone; Vinblastine; Vincristine | 2004 |
[Hodgkin lymphoma of the nasopharynx associated with a pituitary adenoma].
Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Hypophysectomy; Male; Middle Aged; Nasopharyngeal Neoplasms; Pituitary Neoplasms; Radiotherapy, Adjuvant; Sphenoid Sinus; Treatment Outcome; Vinblastine | 2003 |
Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Feasibility Studies; Germany; Hodgkin Disease; Humans; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Quality Assurance, Health Care; Randomized Controlled Trials as Topic; Vinblastine; Vincristine | 2004 |
Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Glyoxal; Hematologic Diseases; Hodgkin Disease; Humans; Ifosfamide; Male; Prednimustine; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vinblastine; Vincristine | 2004 |
Pediatric Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2004 |
How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Vinblastine | 2004 |
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Recurrence; Remission Induction; Treatment Outcome; Vinblastine; Vincristine | 2004 |
Cutaneous involvement in Hodgkin's lymphoma: report of two cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diagnosis, Differential; Epirubicin; Female; Hodgkin Disease; Humans; Skin; Skin Neoplasms; Vinblastine | 2004 |
Cyclooxygenase-2 (Cox-2) expression in lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclooxygenase 2; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Isoenzymes; Life Tables; Lymphoma; Lymphoma, Non-Hodgkin; Male; Membrane Proteins; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Prednisone; Prostaglandin-Endoperoxide Synthases; Survival Analysis; Vinblastine; Vincristine | 2004 |
Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Recurrence; Regression Analysis; Salvage Therapy; Survival Rate; Vinblastine | 2004 |
Significance of splenomegaly in childhood Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Splenomegaly; Treatment Outcome; Vinblastine; Vincristine | 2004 |
Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Child; Dacarbazine; Doxorubicin; Female; Gallium Radioisotopes; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Recurrence; Treatment Outcome; Vinblastine | 2005 |
Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Failure; Vinblastine; Vincristine | 2005 |
Uncommon manifestation of bleomycin-induced pulmonary toxicity in a patient with Hodgkin's disease.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Inflammation; Lung Diseases; Syndrome; Tomography, X-Ray Computed; Vinblastine | 2005 |
[Influence of age on treatment results in children and adolescents with Hodgkin's disease].
Topics: Adolescent; Age Distribution; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dacarbazine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Radiation; Doxorubicin; Female; Hodgkin Disease; Humans; Logistic Models; Male; Multicenter Studies as Topic; Poland; Prednisone; Radiotherapy Dosage; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors; Vincristine | 2004 |
[Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Multicenter Studies as Topic; Poland; Prednisolone; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Time Factors; Vinblastine; Vincristine | 2004 |
Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hair; Hair Diseases; Hodgkin Disease; Humans; Male; Nail Diseases; Nails; Photography; Vinblastine | 2005 |
Chemotherapy alone for early Hodgkin's lymphoma: an emerging option.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Vinblastine | 2005 |
Endothelin-1 and cardiac function in anthracycline-treated patients: a 1-year follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Down-Regulation; Doxorubicin; Echocardiography, Doppler; Endothelin-1; Female; Follow-Up Studies; Heart Diseases; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left; Vinblastine; Vincristine | 2004 |
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Dacarbazine; Disease Progression; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Vinblastine; Vincristine | 2005 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diagnosis, Differential; Doxorubicin; Hodgkin Disease; Humans; Incidence; Neoplasm Staging; Recurrence; Risk Assessment; Vinblastine | 2005 |
Variant lymphoproliferative disorder of granular lymphocytes (LDGL) following Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chromosome Aberrations; Cytogenetic Analysis; Dacarbazine; Doxorubicin; Female; Granulocytes; Hodgkin Disease; Humans; Lymphocytosis; Lymphoproliferative Disorders; Neoplasm Staging; Phenotype; T-Lymphocytes; Vinblastine | 2005 |
No adverse effect of ABVD chemotherapy in a patient with chronic hepatitis C and Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combat Disorders; Croatia; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hepatitis C, Chronic; Hodgkin Disease; Humans; Liver; Liver Function Tests; Neoplasm Staging; Remission Induction; Substance Abuse, Intravenous; Vinblastine | 2004 |
[Primary pulmonary Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lung Neoplasms; Mediastinoscopy; Neoplasm Staging; Sentinel Lymph Node Biopsy; Treatment Outcome; Vinblastine | 2005 |
Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Recurrence; Salvage Therapy; Sex Factors; Treatment Failure; Vinblastine; Vincristine | 2005 |
Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Infant; Male; Recurrence; Retrospective Studies; Salvage Therapy; Vinblastine | 2005 |
Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma.
Topics: Adolescent; Adult; Age Distribution; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Neoplasm Staging; Risk Factors; Survival Rate; Treatment Outcome; Vinblastine | 2005 |
Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Age Factors; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Contraceptives, Oral; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Menstrual Cycle; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Risk Factors; Treatment Outcome; Vinblastine; Vincristine | 2005 |
Axillary swelling and a reduced general condition in a middle-aged man.
Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymph Nodes; Male; Middle Aged; Vinblastine | 2004 |
Evolving approaches to primary treatment of Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Incidence; Neoplasm Staging; Prednisone; Procarbazine; Reed-Sternberg Cells; Stem Cell Transplantation; Vinblastine; Vincristine | 2005 |
Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Incidence; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy; Recurrence; Stem Cell Transplantation; Vinblastine; Vincristine | 2005 |
Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Randomized Controlled Trials as Topic; Survivors; Time Factors; Treatment Outcome; Vinblastine; Vincristine | 1989 |
Radiotherapy and Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Radiotherapy, Adjuvant; Vinblastine | 2005 |
Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Goiter, Nodular; Hodgkin Disease; Humans; Mechlorethamine; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neurilemmoma; Pleural Neoplasms; Prednisone; Procarbazine; Radiotherapy; Recurrence; Skin Neoplasms; Vinblastine; Vincristine | 2005 |
Echocardiographic evaluation of early and chronic cardiotoxicity in adult patients treated for Hodgkin's disease with ABVD regimen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chronic Disease; Dacarbazine; Doxorubicin; Echocardiography; Female; Heart Diseases; Hodgkin Disease; Humans; Male; Middle Aged; Radiography; Stroke Volume; Vinblastine | 2006 |
[Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Mediastinal Neoplasms; Positron-Emission Tomography; Prednisone; Procarbazine; Thymus Hyperplasia; Tomography, X-Ray Computed; Vinblastine; Vincristine | 2006 |
Treatment for relapse in stage I/II Hodgkin's lymphoma after initial single-modality treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cohort Studies; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Risk Assessment; Salvage Therapy; Survival Analysis; Vinblastine | 2006 |
Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Hospitals, Maternity; Hospitals, Pediatric; Hospitals, University; Humans; Infant; Male; Methotrexate; Oregon; Prednisone; Procarbazine; Retrospective Studies; Risk Factors; Salvage Therapy; Survival Analysis; Survival Rate; Tennessee; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Hodgkin lymphoma in a child with Diamond Blackfan anemia.
Topics: Anemia, Diamond-Blackfan; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Fatal Outcome; Hodgkin Disease; Humans; Lymph Nodes; Male; Vinblastine | 2006 |
Neutropenia and febrile neutropenia in patients with Hodgkin's lymphoma treated with doxorubicin (Adriamycin), bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fever; Hodgkin Disease; Humans; Male; Neutropenia; Time Factors; Treatment Outcome; Vinblastine | 2006 |
[Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Heart; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Ventricular Dysfunction, Left; Vinblastine; Vincristine | 2006 |
Hodgkin's lymphoma in adolescents.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; British Columbia; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Incidence; Male; Mechlorethamine; Medical Record Linkage; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Registries; Risk Assessment; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2006 |
Evaluation of acute and early cardiotoxicity in survivors of Hodgkin's disease treated with ABVD or BEACOPP regimens.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Echocardiography; Etoposide; Female; Follow-Up Studies; Heart Diseases; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Prospective Studies; Survivors; Ventricular Function, Left; Vinblastine; Vincristine | 2006 |
[Spinal involvement as first presentation of Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Back Pain; Bleomycin; Dacarbazine; Doxorubicin; Equatorial Guinea; Female; Hodgkin Disease; Humans; Lumbar Vertebrae; Middle Aged; Paraplegia; Spain; Spinal Cord Compression; Thoracic Vertebrae; Vinblastine | 2006 |
Primitive neuroectodermal tumor (PNET) as second malignancy after treatment of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Dacarbazine; Dose Fractionation, Radiation; Doxorubicin; Femur; Hodgkin Disease; Humans; Male; Mediastinum; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive; Vinblastine | 2006 |
Hodgkin's disease presenting with osseous involvement.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Middle Aged; Vinblastine | 2006 |
[Late cardiotoxicity in patients with malignant lymphoma treated with doxorubicin chemotherapy].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Echocardiography; Female; Heart; Heart Diseases; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Ventricular Dysfunction, Left; Vinblastine; Vincristine | 2006 |
[Lymph node tuberculosis as primary manifestation of Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Biopsy; Bleomycin; Dacarbazine; Diagnosis, Differential; Disease Progression; Doxorubicin; Hodgkin Disease; Humans; Lymph Nodes; Recurrence; Tomography, X-Ray Computed; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Vinblastine | 2006 |
Comparison of outcomes in studies of advanced Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Research Design; Treatment Outcome; Vinblastine | 2006 |
Craniofacial fibrous dysplasia and hypophysial microadenoma with Hodgkin's lymphoma: unusual involution of an extensive case.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease Progression; Doxorubicin; Female; Fibrous Dysplasia of Bone; Hodgkin Disease; Humans; Mandibular Diseases; Pituitary Neoplasms; Prolactinoma; Vinblastine | 2006 |
[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukopenia; Lymphatic Irradiation; Lymphatic Metastasis; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Recurrence; Retrospective Studies; Survival Rate; Vinblastine; Vincristine | 2006 |
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ki-1 Antigen; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Treatment Failure; Vinblastine | 2006 |
Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Incidence; Lung; Male; Mediastinum; Middle Aged; Prednisone; Procarbazine; Radiation Pneumonitis; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Vinblastine; Vincristine | 2006 |
[Male patient with Hodgkin's disease with exanthema of the gall bladder with symmetric distribution in hands after chemotherapy treatment].
Topics: Adult; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Eruptions; Exanthema; Gallbladder Diseases; Hand Dermatoses; Hodgkin Disease; Humans; Male; Vinblastine | 2006 |
Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cost-Benefit Analysis; Dacarbazine; Decision Support Techniques; Doxorubicin; Hodgkin Disease; Humans; Life Expectancy; Markov Chains; Neoplasm Staging; Population Surveillance; Predictive Value of Tests; Quality-Adjusted Life Years; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Vinblastine | 2006 |
[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Feasibility Studies; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Proportional Hazards Models; Remission Induction; Retrospective Studies; Vinblastine; Vincristine; Young Adult | 2006 |
High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, B-Cell; Male; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Vinblastine | 2006 |
[Limphomatous meningitis as recurrence site in Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Hodgkin Disease; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Paraneoplastic Syndromes; Prednisone; Procarbazine; Recurrence; Vinblastine; Vincristine | 2006 |
Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Diseases; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Male; Middle Aged; Neutropenia; Pain; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Treatment Outcome; Vinblastine | 2006 |
Unusual manifestation of Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Examination; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Middle Aged; Tomography, X-Ray Computed; Vinblastine | 2006 |
Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Dacarbazine; Doxorubicin; Female; Fertility; Hodgkin Disease; Humans; Pregnancy; Pregnancy Rate; Surveys and Questionnaires; Survivors; Vinblastine | 2007 |
Anti-CD20 monoclonal antibody (rituximab) for therapy of CD20-positive nodular lymphocyte-predominant Hodgkin lymphoma in an 10-year-old girl.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunologic Factors; Remission Induction; Rituximab; Tomography, X-Ray Computed; Vinblastine | 2006 |
ABVD for Hodgkin's lymphoma: full-dose chemotherapy without dose reductions or growth factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Granulocytes; Hodgkin Disease; Humans; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vinblastine | 2007 |
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Prospective Studies; Recurrence; Risk; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Tumor Burden; Vinblastine; Vincristine | 2006 |
Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fertility; Follow-Up Studies; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Pregnancy; Radiotherapy, Adjuvant; Survival Analysis; Vinblastine | 2006 |
Nodular sclerosing Hodgkin disease presenting as a sternal mass.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymph Nodes; Male; Sternum; Tomography, X-Ray Computed; Vinblastine | 2006 |
Recurrent hypoglycemia and hypothermia in a patient with Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Bleomycin; C-Peptide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Hypoglycemia; Hypothermia; Insulin; Middle Aged; Receptor, Insulin; Remission Induction; Vinblastine | 2006 |
The contribution of Gianni Bonadonna to the history of chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cisplatin; Dacarbazine; Doxorubicin; Female; Fluorouracil; History, 20th Century; Hodgkin Disease; Humans; Italy; Methotrexate; Neoplasms; Vinblastine | 2007 |
Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; CD4-Positive T-Lymphocytes; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Proportional Hazards Models; Treatment Outcome; Vinblastine | 2007 |
Malignant fibrous histiocytoma following radiation therapy and chemotherapy for Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Histiocytoma, Malignant Fibrous; Hodgkin Disease; Humans; Male; Mechlorethamine; Muscle Neoplasms; Neoplasms, Radiation-Induced; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Vinblastine; Vincristine | 2007 |
[Our experiences in treating patients with Hodgkin disease in the last decade].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Hungary; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Growth Processes; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Immunophenotyping; Kaplan-Meier Estimate; Ki-67 Antigen; Lewis X Antigen; Male; Neoplasm Staging; Prednisone; Procarbazine; Retrospective Studies; Tumor Suppressor Protein p53; Vinblastine; Vincristine | 2008 |
G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Protocols; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Leukocyte Count; Lung; Male; Middle Aged; Neutrophils; Positron-Emission Tomography; Recombinant Proteins; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2007 |
Presentation of Hodgkin's lymphoma with Ophelia syndrome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Syndrome; Tomography, Emission-Computed, Single-Photon; Vinblastine | 2007 |
[Hodgkin lymphoma in Chile: experience of the national adult cancer program].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Chile; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Mitoxantrone; National Health Programs; Prednisolone; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Survival Analysis; Treatment Outcome; Vinblastine | 2007 |
Hodgkin lymphoma among patients infected with HIV in post-HAART era.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Brazil; Comorbidity; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Primary gastric Hodgkin's lymphoma expressing a B-Cell profile including Oct-2 and Bob-1 proteins.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biomarkers; Bleomycin; Dacarbazine; Doxorubicin; Female; Gastrectomy; Hodgkin Disease; Humans; Immunohistochemistry; Octamer Transcription Factor-2; Remission Induction; Stomach Neoplasms; Trans-Activators; Vinblastine | 2007 |
[Vascular endothelial growth factor and interleukin 6 production by Hodgkin lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Hodgkin Disease; Humans; Interleukin-6; Lymph Nodes; Magnetic Resonance Imaging; Male; Remission Induction; Vascular Endothelial Growth Factor A; Vinblastine | 2007 |
[Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lymph Nodes; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Remission Induction; Rituximab; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Child; Dacarbazine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Ovary; Predictive Value of Tests; Prednisone; Pregnancy; Primary Ovarian Insufficiency; Procarbazine; Remission Induction; Vinblastine; Vincristine | 2007 |
Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Child; Dacarbazine; Doxorubicin; Epirubicin; Fertility; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Inhibins; Male; Mechlorethamine; Prednisone; Procarbazine; Spermatogenesis; Time Factors; Vinblastine; Vincristine | 2007 |
[Description of a peculiar form of Hodgkin's disease associated with Epstein-Barr virus infection].
Topics: Acyclovir; Adolescent; Anemia, Hemolytic, Autoimmune; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Autoantibodies; Bleomycin; Dacarbazine; Doxorubicin; Epstein-Barr Virus Infections; Hodgkin Disease; Humans; Immunoglobulin G; Male; Tumor Virus Infections; Vinblastine | 2007 |
Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Marrow Cells; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymph Nodes; Lymphocytes; Lymphocytosis; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasms, Second Primary; Splenectomy; Splenic Neoplasms; Splenomegaly; Vinblastine | 2007 |
FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung; Middle Aged; Pneumonia; Positron-Emission Tomography; Vinblastine | 2007 |
Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hematologic Neoplasms; Hodgkin Disease; Humans; Lung Neoplasms; Male; Multicenter Studies as Topic; Neoplasm Staging; Prospective Studies; Radiation Dosage; Radiotherapy; Randomized Controlled Trials as Topic; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome; Vinblastine | 2008 |
Thymic 18F-fluorodeoxyglucose uptake on positron emission tomography scanning after doxorubicin, bleomycin, vincristin and dacarbazine chemotherapy and highly-active antiretroviral therapy in HIV-associated Hodgkin's disease in an adult.
Topics: Adult; Anti-HIV Agents; Antibiotics, Antineoplastic; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Disease Progression; Doxorubicin; Fluorodeoxyglucose F18; HIV Infections; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Thymus Gland; Treatment Outcome; Vincristine | 2008 |
[Tracheal involvement revealing Hodgkin's disease. A case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bronchoscopy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Staging; Radiography, Thoracic; Radiotherapy Dosage; Remission Induction; Respiratory Sounds; Time Factors; Tomography, X-Ray Computed; Trachea; Tracheal Neoplasms; Vinblastine | 2007 |
Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Follow-Up Studies; Forecasting; Hodgkin Disease; Humans; Lymph Nodes; Neoplasm Staging; Prospective Studies; Quality Assurance, Health Care; Radiotherapy; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Survival Analysis; Time Factors; Treatment Failure; Treatment Outcome; Vinblastine | 2007 |
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diagnosis, Differential; Doxorubicin; False Positive Reactions; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Sarcoidosis; Vinblastine | 2008 |
Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells.
Topics: Adult; Alkalosis, Respiratory; Amnesia, Retrograde; Amnesia, Transient Global; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Confusion; Cryoprotective Agents; Cytarabine; Dacarbazine; Dexamethasone; Dimethyl Sulfoxide; Doxorubicin; Etoposide; Hippocampus; Hodgkin Disease; Humans; Hyperventilation; Ifosfamide; Magnetic Resonance Imaging; Male; Melphalan; Paresthesia; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Vinblastine; Vision Disorders | 2008 |
Primary biliary cirrhosis following chemotherapy for Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cholagogues and Choleretics; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid; Vinblastine | 2008 |
Hodgkin lymphoma as a complication of primary Sjögren's syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymph Nodes; Middle Aged; Parotid Gland; Reed-Sternberg Cells; Sjogren's Syndrome; Vinblastine | 2008 |
Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Dacarbazine; Doxorubicin; Graft vs Tumor Effect; Hodgkin Disease; Humans; Immunosuppressive Agents; Male; Neoplasm Staging; Positron-Emission Tomography; Skin; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2008 |
Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Deoxycytidine; Doxorubicin; Gemcitabine; Hodgkin Disease; Immunoconjugates; Ki-1 Antigen; Mice; Mice, SCID; Neoplasm Transplantation; Oligopeptides; Tubulin Modulators; Vinblastine | 2008 |
Gonadal damage in Hodgkin's disease from cancer chemotherapeutic regimens.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Castration; Dacarbazine; Doxorubicin; Female; Gonads; Hodgkin Disease; Humans; Infertility, Male; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Spermatogenesis; Vinblastine; Vincristine | 1984 |
[Treatment of Hodgkin's disease with ABVD].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Hodgkin Disease; Humans; Male; Middle Aged; Vinblastine; Vincristine | 1984 |
Influence of chemotherapy on the phagocytic activity of mononuclear cells in patients with Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Monocytes; Phagocytosis; Vinblastine; Vincristine | 1984 |
[Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Dacarbazine; Daunorubicin; Doxorubicin; Hodgkin Disease; Humans; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy; Thioguanine; Vinblastine; Vincristine | 1984 |
[A reserve chemotherapy for Hodgkin's disease (author's transl)].
Topics: Adolescent; Adult; Antineoplastic Agents; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Middle Aged; Vinblastine | 1980 |
Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukopenia; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Thrombocytopenia; Vincristine | 1980 |
[Stage IIIB and IVB Hodgkin's disease. Response to chemotherapy, relapses, survival rates (author's transl)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine | 1981 |
The treatment of advanced hodgkin's disease.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radiotherapy Dosage; Vinblastine; Vincristine | 1981 |
Treatment of lymphocyte depletion Hodgkin's disease in children.
Topics: Adolescent; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphopenia; Male; Neoplasm Staging; Vincristine | 1981 |
Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine | 1982 |
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Vinblastine | 1982 |
[Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine | 1982 |
Alternating drug combinations for advanced Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1982 |
[B-DOPA chemotherapy associated with local radiotherapy in children with malignant lymphoma].
Topics: Antineoplastic Agents; Bleomycin; Child; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Prednisone; Vincristine | 1982 |
Twelve years of experience with cytotoxic therapy in malignant tumors of the neck and head.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Head and Neck Neoplasms; Hodgkin Disease; Humans; Infusions, Intra-Arterial; Leucovorin; Mechlorethamine; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine | 1982 |
Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine | 1982 |
Acute promyelocytic leukemia following ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and radiotherapy for Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Middle Aged; Vinblastine; Vincristine | 1983 |
[Chemotherapy in pretreated Hodgkin's disease with lomustine, bleomycin, vinblastine and dexamethasone].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Prednisone; Procarbazine; Vinblastine; Vincristine | 1983 |
Treatment of 49 unrandomized patients with advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1983 |
MOPP treatment of resistant Hodgkin's disease following ABVD failure.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Drug Resistance; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine | 1983 |
Bone and soft tissue sarcomas in the follow-up of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy; Sarcoma; Soft Tissue Neoplasms; Vinblastine; Vincristine | 1983 |
Bleomycin-induced hypocalcemia?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Hypocalcemia; Male; Middle Aged; Vinblastine; Vincristine | 1984 |
Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Prednisone; Procarbazine; Vincristine | 1983 |
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Resistance; Female; Heart Diseases; Hodgkin Disease; Humans; Lomustine; Lung Diseases; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Vinblastine; Vincristine | 1984 |
Lymphocytosis of large granular lymphocytes in patients with Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD3 Complex; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Killer Cells, Natural; Lymphocytes; Lymphocytosis; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; T-Lymphocytes; Vinblastine; Vincristine | 1995 |
Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Lomustine; Male; Middle Aged; Prednisone; Recurrence; Salvage Therapy; Survival Analysis | 1994 |
Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Life Tables; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Multivariate Analysis; Myocardial Infarction; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Proportional Hazards Models; Prospective Studies; Radiotherapy; Regression Analysis; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1994 |
Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Sedimentation; Bone Marrow; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Proportional Hazards Models; Prospective Studies; Remission Induction; Treatment Outcome; Vinblastine; Vincristine | 1994 |
Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Life Tables; Lomustine; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Remission Induction; Treatment Outcome; Vinblastine; Vincristine | 1994 |
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Pancytopenia; Prednisone; Procarbazine; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Vinblastine; Vincristine | 1994 |
[A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Germany, West; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy Dosage; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1994 |
Membranous nephropathy in Hodgkin's disease in complete remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Glomerulonephritis, Membranous; Hodgkin Disease; Humans; Male; Remission Induction; Vinblastine; Vincristine | 1994 |
Paraneoplastic cerebellar degeneration: a rare presentation of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cerebellar Diseases; Cognition Disorders; Dacarbazine; Diagnosis, Differential; Doxorubicin; Dysarthria; Female; Hodgkin Disease; Humans; Labyrinthitis; Meningitis; Nerve Degeneration; Nystagmus, Pathologic; Paraneoplastic Syndromes; Quality of Life; Remission Induction; Vinblastine; Vincristine | 1994 |
Autologous stem cell transplantation as adjuvant treatment vs no further therapy for poor-risk Hodgkin's disease in first complete remission after MOPP/ABVD.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Retrospective Studies; Survival Rate; Transplantation, Autologous; Vinblastine; Vincristine | 1995 |
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphatic Irradiation; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Patient Compliance; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1995 |
Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bleomycin; Dacarbazine; Doxorubicin; Epirubicin; Female; Herpesviridae Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Mechlorethamine; Middle Aged; Molecular Sequence Data; Pneumonia, Pneumocystis; Prednisone; Procarbazine; Survival Analysis; Tumor Virus Infections; Vinblastine; Vincristine | 1995 |
[Hodgkin disease and amyloidosis].
Topics: Adult; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1994 |
[Primary Hodgkin disease of the lung].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Protein Electrophoresis; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lung Neoplasms; Radiography; Vinblastine; Vincristine | 1993 |
MOPP, ABVD, or both to treat Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1993 |
MOPP, ABVD, or both to treat Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1993 |
Hodgkin's disease associated with central pontine myelinolysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Demyelinating Diseases; Doxorubicin; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Mechlorethamine; Pons; Prednisone; Procarbazine; Remission Induction; Tomography, X-Ray Computed; Vinblastine; Vincristine | 1993 |
Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mediastinal Neoplasms; Melphalan; Middle Aged; Prednisone; Procarbazine; Radiotherapy; Radiotherapy Dosage; Survival Rate; Vinblastine; Vincristine | 1993 |
Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Vinblastine; Vincristine | 1993 |
Pediatric stage IV Hodgkin disease. Long-term survival.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Lung Neoplasms; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Vinblastine; Vincristine | 1993 |
Thymic hyperplasia in adults following chemotherapy for malignancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Thymus Hyperplasia; Tomography, X-Ray Computed; Vinblastine; Vincristine | 1993 |
[Effectiveness of chemotherapy and radiotherapy in 60 cases of Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cobalt Radioisotopes; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radioisotope Teletherapy; Radiotherapy, High-Energy; Survival Rate; Vinblastine; Vincristine | 1993 |
[Cardiomyopathy in the course of treating Hodgkin's disease in a 12-year old girl].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; Heart Failure; Hodgkin Disease; Humans; Prednisone; Vincristine | 1993 |
Pulmonary toxicity of ABVD chemotherapy and G-CSF in Hodgkin's disease: possible synergy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Lung; Male; Vinblastine; Vincristine | 1993 |
Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Time Factors; Vinblastine; Vincristine | 1993 |
Accumulation of O6-methylguanine in human DNA after therapeutic exposure to methylating agents and its relationship with biological effects.
Topics: Animals; Dacarbazine; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Guanine; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Procarbazine; Rats; Species Specificity | 1993 |
Synchronous presentation of Epstein-Barr virus-associated Hodgkin's disease and adult T-cell leukemia/lymphoma (ATLL) in a patient from an endemic area of ATLL.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Fatal Outcome; Herpesviridae Infections; Herpesvirus 4, Human; Hodgkin Disease; Human T-lymphotropic virus 1; Humans; Immunophenotyping; Japan; Leukemia-Lymphoma, Adult T-Cell; Lymph Nodes; Male; Middle Aged; Neoplastic Stem Cells; Prednisone; Procarbazine; Reed-Sternberg Cells; RNA, Viral; Tumor Virus Infections; Vinblastine; Vincristine; Viral Matrix Proteins; Virus Activation | 1995 |
Hodgkin disease in children: reduced tailored chemotherapy for stage I-II disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Remission Induction; Vinblastine; Vincristine | 1996 |
Intermittent G-CSF to maintain dose intensity of chemotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Granulocyte Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Hodgkin Disease; Humans; Neutropenia; Vinblastine; Vincristine | 1995 |
Treatment of childhood Hodgkin's disease with ABVD without radiotherapy.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cohort Studies; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Radiotherapy, Adjuvant; Remission Induction; Survival Rate; Vinblastine | 1996 |
Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Male; Vinblastine; Vincristine | 1996 |
Comparative study of the formation and repair of O6-methylguanine in humans and rodents treated with dacarbazine.
Topics: Animals; Dacarbazine; DNA Damage; DNA Repair; Female; Guanine; Hodgkin Disease; Humans; Male; Methyltransferases; Mice; Mice, Inbred BALB C; O(6)-Methylguanine-DNA Methyltransferase; Rabbits; Rats; Rats, Sprague-Dawley; Species Specificity | 1996 |
Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine | 1996 |
Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Methylprednisolone; Middle Aged; Radiotherapy Dosage; Remission Induction; Survival Rate; Vinblastine | 1996 |
Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Gene Rearrangement, T-Lymphocyte; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Recurrence; Time Factors; Vinblastine; Vincristine | 1995 |
[Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cryopreservation; Cyclophosphamide; Dacarbazine; Doxorubicin; Fertilization in Vitro; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Oligospermia; Prednisone; Procarbazine; Retrospective Studies; Semen Preservation; Sperm Count; Vinblastine; Vincristine | 1996 |
Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cholestasis; Dacarbazine; Diagnosis, Differential; Doxorubicin; Female; Fever; Hodgkin Disease; Humans; Incidence; Liver; Liver Function Tests; Male; Mechlorethamine; Prednisone; Procarbazine; Remission Induction; Survival Analysis; Vinblastine; Vincristine | 1996 |
Serial pulmonary function studies in children treated for newly diagnosed Hodgkin's disease with mantle radiotherapy plus cycles of cyclophosphamide, vincristine, and procarbazine alternating with cycles of doxorubicin, bleomycin, vinblastine, and dacarba
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lung; Male; Vinblastine | 1995 |
Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Diaphragm; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Vinblastine; Vincristine | 1996 |
Hodgkin's disease of middle ear and mastoid.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Ear Neoplasms; Female; Hodgkin Disease; Humans; Lymph Nodes; Mastoid; Neck; Prednisone; Procarbazine; Skull Neoplasms; Tomography, X-Ray Computed; Vinblastine; Vincristine | 1996 |
Prognostic factors in early-stage Hodgkin's disease.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Methylprednisolone; Multivariate Analysis; Prognosis; Prospective Studies; Vinblastine | 1997 |
[Hodgkin's disease in the very young child. Apropos of 11 cases].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Developing Countries; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Remission Induction; Sex Distribution; Socioeconomic Factors; Vinblastine; Vincristine | 1996 |
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Chromosome Deletion; Chromosomes, Human, Pair 20; Clone Cells; Combined Modality Therapy; Cytarabine; Dacarbazine; Doxorubicin; Female; Hematopoietic Cell Growth Factors; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm, Residual; Neoplasms, Second Primary; Neoplastic Stem Cells; Prednisone; Procarbazine; Radiotherapy; Recurrence; Transplantation, Autologous; Vinblastine; Vincristine | 1997 |
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Predictive Value of Tests; Prednisone; Procarbazine; Prognosis; Salvage Therapy; Survival Analysis; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine | 1997 |
[Preliminary results of conservative combination radiotherapy and chemotherapy in early stages of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Epirubicin; Female; Hodgkin Disease; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Radiation Dosage; Remission Induction; Vinblastine | 1996 |
Five-year follow-up of saliva in patients treated for lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoglobulin A, Secretory; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Muramidase; Prednisone; Procarbazine; Saliva; Salivary Proteins and Peptides; Secretory Rate; Statistics, Nonparametric; Vinblastine; Vincristine | 1997 |
Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1997 |
Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Cross-Sectional Studies; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lung; Lung Diseases; Male; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy; Respiratory Function Tests; Vinblastine; Vincristine | 1997 |
[Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Prednisolone; Prednisone; Procarbazine; Prognosis; Risk Factors; Thioguanine; Vinblastine; Vincristine | 1996 |
Granuloma annulare associated with Hodgkin's disease.
Topics: Adipose Tissue; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Collagen; Dacarbazine; Doxorubicin; Giant Cells; Granuloma Annulare; Histiocytes; Hodgkin Disease; Humans; Lymphocytes; Male; Neoplasm Staging; Reed-Sternberg Cells; Skin; Vinblastine | 1997 |
Gonadal function following ABVD therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Fathers; Follicle Stimulating Hormone; Follow-Up Studies; Hodgkin Disease; Humans; Luteinizing Hormone; Male; Mechlorethamine; Oligospermia; Prednisone; Procarbazine; Remission Induction; Semen; Sexual Behavior; Sexual Maturation; Testis; Testosterone; Vinblastine; Vincristine | 1997 |
G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematinics; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nervous System; Neutropenia; Prednisone; Procarbazine; Recombinant Proteins; Remission Induction; Retrospective Studies; Survival Rate; Thrombocytopenia; Treatment Outcome; Vinblastine; Vincristine | 1997 |
Salvage radiotherapy for Hodgkin's disease following chemotherapy failure.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy; Remission Induction; Salvage Therapy; Treatment Failure; Vinblastine; Vincristine | 1997 |
Gluteal manifestation of advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Buttocks; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Middle Aged; Radionuclide Imaging; Sclerosis; Tomography, X-Ray Computed; Vinblastine | 1997 |
Should MOPP-ABVD alone be standard for childhood Hodgkin's?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1998 |
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Combined Modality Therapy; Confidence Intervals; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymph Nodes; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Receptors, Interleukin-2; Recurrence; Reference Values; Retrospective Studies; Vinblastine; Vincristine | 1998 |
[Is the ABVD an optimal regimen for Hodgkins disease?].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Retrospective Studies; Vinblastine | 1998 |
Hodgkin's disease in children in southern Africa: epidemiological characteristics, morbidity and long-term outcome.
Topics: Adolescent; Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Chlorambucil; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Morbidity; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Retrospective Studies; South Africa; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 1997 |
Nodular sclerosing Hodgkin disease with primary manifestation in the orbit.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bleomycin; Child; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Immunohistochemistry; Lymph Nodes; Male; Orbital Neoplasms; Radiotherapy, Adjuvant; Reed-Sternberg Cells; Tomography, X-Ray Computed; Vinblastine | 1998 |
Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.
Topics: Adolescent; Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Ligands; Lymphotoxin-alpha; Male; Mechlorethamine; Middle Aged; Predictive Value of Tests; Prednisone; Procarbazine; Prognosis; Prospective Studies; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Treatment Outcome; Tumor Necrosis Factor-alpha; Vinblastine; Vincristine | 1998 |
Second cancer among long-term survivors from Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Survivors; Time Factors; Vinblastine; Vincristine | 1998 |
Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease Susceptibility; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Italy; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Mechlorethamine; Neoplasms, Second Primary; Prednisone; Procarbazine; Risk; Splenectomy; Vinblastine; Vincristine; Whole-Body Irradiation | 1998 |
Henoch-Schönlein purpura associated with segmental and focal proliferative glomerulonephritis in a patient with Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Glomerulonephritis; Hodgkin Disease; Humans; IgA Vasculitis; Kidney; Male; Nephrotic Syndrome; Vinblastine | 1999 |
Advanced stage and unfavorable Hodgkin's disease in the Chinese-a 20-year experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Hong Kong; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Retrospective Studies; Survival Analysis; Time Factors; Vinblastine; Vincristine | 1999 |
Gemcitabine is active in relapsed Hodgkin's disease.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Deoxycytidine; Doxorubicin; Gemcitabine; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Tomography, X-Ray Computed; Vinblastine; Vincristine | 1999 |
Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 mono- clonal antibody) and interleukin-2.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Idarubicin; Ifosfamide; Immunization, Passive; Interleukin-2; Male; Melphalan; Middle Aged; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Vinblastine; Vincristine | 1999 |
Association between alopecia and response to aggressive chemotherapy in patients with Hodgkin's disease.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neutropenia; Prednisone; Procarbazine; Vinblastine; Vincristine | 1999 |
[Chronic lymphatic leukemia and Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Neoplasms, Second Primary; Prednisone; Remission Induction; Vidarabine; Vinblastine | 1999 |
Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Medical Records; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 1999 |
Composite prolymphocytoid and hodgkin transformation of chronic lymphocytic leukemia.
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Dacarbazine; Doxorubicin; Fatal Outcome; Hodgkin Disease; Humans; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Reed-Sternberg Cells; Vinblastine | 2000 |
Cutaneous flagellate pigmentation by bleomycin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Hyperpigmentation; Pruritus; Vinblastine | 2000 |
Pregnancy after treatment of secondary acute promyelocytic leukemia following Hodgkin's disease: a case report.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia, Promyelocytic, Acute; Neoplasms, Second Primary; Pregnancy; Pregnancy Outcome; Treatment Outcome; Tretinoin; Vinblastine | 2000 |
Follow-up of sperm concentration and motility in patients with lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cryopreservation; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Infertility, Male; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Semen Preservation; Sperm Count; Sperm Motility; Vinblastine; Vincristine | 2000 |
[Diagnostic problems due to alternative medicine].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Dacarbazine; Diagnosis, Differential; Doxorubicin; Female; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Radiography; Skin; Tamoxifen; Vinblastine; Vincristine | 2000 |
Efficacy of standard treatment in patients with Hodgkin's disease--a single center experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2000 |
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cytarabine; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Middle Aged; Podophyllotoxin; Prednisone; Procarbazine; Recurrence; Retrospective Studies; Survival Rate; Time Factors; Vinblastine; Vincristine | 2000 |
Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy Dosage; Retrospective Studies; Treatment Failure; Vinblastine; Vincristine | 2000 |
Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Guillain-Barre Syndrome; Hodgkin Disease; Humans; Mechlorethamine; Middle Aged; Muscle Hypotonia; Paraneoplastic Syndromes; Peripheral Nervous System Diseases; Polyneuropathies; Prednisone; Pregnancy; Procarbazine; Puerperal Disorders; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Reflex, Abnormal; Sensation Disorders; Vinblastine; Vincristine | 2001 |
Gingival overgrowth as the initial paraneoplastic manifestation of Hodgkin's lymphoma in a child. A case report.
Topics: Alveolar Bone Loss; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Dacarbazine; Doxorubicin; Gingival Hyperplasia; Gingival Overgrowth; Hodgkin Disease; Humans; Lymph Nodes; Male; Mechlorethamine; Neoplasm Staging; Paraneoplastic Syndromes; Prednisone; Procarbazine; Remission Induction; Root Resorption; Tooth, Deciduous; Vinblastine; Vincristine | 2001 |
Primary Epstein-Barr virus-associated Hodgkin disease of the ileum complicating Crohn disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Crohn Disease; Dacarbazine; Doxorubicin; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Ileal Neoplasms; Ileitis; Immunohistochemistry; In Situ Hybridization; Male; RNA, Viral; Treatment Outcome; Urinary Bladder Fistula; Vinblastine | 2001 |
[The chemotherapeutic treatment of advanced Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Multivariate Analysis; Prednisone; Procarbazine; Retrospective Studies; Survival Rate; Vinblastine; Vincristine | 2001 |
Risk-adapted therapy for clinical stage I-II Hodgkin's disease: 7-years results of radiotherapy alone for low-risk disease, and ABVD and radiotherapy for high-risk disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Salvage Therapy; Treatment Outcome; Vinblastine | 2000 |
[Gastric adenocarcinoma secondary to Hodgkin's disease treatment].
Topics: Adenocarcinoma; Adult; Aftercare; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Deglutition Disorders; Doxorubicin; Fatal Outcome; Hodgkin Disease; Humans; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Stomach Neoplasms; Tomography, X-Ray Computed; Vinblastine; Weight Loss | 2001 |
Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after Rituximab monotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Resistance, Neoplasm; Female; Hodgkin Disease; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Remission Induction; Rituximab; Vinblastine; Vincristine | 2001 |
ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Practice Guidelines as Topic; Prednisone; Procarbazine; Radiotherapy; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine | 2001 |
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease-Free Survival; Doxorubicin; Etoposide; False Negative Reactions; False Positive Reactions; Fibrosis; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Life Tables; Mediastinal Neoplasms; Melphalan; Neoplasm Recurrence, Local; Predictive Value of Tests; Prednisone; Procarbazine; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Tomography, Emission-Computed; Transplantation, Autologous; Vinblastine; Vincristine | 2001 |
The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Blood Proteins; Child; Dacarbazine; Disease-Free Survival; Doxorubicin; Eosinophil Granule Proteins; Eosinophils; Female; Hodgkin Disease; Humans; Immunohistochemistry; Mechlorethamine; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prednisone; Procarbazine; Prognosis; Ribonucleases; Time Factors; Vinblastine; Vincristine | 2001 |
37th Annual American Society of Clinical Oncology Meeting. San Francisco, CA. May 12-15, 2001.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Adhesion Molecules; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immunosuppressive Agents; Immunotoxins; Lectins; Leukemia, Hairy Cell; Lymphoma, Non-Hodgkin; Multiple Myeloma; Rituximab; Sialic Acid Binding Ig-like Lectin 2; Thalidomide; Vinblastine | 2001 |
Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomycin; Body Height; Body Weight; Child; Child Development; Child, Preschool; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Intelligence; Leukemia; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Procarbazine; Vinblastine; Vincristine | 2001 |
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases, Fungal; Male; Melphalan; Neoplasm Recurrence, Local; Opportunistic Infections; Pneumonia, Bacterial; Pneumonia, Pneumocystis; Prednisone; Procarbazine; Salvage Therapy; Skin; Transplantation, Homologous; Vinblastine; Vincristine | 2001 |
Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cholestasis, Intrahepatic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Syndrome; Transplantation, Autologous; Vinblastine | 2002 |
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Prednisone; Reed-Sternberg Cells; Survival Rate; Vinblastine | 2002 |
Renal Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Marrow Cells; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Kidney; Kidney Diseases; Tomography, X-Ray Computed; Uterus; Vinblastine | 2002 |
[A case of Hodgkin's disease of mesenteric origin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Mesentery; Middle Aged; Peritoneal Neoplasms; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine | 2002 |
Unusual presentation of Hodgkin's lymphoma.
Topics: Abdominal Pain; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cholangiopancreatography, Endoscopic Retrograde; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Pancreatic Neoplasms; Prognosis; Vinblastine | 2002 |
Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk; Vinblastine; Vincristine | 2002 |
[Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine | 1976 |
New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease.
Topics: Adult; Aged; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Triazenes; Vinblastine; Vincristine | 1976 |
[Simultaneous combination of adriamycin, bleomycin, cyclohexyl-chloroethyl nitrosourea with dimethyl-triazeno imidazole carboxamide in the treatment of Hodgkin's lymphoma].
Topics: Adult; Bleomycin; Bone Marrow; Bone Marrow Cells; Dacarbazine; Dermatitis, Exfoliative; Doxorubicin; Drug Therapy, Combination; Female; Fever; Hodgkin Disease; Humans; Male; Nausea; Nitrosourea Compounds; Remission, Spontaneous; Stomatitis; Triazenes; Vomiting | 1976 |
Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations.
Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Triazenes; Vinblastine; Vincristine | 1977 |
Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV).
Topics: Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Triazenes; Vinblastine; Vincristine | 1977 |
[Effect of combined chemotherapy on the prognosis of Hodgkin's disease: retrospective study of 74 cases from 1959-1973].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Streptonigrin; Vincristine | 1977 |
Hodgkin's disease: combination chemotherapy in resistant Hodgkin's disease.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone | 1977 |
[Cytostatic chemotherapy of lymphogranulomatosis].
Topics: Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Procarbazine; Remission, Spontaneous; Vinblastine; Vincristine | 1978 |
Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Triazenes; Vinblastine; Vincristine | 1978 |
Hodgkin's disease. Treatment of resistant patients.
Topics: Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Vinblastine | 1979 |
Acute hepatic vein thrombosis occurring during therapy for Hodgkin's disease: a case report.
Topics: Antineoplastic Agents; Budd-Chiari Syndrome; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Male; Middle Aged; Vinblastine | 1979 |
[DTIC--one component of ABVD combination therapy in Hodgkin's disease (author's transl)].
Topics: Adult; Aged; Antineoplastic Agents; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Remission, Spontaneous; Time Factors; Triazenes | 1978 |
[Dimethyl-triazeno-imidazol-carboxamide (DTIC)--a new cytostatic agent].
Topics: Dacarbazine; Hodgkin Disease; Humans; Melanoma; Sarcoma; Triazenes | 1975 |
Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Density; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Hormones; Humans; Male; Middle Aged; Ovary; Prednisone; Procarbazine; Radiotherapy Dosage; Semen; Testis; Vinblastine; Vincristine | 1992 |
The Second International Symposium on Hodgkin's Disease. Workshop III: Recommendations for future clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Remission Induction; Vinblastine; Vincristine | 1992 |
[Cancer of the testis after Hodgkin's disease. Apropos of 2 cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Dysgerminoma; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasms, Radiation-Induced; Orchiectomy; Prednisone; Procarbazine; Teratoma; Testicular Neoplasms; Vinblastine; Vincristine | 1992 |
Salivary flow and composition in lymphoma patients before, during and after treatment with cytostatic drugs.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoglobulin A, Secretory; Immunoglobulin G; Immunoglobulin M; Leucovorin; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Saliva; Salivary Proteins and Peptides; Salivation; Secretory Rate; Sex Factors; Vinblastine; Vincristine | 1992 |
Mediastinal masses in children with Hodgkin's disease. An analysis of the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania experience.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Prednisone; Procarbazine; Sex Factors; Survival Rate; Vinblastine; Vincristine | 1992 |
[Hodgkin's disease and infection with human immunodeficiency virus].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; HIV Infections; Hodgkin Disease; Humans; Incidence; Male; Prednisone; Procarbazine; Vinblastine; Vincristine | 1992 |
Avascular necrosis of the femoral head after treatment of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Femur Head Necrosis; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy; Vinblastine; Vincristine | 1992 |
Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Diaphragm; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymphatic Diseases; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine | 1992 |
[Secondary acute leukemia in Hodgkin's disease].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vinblastine; Vincristine | 1992 |
Induction of chromosome breaks and sister chromatid exchanges in patients with Hodgkin's disease by two combination chemotherapy regimens of different leukemogenic potential.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Chromosomes; Dacarbazine; DNA Damage; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Nitroso Compounds; Prednisone; Procarbazine; Sister Chromatid Exchange; Vinblastine; Vincristine | 1990 |
Treatment of Hodgkin's disease with MOPP chemotherapy: effect of dose and schedule modification on treatment outcome.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance; Hodgkin Disease; Humans; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine | 1990 |
Secondary uncommon solid neoplasms in cured Hodgkin's disease and follow-up of the original B-DOPA chemotherapy patient group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Dacarbazine; Doxorubicin; Esophageal Neoplasms; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lung Neoplasms; Male; Mechlorethamine; Middle Aged; Neoplasms, Multiple Primary; Palatal Neoplasms; Prednisone; Procarbazine; Rectal Neoplasms; Retrospective Studies; Vincristine | 1990 |
Combination of ABVD and radiotherapy in early stages of Hodgkin's disease: analysis of a series of 94 patients. Pierre and Marie Curie Group (GPMC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Radiotherapy, High-Energy; Vinblastine; Vincristine | 1990 |
[High dose intensity with COP-BLAM in Hodgkin's disease with unfavorable risk factors].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Risk Factors; Vinblastine; Vincristine | 1990 |
Development of pulmonary histiocytosis X after chemotherapy for Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Lung Diseases; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1990 |
[Icteric cholestasis as an early symptom in Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cholestasis; Cyclophosphamide; Dacarbazine; Diagnosis, Differential; Doxorubicin; Hodgkin Disease; Humans; Ilium; Liver; Lymph Nodes; Lymphatic Metastasis; Male; Prednisone; Procarbazine; Pruritus; Salmonella Infections; Time Factors; Vinblastine; Vincristine | 1990 |
In vivo formation and repair of O6-methylguanine in human leukocyte DNA after intravenous exposure to dacarbazine.
Topics: Adolescent; Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; DNA; DNA Repair; Doxorubicin; Female; Guanine; Hodgkin Disease; Humans; Injections, Intravenous; Leukocytes; Lymphoma, Non-Hodgkin; Male; Methyltransferases; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Pilot Projects; Rats; Rats, Inbred Strains; Vinblastine; Vincristine | 1991 |
[Hodgkin's disease treated with chemotherapy at reduced dosage].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Life Tables; Mexico; Remission Induction; Survival Rate; Vinblastine; Vincristine | 1990 |
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednimustine; Prednisone; Procarbazine; Recurrence; Vinblastine; Vincristine | 1990 |
Hodgkin's disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only, for both localized and advanced disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Saudi Arabia; Vinblastine; Vincristine | 1991 |
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomycin; Body Height; Body Weight; Child; Child Development; Child, Preschool; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoglobulins; Intelligence; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Procarbazine; Sex Characteristics; Vinblastine; Vincristine | 1991 |
Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Opportunistic Infections; Prednisone; Procarbazine; Remission Induction; Substance Abuse, Intravenous; Survival Rate; Vinblastine; Vincristine | 1991 |
Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Echocardiography; Electrocardiography; Female; Heart Diseases; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Neoplasm Staging; Radiation Injuries; Radiography; Radiotherapy Dosage; Respiratory Function Tests; Stroke Volume; Vinblastine; Vincristine | 1991 |
Haematological toxicity compromises MOPP/ABVD chemotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine | 1991 |
In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cells, Cultured; Clone Cells; Cohort Studies; Combined Modality Therapy; Dacarbazine; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Hypoxanthine Phosphoribosyltransferase; Lymphocytes; Mechlorethamine; Middle Aged; Mutagenesis; Mutation; Prednisone; Procarbazine; Risk Factors; Smoking; Vinblastine; Vincristine | 1991 |
Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Rate; Vinblastine; Vincristine | 1991 |
[Hodgkin's disease during pregnancy. Study of late effects in the newborn infants].
Topics: Abnormalities, Drug-Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Banding; Contraindications; Dacarbazine; Doxorubicin; Female; Fetus; Growth Disorders; Hodgkin Disease; Humans; Infant, Newborn; Male; Mechlorethamine; Mental Disorders; Mexico; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Prenatal Exposure Delayed Effects; Procarbazine; Remission Induction; Retrospective Studies; Vinblastine; Vincristine | 1991 |
Chemotherapy combined with involved-field radiotherapy for 177 children with Hodgkin's disease treated in 1983-1987.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Radiotherapy Dosage; Remission Induction; Vinblastine; Vincristine | 1991 |
Case report: development of Hodgkin's disease in patient receiving long-term administration of dacarbazine and interleukin-2 for metastatic melanoma.
Topics: Combined Modality Therapy; Dacarbazine; Female; Hodgkin Disease; Humans; Interleukin-2; Melanoma; Middle Aged | 1990 |
Laparotomy and splenectomy in Hodgkin's disease: a reappraisal after twenty years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Splenectomy; Vinblastine; Vincristine | 1985 |
Intrathoracic Hodgkin's disease. A case presentation with multiple pulmonary nodules in the absence of mediastinal or hilar node disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Lymphography; Mediastinal Neoplasms; Tomography, X-Ray Computed; Vinblastine; Vincristine | 1985 |
Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Resistance; Female; Graft vs Host Disease; Herpes Zoster; Hodgkin Disease; Humans; Legionnaires' Disease; Male; Mechlorethamine; Pneumonia, Aspiration; Postoperative Complications; Prednisone; Procarbazine; Time Factors; Transplantation, Homologous; Vinblastine; Vincristine | 1985 |
CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Prednimustine; Prednisone; Procarbazine; Time Factors; Vinblastine; Vincristine | 1986 |
[Early results of the treatment of Hodgkin's disease with alternating use in the CVPP and ABVD protocol].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine | 1986 |
Neutrophilic eccrine hidradenitis associated with Hodgkin's disease and chemotherapy. A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Inflammation; Male; Neutrophils; Sweat Gland Diseases; Sweat Glands; Vinblastine | 1986 |
Fatal necrosis of the liver during ABVD chemotherapy for Hodgkin's disease. A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Budd-Chiari Syndrome; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Liver; Male; Middle Aged; Necrosis; Vinblastine; Vincristine | 1986 |
Prognosis of bulky Hodgkin's disease treated with chemotherapy alone or combined with radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine | 1985 |
[Laparotomy with splenectomy in the evaluation of the results of cytostatic treatment of patients with advanced Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Splenectomy; Vinblastine; Vincristine | 1986 |
ABVD versus MOPP: which is better?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1987 |
Prognostic value of response after three MOPP cycles in Hodgkin's disease--stage III and IV.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Time Factors; Vinblastine; Vincristine | 1987 |
Hodgkin's disease (HD): a historical perspective.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; History, 20th Century; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Vinblastine; Vincristine | 1986 |
[Cardiogenic shock during polychemotherapy in a patient with Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Middle Aged; Shock, Cardiogenic; Vinblastine; Vincristine | 1986 |
[Contribution of anthracyclines in treatment of lymphoproliferative disorders].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma; Multiple Myeloma; Prednisone; Vinblastine; Vincristine | 1987 |
Treatment of Hodgkin's disease in children with or without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphatic Metastasis; Male; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Puberty; Vinblastine; Vincristine | 1987 |
[Controversial aspects in the current treatment of Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Radiography; Vinblastine; Vincristine | 1987 |
[Esophageal localization revealing Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Esophageal Neoplasms; Hodgkin Disease; Humans; Male; Vinblastine; Vincristine | 1987 |
[The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Evaluation; Epirubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Time Factors; Vinblastine; Vincristine | 1987 |
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the Ge
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Multi-Institutional Systems; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1987 |
[Autoimmune thrombocytopenic purpura preceding Hodgkin lymphoma].
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bleomycin; Child; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Immunity, Cellular; Immunoglobulin Isotypes; Killer Cells, Natural; Male; Prednisone; Procarbazine; Purpura, Thrombocytopenic; T-Lymphocytes; Vinblastine; Vincristine | 1987 |
[Hodgkin's disease in children. Current therapeutic strategies].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1988 |
Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Leukemia; Lymphocytes; Lymphoma, Non-Hodgkin; Mechlorethamine; Methyltransferases; O(6)-Methylguanine-DNA Methyltransferase; Prednisone; Procarbazine; Reference Values; Vinblastine; Vincristine | 1988 |
Is first salvage chemotherapy the last-line chemotherapy in children with Hodgkin's disease? A tentative answer based on long observation of two patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Lymph Nodes; Male; Mechlorethamine; Prednisolone; Prednisone; Procarbazine; Vinblastine; Vincristine | 1987 |
[Improved survival rates in Hodgkin's disease].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Japan; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Remission Induction; Retrospective Studies; Vinblastine; Vincristine | 1988 |
[Hodgkin's disease and AIDS. Presentation of 5 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Heroin Dependence; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1988 |
[Fibrosing alveolitis after combined radio- and chemotherapy. A case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Pulmonary Fibrosis; Radiotherapy; Vinblastine; Vincristine | 1988 |
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Italy; Lomustine; Male; Mechlorethamine; Prednimustine; Prednisone; Procarbazine; Transplantation, Autologous; Vinblastine; Vincristine | 1988 |
[Treatment with CEP (CCNU, VP-16 and prednimustine) in Hodgkin's disease resistant to CVPP and ABVD. Results in 21 patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Drug Evaluation; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednimustine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1988 |
Toxicity of a combination of ABVD chemotherapy and mediastinal irradiation for Hodgkin's disease patients with massive initial mediastinal involvement.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Mediastinal Neoplasms; Radiotherapy; Radiotherapy Dosage; Respiratory Insufficiency; Vinblastine; Vincristine | 1988 |
Procarbazine hypersensitivity manifested as a fixed drug eruption.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Eruptions; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Skin Tests; Vinblastine; Vincristine | 1988 |
Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Heart; Hodgkin Disease; Humans; Lung; Male; Mechlorethamine; Prednisone; Procarbazine; Thyroid Gland; Vinblastine; Vincristine | 1989 |
[Treatment of Hodgkin's disease with alternately used drug combinations CVPP/ABVD].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine | 1988 |
[Femoral osteonecrosis in patients treated with radiochemotherapy of Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cobalt Radioisotopes; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Femur Head; Femur Head Necrosis; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radiography; Retrospective Studies; Time Factors; Vinblastine; Vincristine | 1989 |
[Function of the lungs in patients with Hodgkin's disease after chemotherapy and radiotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cobalt Radioisotopes; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lung; Male; Mechlorethamine; Prednisolone; Procarbazine; Vinblastine; Vincristine | 1988 |
Allogeneic marrow transplantation for refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine | 1989 |
Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Mechlorethamine; Prednisone; Procarbazine; Transplantation, Autologous; Vinblastine; Vincristine | 1989 |
[Treatment of localized forms of Hodgkin's disease with 3 courses of chemotherapy (ABVD-MP) in combination with wide focal and prophylactic lumbo-splenic radiotherapy. The POF 81/12 protocol].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Prednisone; Radiation Dosage; Vinblastine; Vincristine | 1989 |
Conventional salvage therapy for Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Dacarbazine; Doxorubicin; Forecasting; Hodgkin Disease; Mechlorethamine; Prednisone; Procarbazine; Risk Factors; Vinblastine; Vincristine | 1989 |
Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine | 1989 |
Combined modality therapy for mediastinal Hodgkin's disease. Prognostic significance of constitutional symptoms and size of disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Resistance; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine | 1985 |
Third-line salvage chemotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Middle Aged; Prednimustine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1985 |
[Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisolone; Prednisone; Procarbazine; Vinblastine; Vincristine | 1985 |
[Treatment of malignant lymphoma in childhood].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Infant; Lymphoma; Male; Prednisone; Vinblastine; Vincristine | 1985 |